| Customer Name | ####### | Customer Institutaion | ####### | Customer Email | ####### | Project ID | ####### |
|---|---|
| Salesperson | Kyle Navel | knavel@lcsciences.com |
Your reliable partner in genomics, transcriptomics and proteomics
microRNA (abbreviated miRNA) is small non-coding RNA molecules (containing about 22 nucleotides) found in plants, animals and some viruses, which functions in RNA silencing and post-transcriptional regulation of gene expression. While the majority of miRNAs are located within the cell, some miRNAs, commonly known as circulating miRNAs or extracellular miRNAs, have also been found in extracellular environment, including various biological fluids and cell culture media.
Encoded by eukaryotic nuclear DNA in plants and animals and by viral DNA in certain viruses whose genome is based on DNA, miRNAs function via base-pairing with complementary sequences within mRNA molecules. As a result, these mRNA molecules are silenced, by one or more of the following processes: (a) cleavage of the mRNA strand into two pieces, (b) destabilization of the mRNA through shortening of its poly(A) tail, and (c) less efficient translation of the mRNA into proteins by ribosomes.
Generation of miRNAs in animals and plants
miRNAs resemble the small interfering RNAs (siRNAs) of the RNA interference (RNAi) pathway, except miRNAs derive from regions of RNA transcripts that fold back on themselves to form short hairpins, whereas siRNAs derive from longer regions of double-stranded RNA. The human genome may encode over 1000 miRNAs, which are abundant in many mammalian cell types and appear to target about 60% of the genes of humans and other mammals
miRNAs are well conserved in both plants and animals, and are thought to be a vital and evolutionarily ancient component of gene regulation. While core components of the microRNA pathway are conserved between plants and animals, miRNA repertoires in the two kingdoms appear to have emerged independently with different primary modes of action.
Plant miRNAs usually have near-perfect pairing with their mRNA targets, which induces gene repression through cleavage of the target transcripts. In contrast, animal miRNAs are able to recognize their target mRNAs by using as little as 6–8 nucleotides (the seed region) at the 5' end of the miRNA, which is not enough pairing to induce cleavage of the target mRNAs. Combinatorial regulation is a feature of miRNA regulation in animals. A given miRNA may have hundreds of different mRNA targets, and a given target might be regulated by multiple miRNAs.
The first miRNA was discovered in the early 1990s. However, miRNAs were not recognized as a distinct class of biological regulators until the early 2000s. miRNA research revealed different sets of miRNAs expressed in different cell types and tissues and multiple roles for miRNAs in plant and animal development and in many other biological processes. Aberrant miRNA expression are implicated in disease states. MiRNA-based therapies are under investigation.
Estimates of the average number of unique messenger RNAs that are targets for repression by a typical miRNA vary, depending on the estimation method, but multiple approaches show that mammalian miRNAs can have many unique targets. For example, an analysis of the miRNAs highly conserved in vertebrates shows that each has, on average, roughly 400 conserved targets. Likewise, experiments show that a single miRNA species can reduce the stability of hundreds of unique messenger RNAs. Other experiments show that a single miRNA species may repress the production of hundreds of proteins, but that this repression often is relatively mild (much less than 2-fold). The first human disease associated with deregulation of miRNAs was chronic lymphocytic leukemia. Other B cell malignancies followed.
Total RNA was extracted using Trizol reagent (Invitrogen, CA, USA) following the manufacturer's procedure. The total RNA quality and quantity were analysis of Bioanalyzer 2100 (Agilent, CA, USA) with RIN number >7.0. Approximately 1 ug of total RNA were used to prepare small RNA library according to protocol of TruSeq Small RNA Sample Prep Kits(Illumina, San Diego, USA). And then we performed the single-end sequencing 50bp on an Illumina Hiseq 4000 at LC Sciences following the vendor's recommended protocol.
Workflow of library construction
Animal: Raw reads were subjected to an in-house program, ACGT101-miR (LC Sciences, Houston, Texas, USA) to remove adapter dimers, junk, low complexity, common RNA families (rRNA, tRNA, snRNA, snoRNA) and repeats. Subsequently, unique sequences with length in 18~26 nucleotide were mapped to specific species precursors in miRBase 21.0 by BLAST search to identify known miRNAs and novel 3p- and 5p- derived miRNAs. Length variation at both 3’ and 5’ ends and one mismatch inside of the sequence were allowed in the alignment. The unique sequences mapping to specific species mature miRNAs in hairpin arms were identified as known miRNAs. The unique sequences mapping to the other arm of known specific species precursor hairpin opposite to the annotated mature miRNA-containing arm were considered to be novel 5p- or 3p derived miRNA candidates. The remaining sequences were mapped to other selected species precursors (with the exclusion of specific species) in miRBase 21.0 by BLAST search, and the mapped pre-miRNAs were further BLASTed against the specific species genomes to determine their genomic locations. The above two we defined as known miRNAs. The unmapped sequences were BLASTed against the specific genomes, and the hairpin RNA structures containing sequences were predicated from the flank 80 nt sequences using RNAfold software (http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi). The criteria for secondary structure prediction were: (1) number of nucleotides in one bulge in stem (≤12) (2) number of base pairs in the stem region of the predicted hairpin (≥16) (3) cutoff of free energy (kCal/mol ≤-15) (4) length of hairpin (up and down stems + terminal loop ≥50) (5) length of hairpin loop (≤20). (6) number of nucleotides in one bulge in mature region (≤8) (7) number of biased errors in one bulge in mature region (≤4) (8) number of biased bulges in mature region (≤2) (9) number of errors in mature region (≤7) (10) number of base pairs in the mature region of the predicted hairpin (≥12) (11) percent of mature in stem (≥80).
Plant: Raw reads were subjected to an in-house program, ACGT101-miR (LC Sciences, Houston, Texas, USA) to remove adapter dimers, junk, low complexity, common RNA families (rRNA, tRNA, snRNA, snoRNA) and repeats. Subsequently, unique sequences with length in 18~25 nucleotide were mapped to specific species precursors in miRBase 21.0 by BLAST search to identify known miRNAs and novel 3p- and 5p- derived miRNAs. Length variation at both 3’ and 5’ ends and one mismatch inside of the sequence were allowed in the alignment. The unique sequences mapping to specific species mature miRNAs in hairpin arms were identified as known miRNAs. The unique sequences mapping to the other arm of known specific species precursor hairpin opposite to the annotated mature miRNA-containing arm were considered to be novel 5p- or 3p derived miRNA candidates. The remaining sequences were mapped to other selected species precursors (with the exclusion of specific species) in miRBase 21.0 by BLAST search, and the mapped pre-miRNAs were further BLASTed against the specific species genomes to determine their genomic locations. The above two we defined as known miRNAs. The unmapped sequences were BLASTed against the specific genomes, and the hairpin RNA structures containing sequences were predicated from the flank 120 nt sequences using RNAfold software (http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi). The criteria for secondary structure prediction were: (1) number of nucleotides in one bulge in stem (≤12) (2) number of base pairs in the stem region of the predicted hairpin (≥16) (3) cutoff of free energy (kCal/mol ≤-15) (4) length of hairpin (up and down stems + terminal loop ≥50) (5) length of hairpin loop (≤200). (6) number of nucleotides in one bulge in mature region (≤4) (7) number of biased errors in one bulge in mature region (≤2) (8) number of biased bulges in mature region (≤2) (9) number of errors in mature region (≤4) (10) number of base pairs in the mature region of the predicted hairpin (≥12) (11) percent of mature in stem (≥80).
Bioinformatics pipeline for miRNA
Species name: Mice
Latin name: Mus musculus
Specimens: tissue
| Sample Name | Sample Species | Biological Replicates |
| C_3MK5 | Mus_musculus | C_3MK |
| C_3MK6 | Mus_musculus | C_3MK |
| C_3MK7 | Mus_musculus | C_3MK |
| C_3MK8 | Mus_musculus | C_3MK |
| C_3MK9 | Mus_musculus | C_3MK |
| C_12MK17 | Mus_musculus | C_12MK |
| C_12MK18 | Mus_musculus | C_12MK |
| C_12MK19 | Mus_musculus | C_12MK |
| C_12MK20 | Mus_musculus | C_12MK |
| C_12MK21 | Mus_musculus | C_12MK |
| C_24MK31 | Mus_musculus | C_24MK |
| C_24MK32 | Mus_musculus | C_24MK |
| C_24MK33 | Mus_musculus | C_24MK |
| C_24MK34 | Mus_musculus | C_24MK |
| C_24MK35 | Mus_musculus | C_24MK |
| Dababase | Web links | Version/date |
|---|---|---|
| miRNA/Pre-miRNA database (miRbase) | ftp://miRbase.org/pub/miRbase/CURRENT | 21.0 |
| Rfam | http://rfam.janelia.org | 13.0 |
| Repbase | http://www.girinst.org/repbase | 2017.09 |
| Genome | ftp://ftp.sanger.ac.uk/pub/gencode/Gencode_mouse/release_M16/GRCm38.p5.genome.fa.gz | GRCm38.p5 |
| Gene Ontology (GO) | ftp://ftp.ncbi.nih.gov/gene/DATA/gene2go.gz | 2016.04 |
| KEGG | http://www.genome.jp/kegg/pathway.html | 2017.06 |
| eggNOG | http://eggnogdb.embl.de/ | 4.5 |
Small RNA sequencing data were analyzed by in-house program ACGT101-miR. More details were mentioned in 2.2 Bioinformatics analysis.
We assessed the general characteristics of the reads obtained for the different libraries. 3' adapter sequence must be removed prior to further processing of the data. After adapter removal, the length distribution of of the trimmed reads should correspond to the length distribution of the RNAs sequenced as showed in 4.1.3 Length distribution of sRNA below. Only the 18–30 nt size range is shown as this was the input for sequencing. 4.1.1 Overview of reads from rawdata to cleandata shows valid reads by removing mRNA, junk reads and other kinds of reads from Rfam (rRNA, snoRNA, tRNA, etc.). 4.1.2 Rfam category shows distribution of different RNA class in small RNA sequencing data. What's more, results of FastQC, PCA analysis and sample correlation were deposited in Final_Report/3_Summary/0_Quality_Control.
Raw data were filtered using a filter module in a in-house program ACGT101-miR to delete low-quality reads, 3' adapter sequences, and contaminations. The sequences ≥18 nt of clean data were annotated in the Rfam database (http://www.sanger.ac.uk/software/Rfam) to remove non-coding RNA (rRNA, tRNA, snRNA, snoRNA) and degradation fragments of mRNA. The remaining sequences were aligned against miRNA database, miRbase (Release 21) (http://www.miRbase.org/) and perfectly matched sequences were considered conserved Mus musculus miRNAs.
| C_3MK5 | C_3MK6 | C_3MK7 | C_3MK8 | C_3MK9 | C_12MK17 | C_12MK18 | C_12MK19 | C_12MK20 | C_12MK21 | C_24MK31 | C_24MK32 | C_24MK33 | C_24MK34 | C_24MK35 | |||||||||||||||||||||||||||||||||||||||||||||||
| lib | type | Total | % of Total | uniq | % of uniq | Total | % of Total | uniq | % of uniq | Total | % of Total | uniq | % of uniq | Total | % of Total | uniq | % of uniq | Total | % of Total | uniq | % of uniq | Total | % of Total | uniq | % of uniq | Total | % of Total | uniq | % of uniq | Total | % of Total | uniq | % of uniq | Total | % of Total | uniq | % of uniq | Total | % of Total | uniq | % of uniq | Total | % of Total | uniq | % of uniq | Total | % of Total | uniq | % of uniq | Total | % of Total | uniq | % of uniq | Total | % of Total | uniq | % of uniq | Total | % of Total | uniq | % of uniq |
| Raw reads | NA | 14578293 | 100.00 | 576510 | 100.00 | 16475059 | 100.00 | 659931 | 100.00 | 20661946 | 100.00 | 721667 | 100.00 | 14371816 | 100.00 | 551980 | 100.00 | 17274337 | 100.00 | 575333 | 100.00 | 14982298 | 100.00 | 608337 | 100.00 | 15652841 | 100.00 | 600300 | 100.00 | 18987387 | 100.00 | 631713 | 100.00 | 14756089 | 100.00 | 591895 | 100.00 | 17586591 | 100.00 | 761879 | 100.00 | 18557746 | 100.00 | 656899 | 100.00 | 17156205 | 100.00 | 687680 | 100.00 | 13967605 | 100.00 | 551509 | 100.00 | 22929871 | 100.00 | 718885 | 100.00 | 20149042 | 100.00 | 713151 | 100.00 |
| 3ADT&length filter | Sequence type | 1011547 | 6.94 | 356114 | 61.77 | 2260620 | 13.72 | 413841 | 62.71 | 1875844 | 9.08 | 463273 | 64.19 | 1300625 | 9.05 | 329329 | 59.66 | 1210763 | 7.01 | 361570 | 62.85 | 1308692 | 8.73 | 380545 | 62.55 | 1331444 | 8.51 | 382671 | 63.75 | 1174141 | 6.18 | 417841 | 66.14 | 1043984 | 7.07 | 396522 | 66.99 | 1449497 | 8.24 | 516492 | 67.79 | 996709 | 5.37 | 431170 | 65.64 | 1416714 | 8.26 | 445087 | 64.72 | 1112985 | 7.97 | 373853 | 67.79 | 1133993 | 4.95 | 494116 | 68.73 | 1164898 | 5.78 | 453817 | 63.64 |
| Junk reads | Sequence type | 34440 | 0.24 | 5077 | 0.88 | 33953 | 0.21 | 5331 | 0.81 | 24302 | 0.12 | 5117 | 0.71 | 26229 | 0.18 | 5184 | 0.94 | 22454 | 0.13 | 4770 | 0.83 | 19108 | 0.13 | 4648 | 0.76 | 23207 | 0.15 | 5552 | 0.92 | 22850 | 0.12 | 5181 | 0.82 | 15445 | 0.10 | 3975 | 0.67 | 23578 | 0.13 | 5801 | 0.76 | 19367 | 0.10 | 4826 | 0.73 | 22048 | 0.13 | 5294 | 0.77 | 15280 | 0.11 | 3800 | 0.69 | 31037 | 0.14 | 5994 | 0.83 | 20511 | 0.10 | 5027 | 0.70 |
| Rfam | RNA class | 107469 | 0.74 | 3129 | 0.54 | 142996 | 0.87 | 4643 | 0.70 | 204054 | 0.99 | 4080 | 0.57 | 114788 | 0.80 | 3079 | 0.56 | 145336 | 0.84 | 3013 | 0.52 | 135199 | 0.90 | 3359 | 0.55 | 148957 | 0.95 | 3191 | 0.53 | 161411 | 0.85 | 3274 | 0.52 | 143415 | 0.97 | 2943 | 0.50 | 138743 | 0.79 | 3868 | 0.51 | 128207 | 0.69 | 2881 | 0.44 | 172248 | 1.00 | 3769 | 0.55 | 89783 | 0.64 | 2310 | 0.42 | 143531 | 0.63 | 3223 | 0.45 | 154913 | 0.77 | 3194 | 0.45 |
| mRNA | RNA class | 1591468 | 10.92 | 3071 | 0.53 | 1944487 | 11.80 | 4110 | 0.62 | 2438063 | 11.80 | 3649 | 0.51 | 1592887 | 11.08 | 3086 | 0.56 | 2012822 | 11.65 | 2927 | 0.51 | 2022122 | 13.50 | 3183 | 0.52 | 2077423 | 13.27 | 3167 | 0.53 | 2455139 | 12.93 | 3185 | 0.50 | 1849089 | 12.53 | 2771 | 0.47 | 2119225 | 12.05 | 3570 | 0.47 | 2211237 | 11.92 | 3011 | 0.46 | 2082548 | 12.14 | 3396 | 0.49 | 1591303 | 11.39 | 2399 | 0.43 | 2639378 | 11.51 | 3200 | 0.45 | 2401162 | 11.92 | 3172 | 0.44 |
| Repeats | RNA class | 18937 | 0.13 | 470 | 0.08 | 23945 | 0.15 | 686 | 0.10 | 37860 | 0.18 | 626 | 0.09 | 23742 | 0.17 | 512 | 0.09 | 29629 | 0.17 | 505 | 0.09 | 32262 | 0.22 | 532 | 0.09 | 28183 | 0.18 | 538 | 0.09 | 31230 | 0.16 | 548 | 0.09 | 30462 | 0.21 | 517 | 0.09 | 25085 | 0.14 | 625 | 0.08 | 28087 | 0.15 | 495 | 0.08 | 36605 | 0.21 | 608 | 0.09 | 20049 | 0.14 | 418 | 0.08 | 24892 | 0.11 | 529 | 0.07 | 40389 | 0.20 | 561 | 0.08 |
| valid reads | Sequence type | 11855131 | 81.32 | 209541 | 36.35 | 12129977 | 73.63 | 232725 | 35.27 | 16148758 | 78.16 | 246063 | 34.10 | 11357361 | 79.03 | 211712 | 38.36 | 13899738 | 80.46 | 203412 | 35.36 | 11518353 | 76.88 | 217029 | 35.68 | 12092689 | 77.26 | 206137 | 34.34 | 15192912 | 80.02 | 202645 | 32.08 | 11722455 | 79.44 | 186044 | 31.43 | 13883043 | 78.94 | 232665 | 30.54 | 15216449 | 82.00 | 215355 | 32.78 | 13490486 | 78.63 | 230624 | 33.54 | 11169025 | 79.96 | 169416 | 30.72 | 18999435 | 82.86 | 212741 | 29.59 | 16424432 | 81.51 | 248340 | 34.82 |
| rRNA | RNA class | 39332 | 0.27 | 925 | 0.01 | 67915 | 0.41 | 2037 | 0.01 | 55011 | 0.27 | 1072 | 0.01 | 36523 | 0.25 | 916 | 0.01 | 33278 | 0.19 | 517 | 0.00 | 38077 | 0.25 | 938 | 0.01 | 39807 | 0.25 | 794 | 0.01 | 35439 | 0.19 | 663 | 0.00 | 33637 | 0.23 | 593 | 0.00 | 54595 | 0.31 | 1365 | 0.01 | 34169 | 0.18 | 520 | 0.00 | 48385 | 0.28 | 1043 | 0.01 | 26909 | 0.19 | 394 | 0.00 | 40213 | 0.18 | 599 | 0.00 | 39036 | 0.19 | 585 | 0.00 |
| tRNA | RNA class | 40691 | 0.28 | 1278 | 0.01 | 40215 | 0.24 | 1249 | 0.01 | 107349 | 0.52 | 1768 | 0.01 | 49256 | 0.34 | 1211 | 0.01 | 78001 | 0.45 | 1519 | 0.01 | 65726 | 0.44 | 1376 | 0.01 | 76949 | 0.49 | 1388 | 0.01 | 88102 | 0.46 | 1527 | 0.01 | 79992 | 0.54 | 1431 | 0.01 | 46106 | 0.26 | 1248 | 0.01 | 58725 | 0.32 | 1342 | 0.01 | 86264 | 0.50 | 1529 | 0.01 | 36504 | 0.26 | 1088 | 0.01 | 59348 | 0.26 | 1445 | 0.01 | 75296 | 0.37 | 1500 | 0.01 |
| snoRNA | RNA class | 21587 | 0.15 | 646 | 0.00 | 25141 | 0.15 | 798 | 0.00 | 33196 | 0.16 | 874 | 0.00 | 22301 | 0.16 | 671 | 0.00 | 28106 | 0.16 | 784 | 0.00 | 23894 | 0.16 | 735 | 0.00 | 25498 | 0.16 | 740 | 0.00 | 31054 | 0.16 | 837 | 0.00 | 23951 | 0.16 | 704 | 0.00 | 29416 | 0.17 | 842 | 0.00 | 29365 | 0.16 | 790 | 0.00 | 28673 | 0.17 | 836 | 0.00 | 21527 | 0.15 | 657 | 0.00 | 36529 | 0.16 | 924 | 0.00 | 32484 | 0.16 | 861 | 0.00 |
| snRNA | RNA class | 2991 | 0.02 | 63 | 0.00 | 4415 | 0.03 | 97 | 0.00 | 3565 | 0.02 | 83 | 0.00 | 3292 | 0.02 | 54 | 0.00 | 2571 | 0.01 | 61 | 0.00 | 3544 | 0.02 | 66 | 0.00 | 2820 | 0.02 | 58 | 0.00 | 2917 | 0.02 | 70 | 0.00 | 2527 | 0.02 | 58 | 0.00 | 3881 | 0.02 | 77 | 0.00 | 2562 | 0.01 | 63 | 0.00 | 3981 | 0.02 | 87 | 0.00 | 2238 | 0.02 | 57 | 0.00 | 3157 | 0.01 | 67 | 0.00 | 3276 | 0.02 | 74 | 0.00 |
| other Rfam RNA | RNA class | 2868 | 0.02 | 217 | 0.00 | 5310 | 0.03 | 462 | 0.00 | 4933 | 0.02 | 283 | 0.00 | 3416 | 0.02 | 227 | 0.00 | 3380 | 0.02 | 132 | 0.00 | 3958 | 0.03 | 244 | 0.00 | 3883 | 0.02 | 211 | 0.00 | 3899 | 0.02 | 177 | 0.00 | 3308 | 0.02 | 157 | 0.00 | 4745 | 0.03 | 336 | 0.00 | 3386 | 0.02 | 166 | 0.00 | 4945 | 0.03 | 274 | 0.00 | 2605 | 0.02 | 114 | 0.00 | 4284 | 0.02 | 188 | 0.00 | 4821 | 0.02 | 174 | 0.00 |
document location: Final_Report/3_Summary/1_SequencingData_Overview/Table2_Overview_of_reads_from_raw_data_to_cleaned_sequences.xlsx
document location: Final_Report/3_Summary/1_SequencingData_Overview/Fig1_Rfam_sequence_category.pdf
document location:
Final_Report/3_Summary/1_SequencingData_Overview/Fig3_Length_distribution_of_counts_of_total_and_unique_sRNAs_in_this_study.pdf
Final_Report/3_Summary/1_SequencingData_Overview/Table4_The_length_and_counts_characteristics_of_the_sequencing_results.xlsx
After processed by filter module in ACGT101-miR, unique reads were analyzed using ACGT101-miR to detect conserved and novel Mus musculus miRNAs. Briefly, those unique reads which were mapped to miRNAs/pre-miRNAs of specific species in miRbase and the pre-miRNAs were further mapped to genome & EST were belonged to gp1a. In gp1b, reads were mapped to (except for specific species) miRNAs/pre-miRNAs of selected species in miRbase and the pre-miRNAs were further mapped to genome & EST. Reads from gp2a were mapped to miRNAs/pre-miRNAs of selected species in miRbase and the mapped pre-miRNAs were not further mapped to genome, but the reads (and of course the miRNAs of the pre-miRNAs) were mapped to genome. The extended genome sequences from the genome loci may form hairpins. In gp2b, Reads were mapped to miRNAs/pre-miRNAs of selected species in miRbase and the mapped pre-miRNAs were not further mapped to genome, but the reads (and of course the miRNAs of the pre-miRNAs) were mapped to genome. The extended genome sequences from the genome loci may not form hairpins. Those reads which were mapped to miRNAs/pre-miRNAs of selected species in miRbase and the mapped pre-miRNAs were not further mapped to genome, and the reads were not mapped to genome, either, but the reads were mapped to the miRNAS(Matures), were classified as gp3. Reads in gp4 were not mapped to pre-miRNAs of selected species in miRbase. But the reads were mapped to genome & the extended genome sequences from genome may form hairpins. More details and informations are listed in Table5_All_Expressed_miRNA.xlsx.
Normalization of sequence counts in each sample (or data set) is achieved by dividing the counts by a library size parameter of the corresponding sample. The library size parameter is a median value of the ratio between the counts a specific sample and a pseudo-reference sample. A count number in the pseudo-reference sample is the count geometric mean across all samples.
, where Sj is the library size parameter; cij is the count number of sequence i of sample j; m is the total number of samples involved.
| Pre-miRNA Index | miRNA_Index | miR_name | miR_seq | len | genomeID | strand | start | end | pre-miRNA_seq | #mir/MIR | mirIDs, | rep_mirID | rep_mirSeq | rep_miRID | rep_miRSeq | type | Sequence in miRbase | group | SS | hairpinLen | CG% | dG | C_3MK5(raw) | C_3MK6(raw) | C_3MK7(raw) | C_3MK8(raw) | C_3MK9(raw) | C_12MK17(raw) | C_12MK18(raw) | C_12MK19(raw) | C_12MK20(raw) | C_12MK21(raw) | C_24MK31(raw) | C_24MK32(raw) | C_24MK33(raw) | C_24MK34(raw) | C_24MK35(raw) | C_3MK5(norm) | C_3MK6(norm) | C_3MK7(norm) | C_3MK8(norm) | C_3MK9(norm) | C_12MK17(norm) | C_12MK18(norm) | C_12MK19(norm) | C_12MK20(norm) | C_12MK21(norm) | C_24MK31(norm) | C_24MK32(norm) | C_24MK33(norm) | C_24MK34(norm) | C_24MK35(norm) | Expression level |
| 1 | 1 | mmu-miR-1a-3p | TGGAATGTAAAGAAGTATGTAT | 22 | chr18 | - | 10785474 | 10785557 | cctactcagagcacatacttctttatgtacccatatgaacattcagtgctaTGGAATGTAAAGAAGTATGTATtttgggtaggt | 12 | mmu-mir-1a-2,hsa-mir-1-2,bta-mir-1-2,ppa-mir-1,eca-mir-1-1,ptr-mir-1-2,mml-mir-1-2,cfa-mir-1-2,efu-mir-1-1,mdo-mir-1-1,gga-mir-1a-2,tgu-mir-1-2, | mmu-mir-1a-2 | tcagagcACATACTTCTTTATGTACCCATAtgaacattcagtgctaTGGAATGTAAAGAAGTATGTATtttg | mmu-miR-1a-3p | TGGAATGTAAAGAAGTATGTAT | 3' | Yes | gp1a | ((((((((((..(((((((((((((..(..(((((...((.....))..))))).)..)))))))))))))..)))))))))). | 83 | 36.90 | -37.70 | 1510 | 858.50 | 946 | 1059 | 1490 | 923.50 | 754 | 1171 | 884 | 925 | 1135.50 | 918 | 754.50 | 1326 | 1010 | 1781.71 | 972.94 | 764.63 | 1334.57 | 1422.63 | 1030.76 | 827.80 | 1017.99 | 997.51 | 888.39 | 1021.64 | 904.85 | 916.05 | 965.67 | 836.43 | middle |
| 2 | 2 | mmu-miR-1a-3p | TGGAATGTAAAGAAGTATGTAT | 22 | chr2 | + | 180389043 | 180389135 | tacctgcttgggacacatacttctttatatgcccatatgaacctgctaagctaTGGAATGTAAAGAAGTATGTATttcaggctaggaactctc | 15 | mmu-mir-1a-1,rno-mir-1b,hsa-mir-1-1,ppy-mir-1-1,bta-mir-1-1,eca-mir-1-2,ptr-mir-1-1,mml-mir-1-1,cfa-mir-1-1,mdo-mir-1-2,ssc-mir-1,chi-mir-1,gga-mir-1a-1,tgu-mir-1-1,xtr-mir-1a-2, | mmu-mir-1a-1 | gcttgggacACATACTTCTTTATATGCCCATAtgaacctgctaagctaTGGAATGTAAAGAAGTATGTATttcaggc | mmu-miR-1a-3p | TGGAATGTAAAGAAGTATGTAT | 3' | Yes | gp1a | ..((((((((..(.((((((((((((((((..(((((..............))))).)))))))))))))))).)..))))).)))....... | 84 | 39.80 | -37.60 | 1510 | 858.50 | 946 | 1059 | 1490 | 923.50 | 754 | 1171 | 884 | 925 | 1135.50 | 918 | 754.50 | 1326 | 1010 | 1781.71 | 972.94 | 764.63 | 1334.57 | 1422.63 | 1030.76 | 827.80 | 1017.99 | 997.51 | 888.39 | 1021.64 | 904.85 | 916.05 | 965.67 | 836.43 | middle |
| 3 | 3 | mmu-miR-1b-3p | TGGGTACATAAAGAAGTATGTGC | 23 | chr18 | + | 10785446 | 10785567 | ttcctttagcttcttcttggcggacattacctacccaaaatacatacttctttacattccatagcactgaatgttcataTGGGTACATAAAGAAGTATGTGCtctgagtaggcactcctgcg | 2 | mmu-mir-1b,rno-mir-3571, | mmu-mir-1b | ttcctttagcttcttcttggcggacattacctacccaaaaTACATACTTCTTTACATTCCAtagcactgaatgttcataTGGGTACATAAAGAAGTATGTGCtctgagtaggcactcctgcg | mmu-miR-1b-3p | TGGGTACATAAAGAAGTATGTGC | 3' | Yes | gp1a | ...................((((......(((((.((...((((((((((((((...((((((..((.....))...))))))....))))))))))))))...)).))))).....)))). | 102 | 41 | -35.20 | 0 | 5 | 0 | 0 | 6 | 0 | 0 | 6 | 0 | 8 | 0 | 0 | 0 | 8 | 0 | 0 | 5.67 | 0 | 0 | 5.73 | 0 | 0 | 5.22 | 0 | 7.68 | 0 | 0 | 0 | 5.83 | 0 | low |
| 4 | 4 | mmu-let-7d-5p | AGAGGTAGTAGGTTGCATAGTT | 22 | chr13 | - | 48536010 | 48536115 | aaatgggttcctaggaAGAGGTAGTAGGTTGCATAGTTttagggcagagattttgcccacaaggagttaaCTATACGACCTGCTGCCTTTCTtagggccttattat | 16 | mmu-let-7d,rno-let-7d,cgr-let-7d,hsa-let-7d,ppy-let-7d,mml-let-7d,oar-let-7d,bta-let-7d,eca-let-7d,ptr-let-7d,cfa-let-7d,mdo-let-7d,oan-let-7d,ssc-let-7d,chi-let-7d,tgu-let-7d, | mmu-let-7d | aatgggttcctaggaAGAGGTAGTAGGTTGCATAGTTttagggcagagattttgcccacaaggagttaaCTATACGACCTGCTGCCTTTCTtagggccttatt | mmu-let-7d-5p | AGAGGTAGTAGGTTGCATAGTT | 5' | Yes | gp1a | .(((..(..((((((.(((((((((((((((.((((((...(((((((...)))))))..........)))))).)))))))))))))))))))))..)..))).. | 103 | 43.40 | -49.40 | 87430.75 | 95932.75 | 124162.75 | 82723.50 | 95685 | 88941.25 | 83448.50 | 115566.45 | 83961.25 | 95370 | 109253.90 | 103739.20 | 74165.30 | 125374.50 | 111162.75 | 103163.28 | 108720.56 | 100357.35 | 104249.94 | 91358.73 | 99271.49 | 91616.53 | 100465.66 | 94742.35 | 91595.72 | 98298.29 | 102252.88 | 90044.83 | 91304.64 | 92059.33 | high |
| 4 | 5 | mmu-let-7d-3p | CTATACGACCTGCTGCCTTTCT | 22 | chr13 | - | 48536010 | 48536115 | aaatgggttcctaggaAGAGGTAGTAGGTTGCATAGTTttagggcagagattttgcccacaaggagttaaCTATACGACCTGCTGCCTTTCTtagggccttattat | 16 | mmu-let-7d,rno-let-7d,cgr-let-7d,hsa-let-7d,ppy-let-7d,mml-let-7d,oar-let-7d,bta-let-7d,eca-let-7d,ptr-let-7d,cfa-let-7d,mdo-let-7d,oan-let-7d,ssc-let-7d,chi-let-7d,tgu-let-7d, | mmu-let-7d | aatgggttcctaggaAGAGGTAGTAGGTTGCATAGTTttagggcagagattttgcccacaaggagttaaCTATACGACCTGCTGCCTTTCTtagggccttatt | mmu-let-7d-3p | CTATACGACCTGCTGCCTTTCT | 3' | Yes | gp1a | .(((..(..((((((.(((((((((((((((.((((((...(((((((...)))))))..........)))))).)))))))))))))))))))))..)..))).. | 103 | 43.40 | -49.40 | 5892 | 6692 | 9600 | 5466 | 6539 | 6036 | 6448 | 7021 | 5111 | 7416 | 7361 | 7955 | 5064 | 7453 | 6617 | 6952.22 | 7584.04 | 7759.42 | 6888.37 | 6243.35 | 6737.06 | 7079.14 | 6103.58 | 5767.28 | 7122.51 | 6622.86 | 7841.02 | 6148.25 | 5427.69 | 5479.86 | middle |
| 5 | 6 | mmu-let-7i-5p | TGAGGTAGTAGTTTGTGCTGTT | 22 | chr10 | - | 122985632 | 122985735 | acaccatggccctggcTGAGGTAGTAGTTTGTGCTGTTggtcgggttgtgacattgcccgctgtggagataaCTGCGCAAGCTACTGCCTTGCTagtgctggtg | 18 | mmu-let-7i,rno-let-7i,mml-let-7i,ssc-let-7i,aja-let-7i,cgr-let-7i,hsa-let-7i,bta-let-7i,ppy-let-7i,mdo-let-7i,oar-let-7i,gga-let-7i,ptr-let-7i,ggo-let-7i,chi-let-7i,tch-let-7i,tgu-let-7i,xtr-let-7i, | mmu-let-7i | ctggcTGAGGTAGTAGTTTGTGCTGTTggtcgggttgtgacattgcccgctgtggagataaCTGCGCAAGCTACTGCCTTGCTag | mmu-let-7i-5p | TGAGGTAGTAGTTTGTGCTGTT | 5' | Yes | gp1a | .((((..(((.(((((.(((((((((((((((((.(((((.(((((.........)))))))........))).)))))))))))))))))))))).))))))) | 103 | 55.80 | -51.90 | 63879 | 56933 | 90960 | 55062 | 76767.50 | 67125.50 | 73201.50 | 87144 | 59565 | 66241 | 79112.50 | 73630 | 54588 | 91369.50 | 88415.50 | 75373.56 | 64522.15 | 73520.48 | 69390.32 | 73296.56 | 74921.91 | 80366.54 | 75757.11 | 67213.48 | 63619.51 | 71179.37 | 72575.07 | 66275.84 | 66540.32 | 73221.21 | high |
| 5 | 7 | mmu-let-7i-3p | CTGCGCAAGCTACTGCCTTGCT | 22 | chr10 | - | 122985632 | 122985735 | acaccatggccctggcTGAGGTAGTAGTTTGTGCTGTTggtcgggttgtgacattgcccgctgtggagataaCTGCGCAAGCTACTGCCTTGCTagtgctggtg | 18 | mmu-let-7i,rno-let-7i,mml-let-7i,ssc-let-7i,aja-let-7i,cgr-let-7i,hsa-let-7i,bta-let-7i,ppy-let-7i,mdo-let-7i,oar-let-7i,gga-let-7i,ptr-let-7i,ggo-let-7i,chi-let-7i,tch-let-7i,tgu-let-7i,xtr-let-7i, | mmu-let-7i | ctggcTGAGGTAGTAGTTTGTGCTGTTggtcgggttgtgacattgcccgctgtggagataaCTGCGCAAGCTACTGCCTTGCTag | mmu-let-7i-3p | CTGCGCAAGCTACTGCCTTGCT | 3' | Yes | gp1a | .((((..(((.(((((.(((((((((((((((((.(((((.(((((.........)))))))........))).)))))))))))))))))))))).))))))) | 103 | 55.80 | -51.90 | 672 | 690 | 1117 | 583 | 895 | 815 | 715 | 998 | 755 | 785 | 822 | 752 | 708 | 1146 | 1051 | 792.92 | 781.98 | 902.84 | 734.71 | 854.53 | 909.66 | 784.98 | 867.59 | 851.95 | 753.93 | 739.57 | 741.23 | 859.59 | 834.58 | 870.38 | middle |
| 6 | 8 | mmu-let-7b-5p | TGAGGTAGTAGGTTGTGTGGTT | 22 | chr15 | + | 85707316 | 85707415 | accgcagggTGAGGTAGTAGGTTGTGTGGTTtcagggcagtgatgttgcccctccgaagataaCTATACAACCTACTGCCTTCCCtgaggcgcccaggga | 16 | mmu-let-7b,rno-let-7b,cgr-let-7b,hsa-let-7b,bta-let-7b,ppy-let-7b,mml-let-7b,ptr-let-7b,cfa-let-7b,mdo-let-7b,oan-let-7b,ggo-let-7b,chi-let-7b,oar-let-7b,gga-let-7b,tgu-let-7b, | mmu-let-7b | gcagggTGAGGTAGTAGGTTGTGTGGTTtcagggcagtgatgttgcccctccgaagataaCTATACAACCTACTGCCTTCCCtga | mmu-let-7b-5p | TGAGGTAGTAGGTTGTGTGGTT | 5' | Yes | gp1a | .((.(((((.(((((((((((((((((((((((.((((((.....))))))....))....)))))))))))))))))))))))))).)).......... | 89 | 56 | -52.20 | 124074.17 | 111457.67 | 173696.17 | 101741.83 | 121245.25 | 114322.42 | 118948.75 | 146691.75 | 113715.50 | 137365.42 | 151068 | 153744.08 | 109373.75 | 181118.42 | 168965.33 | 146400.41 | 126314.94 | 140393.86 | 128217.25 | 115763.31 | 127600.59 | 130591.58 | 127523.90 | 128317.21 | 131929.17 | 135919.42 | 151541.31 | 132791.76 | 131900.45 | 139928.48 | high |
| 6 | 9 | mmu-let-7b-3p_1ss22CT | CTATACAACCTACTGCCTTCCT | 22 | chr15 | + | 85707316 | 85707415 | accgcagggTGAGGTAGTAGGTTGTGTGGTTtcagggcagtgatgttgcccctccgaagataaCTATACAACCTACTGCCTTCCCtgaggcgcccaggga | 16 | mmu-let-7b,rno-let-7b,cgr-let-7b,hsa-let-7b,bta-let-7b,ppy-let-7b,mml-let-7b,ptr-let-7b,cfa-let-7b,mdo-let-7b,oan-let-7b,ggo-let-7b,chi-let-7b,oar-let-7b,gga-let-7b,tgu-let-7b, | mmu-let-7b | gcagggTGAGGTAGTAGGTTGTGTGGTTtcagggcagtgatgttgcccctccgaagataaCTATACAACCTACTGCCTTCCCtga | mmu-let-7b-3p | CTATACAACCTACTGCCTTCCC | 3' | Diff | gp1a | .((.(((((.(((((((((((((((((((((((.((((((.....))))))....))....)))))))))))))))))))))))))).)).......... | 89 | 56 | -52.20 | 1238 | 1215 | 1802 | 1055 | 1335 | 1095 | 1283 | 1431 | 1023 | 1397 | 1513 | 1465 | 1100 | 1704 | 1683 | 1460.77 | 1376.96 | 1456.51 | 1329.53 | 1274.64 | 1222.18 | 1408.58 | 1244.01 | 1154.36 | 1341.71 | 1361.28 | 1444.01 | 1335.52 | 1240.95 | 1393.77 | middle |
| 7 | 10 | mmu-let-7e-5p | TGAGGTAGGAGGTTGTATAGTT | 22 | chr17 | + | 17830346 | 17830450 | acctgccgcgccccccgggcTGAGGTAGGAGGTTGTATAGTTgaggaagacacccgaggagatcaCTATACGGCCTCCTAGCTTTCCccaggctgcgccctgcac | 13 | mmu-let-7e,rno-let-7e,hsa-let-7e,bta-let-7e,ppy-let-7e,mml-let-7e,eca-let-7e,ptr-let-7e,cfa-let-7e,ssc-let-7e,ggo-let-7e,chi-let-7e,tch-let-7e, | mmu-let-7e | cgcgccccccgggcTGAGGTAGGAGGTTGTATAGTTgaggaagacacccgaggagatcaCTATACGGCCTCCTAGCTTTCCccaggctgcgcc | mmu-let-7e-5p | TGAGGTAGGAGGTTGTATAGTT | 5' | Yes | gp1a | ...(((.((((..((.(((..(((.(((((((..(((((((.((..................)))))))))..))))))).)))..))).))..))))...))). | 101 | 62.90 | -46.30 | 21220.17 | 20859.92 | 31673.42 | 18465.17 | 24169.92 | 20610.83 | 21243.67 | 27824.25 | 20395 | 22601.33 | 26003.83 | 25761.67 | 18812.50 | 31521 | 31626.58 | 25038.58 | 23640.54 | 25600.76 | 23270.20 | 23077.11 | 23004.71 | 23323.02 | 24188.52 | 23013.83 | 21706.88 | 23396.26 | 25392.57 | 22840.44 | 22955.34 | 26191.52 | high |
| 7 | 11 | mmu-let-7e-3p | CTATACGGCCTCCTAGCTTTCC | 22 | chr17 | + | 17830346 | 17830450 | acctgccgcgccccccgggcTGAGGTAGGAGGTTGTATAGTTgaggaagacacccgaggagatcaCTATACGGCCTCCTAGCTTTCCccaggctgcgccctgcac | 13 | mmu-let-7e,rno-let-7e,hsa-let-7e,bta-let-7e,ppy-let-7e,mml-let-7e,eca-let-7e,ptr-let-7e,cfa-let-7e,ssc-let-7e,ggo-let-7e,chi-let-7e,tch-let-7e, | mmu-let-7e | cgcgccccccgggcTGAGGTAGGAGGTTGTATAGTTgaggaagacacccgaggagatcaCTATACGGCCTCCTAGCTTTCCccaggctgcgcc | mmu-let-7e-3p | CTATACGGCCTCCTAGCTTTCC | 3' | Yes | gp1a | ...(((.((((..((.(((..(((.(((((((..(((((((.((..................)))))))))..))))))).)))..))).))..))))...))). | 101 | 62.90 | -46.30 | 324 | 352 | 641 | 334 | 480 | 381 | 384 | 468 | 353 | 406 | 473 | 399 | 370 | 574 | 497 | 382.30 | 398.92 | 518.10 | 420.91 | 458.30 | 425.25 | 421.59 | 406.85 | 398.33 | 389.93 | 425.57 | 393.28 | 449.22 | 418.02 | 411.59 | middle |
| 8 | 12 | mmu-miR-7b-5p | TGGAAGACTTGTGATTTTGTTGT | 23 | chr17 | + | 56242988 | 56243098 | aggagcggagtacgtgagccagtgctatgTGGAAGACTTGTGATTTTGTTGTtctgatatgatatgacaacaagtcacagccagcctcatagcgtggactcctatcacctt | 3 | mmu-mir-7b,rno-mir-7b,cgr-mir-7b, | mmu-mir-7b | aggagcggagtacgtgagccagtgctatgTGGAAGACTTGTGATTTTGTTGTtctgatatgatatgaCAACAAGTCACAGCCAGCCTCAtagcgtggactcctatcacctt | mmu-miR-7b-5p | TGGAAGACTTGTGATTTTGTTGT | 5' | Yes | gp1a | (((.(((.....)))((((((.(((((((.((.....(((((((((.(((((..((......))..))))))))))))))....)).)))))))))).)))......))). | 86 | 46.80 | -35.80 | 7 | 8 | 6 | 6 | 9 | 0 | 12 | 6 | 0 | 0 | 0 | 0 | 5 | 24 | 0 | 8.26 | 9.07 | 4.85 | 7.56 | 8.59 | 0 | 13.17 | 5.22 | 0 | 0 | 0 | 0 | 6.07 | 17.48 | 0 | middle |
| 9 | 13 | mmu-let-7f-5p | TGAGGTAGTAGATTGTATAGTT | 22 | chr13 | - | 48537811 | 48537940 | attccagaagaaaaacttgctctatcagagTGAGGTAGTAGATTGTATAGTTgtggggtagtgattttaccctgtttaggagataaCTATACAATCTATTGCCTTCCCtgaggagtagacttgctgcatt | 18 | mmu-let-7f-1,rno-let-7f-1,cgr-let-7f,hsa-let-7f-1,bta-let-7f-1,ppy-let-7f-1,mml-let-7f-1,mdo-let-7f-1,eca-let-7f,ptr-let-7f-1,cfa-let-7f,tch-let-7f,efu-let-7f,ssc-let-7f-2,ggo-let-7f,chi-let-7f,gga-let-7f,tgu-let-7f, | mmu-let-7f-1 | atcagagTGAGGTAGTAGATTGTATAGTTgtggggtagtgattttaccctgtttaggagataaCTATACAATCTATTGCCTTCCCtgag | mmu-let-7f-5p | TGAGGTAGTAGATTGTATAGTT | 5' | Yes | gp1a | ....((((((......(((((((.((((...((((((((((((((((((((((((((((((.....))))))).........)))))))))))))))))))))))..))))))))))).))).))).... | 122 | 39.20 | -50.30 | 223988.23 | 224054.36 | 310075.11 | 216241.50 | 263199.10 | 228574.61 | 227177.07 | 309683.24 | 224084.71 | 239972.10 | 295836.61 | 253926.48 | 194858.84 | 350808.30 | 318058.70 | 264293.29 | 253920.74 | 250625.22 | 272512.21 | 251298.92 | 255122.81 | 249413.40 | 269217.69 | 252858.46 | 230475.18 | 266171.12 | 250288.34 | 236580.07 | 255478.01 | 263400.01 | high |
| 9 | 14 | mmu-let-7f-1-3p_1ss22CT | CTATACAATCTATTGCCTTCCT | 22 | chr13 | - | 48537811 | 48537940 | attccagaagaaaaacttgctctatcagagTGAGGTAGTAGATTGTATAGTTgtggggtagtgattttaccctgtttaggagataaCTATACAATCTATTGCCTTCCCtgaggagtagacttgctgcatt | 18 | mmu-let-7f-1,rno-let-7f-1,cgr-let-7f,hsa-let-7f-1,bta-let-7f-1,ppy-let-7f-1,mml-let-7f-1,mdo-let-7f-1,eca-let-7f,ptr-let-7f-1,cfa-let-7f,tch-let-7f,efu-let-7f,ssc-let-7f-2,ggo-let-7f,chi-let-7f,gga-let-7f,tgu-let-7f, | mmu-let-7f-1 | atcagagTGAGGTAGTAGATTGTATAGTTgtggggtagtgattttaccctgtttaggagataaCTATACAATCTATTGCCTTCCCtgag | mmu-let-7f-1-3p | CTATACAATCTATTGCCTTCCC | 3' | Diff | gp1a | ....((((((......(((((((.((((...((((((((((((((((((((((((((((((.....))))))).........)))))))))))))))))))))))..))))))))))).))).))).... | 122 | 39.20 | -50.30 | 513 | 384 | 629 | 380 | 593 | 395 | 525 | 564 | 402 | 594 | 637 | 591 | 383 | 625 | 573 | 605.31 | 435.19 | 508.40 | 478.88 | 566.19 | 440.88 | 576.39 | 490.30 | 453.62 | 570.49 | 573.12 | 582.53 | 465.00 | 455.16 | 474.53 | middle |
| 10 | 15 | mmu-let-7j_R-1_1ss8TG | TGAGGTAGTAGTTTGTGCTGTTA | 23 | chr3 | + | 140028249 | 140028370 | attggaggctatttctgatcatgataatttccTGAGGTATTAGTTTGTGCTGTTAtatgaatcgaataatatcccttgctcagattaaaagcctggagttaaaaaaatcaagtgccttgaac | 1 | mmu-let-7j, | mmu-let-7j | attggaggctatttctgatcatgataatttccTGAGGTATTAGTTTGTGCTGTTATatgaatcgaataatatcccttgctcagattaaaagcctggagttaaaaaaatcaagtgccttgaac | mmu-let-7j | TGAGGTATTAGTTTGTGCTGTTAT | 5' | Diff | gp1a | ....(((((.(((..((((.....(((((((...((((.((((((((.((....((((..........)))).....)).))))))))..))))))))))).....)))))))))))).... | 114 | 34.40 | -23.30 | 3713.50 | 3786.50 | 4993 | 3651 | 4381.50 | 4309 | 4171.50 | 5551.50 | 3637 | 4194 | 4615.50 | 4545.50 | 3312 | 5772 | 4976.50 | 4381.72 | 4291.24 | 4035.71 | 4601.07 | 4183.40 | 4809.48 | 4579.81 | 4826.10 | 4104.01 | 4028.02 | 4152.67 | 4480.37 | 4021.13 | 4203.49 | 4121.28 | middle |
| 11 | 16 | mmu-let-7a-5p | TGAGGTAGTAGGTTGTATAGTT | 22 | chr9 | + | 41536716 | 41536812 | ctgcatgttcccaggtTGAGGTAGTAGGTTGTATAGTTtagagttacatcaagggagataaCTGTACAGCCTCCTAGCTTTCCttgggacttgcaca | 13 | mmu-let-7a-2,rno-let-7a-2,hsa-let-7a-2,bta-let-7a-2,eca-let-7a,ppy-let-7a-2,ptr-let-7a-2,mml-let-7a-2,cfa-let-7a-2,mdo-let-7a-2,ssc-let-7a-1,gga-let-7a-2,tgu-let-7a-2, | mmu-let-7a-2 | ctgcatgttcccaggtTGAGGTAGTAGGTTGTATAGTTtagagttacatcaagggagataaCTGTACAGCCTCCTAGCTTTCcttgggacttgcac | mmu-let-7a-5p | TGAGGTAGTAGGTTGTATAGTT | 5' | Yes | gp1a | .((((.(.(((((((..(((.(((.(((((((((((((.........(((......)))))))))))))))).))).)))..)))))))).)))).. | 94 | 45.40 | -41.10 | 98639.42 | 94202.88 | 137356.73 | 89197.09 | 106817.52 | 96001.56 | 95779.28 | 125896.74 | 96625.36 | 107807.40 | 127633.44 | 118942.68 | 85914.39 | 151662.25 | 139922.05 | 116388.86 | 106760.09 | 111021.68 | 112408.09 | 101987.91 | 107151.83 | 105154.26 | 109446.12 | 109032.61 | 103540.91 | 114834.80 | 117238.52 | 104309.52 | 110448.84 | 115876.32 | high |
| 11 | 17 | mmu-let-7a-2-3p_R+1 | CTGTACAGCCTCCTAGCTTTCC | 22 | chr9 | + | 41536716 | 41536812 | ctgcatgttcccaggtTGAGGTAGTAGGTTGTATAGTTtagagttacatcaagggagataaCTGTACAGCCTCCTAGCTTTCCttgggacttgcaca | 13 | mmu-let-7a-2,rno-let-7a-2,hsa-let-7a-2,bta-let-7a-2,eca-let-7a,ppy-let-7a-2,ptr-let-7a-2,mml-let-7a-2,cfa-let-7a-2,mdo-let-7a-2,ssc-let-7a-1,gga-let-7a-2,tgu-let-7a-2, | mmu-let-7a-2 | ctgcatgttcccaggtTGAGGTAGTAGGTTGTATAGTTtagagttacatcaagggagataaCTGTACAGCCTCCTAGCTTTCcttgggacttgcac | mmu-let-7a-2-3p | CTGTACAGCCTCCTAGCTTTC | 3' | Diff | gp1a | .((((.(.(((((((..(((.(((.(((((((((((((.........(((......)))))))))))))))).))).)))..)))))))).)))).. | 94 | 45.40 | -41.10 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 10 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.68 | 0 | 0 | 8.69 | 0 | 0 | 0 | 4.93 | 0 | 0 | 0 | low |
| 12 | 18 | mmu-let-7g-5p | TGAGGTAGTAGTTTGTACAGTT | 22 | chr9 | + | 106178827 | 106178932 | cttttgcctgattccaggcTGAGGTAGTAGTTTGTACAGTTtgagggtctatgataccacccggtacaggagataaCTGTACAGGCCACTGCCTTGCCaggaacag | 21 | mmu-let-7g,rno-let-7g,eca-let-7g,cgr-let-7g,hsa-let-7g,ppy-let-7g,mml-let-7g,bta-let-7g,ptr-let-7g,mdo-let-7g,oar-let-7g,gga-let-7g,cfa-let-7g,tch-let-7g,oan-let-7g,ssc-let-7g,ggo-let-7g,chi-let-7g,tgu-let-7g-1,tgu-let-7g-2,xtr-let-7g, | mmu-let-7g | ccaggcTGAGGTAGTAGTTTGTACAGTTtgagggtctatgataccacccggtacaggagataACTGTACAGGCCACTGCCTTGCcagg | mmu-let-7g-5p | TGAGGTAGTAGTTTGTACAGTT | 5' | Yes | gp1a | .......(((.((((.(((.((((((((.(..(((((((((.....((((.((.((((....))))))..)))))))))))))..).))))))))))).))))))) | 99 | 50 | -45.90 | 347981.50 | 357863.91 | 484141.81 | 334419.90 | 401024.85 | 339955.28 | 348518.37 | 484052.18 | 345706.55 | 374166.47 | 444641.58 | 382631.48 | 292987.13 | 515333.09 | 453415.15 | 410598.24 | 405567.06 | 391318.57 | 421443.18 | 382893.06 | 379439.98 | 382631.72 | 420802.26 | 390097.22 | 359358.79 | 400054.43 | 377149.32 | 355718.60 | 375294.05 | 375495.33 | high |
| 12 | 19 | mmu-let-7g-3p_L-1R+1 | CTGTACAGGCCACTGCCTTGCT | 22 | chr9 | + | 106178827 | 106178932 | cttttgcctgattccaggcTGAGGTAGTAGTTTGTACAGTTtgagggtctatgataccacccggtacaggagataaCTGTACAGGCCACTGCCTTGCCaggaacag | 21 | mmu-let-7g,rno-let-7g,eca-let-7g,cgr-let-7g,hsa-let-7g,ppy-let-7g,mml-let-7g,bta-let-7g,ptr-let-7g,mdo-let-7g,oar-let-7g,gga-let-7g,cfa-let-7g,tch-let-7g,oan-let-7g,ssc-let-7g,ggo-let-7g,chi-let-7g,tgu-let-7g-1,tgu-let-7g-2,xtr-let-7g, | mmu-let-7g | ccaggcTGAGGTAGTAGTTTGTACAGTTtgagggtctatgataccacccggtacaggagataACTGTACAGGCCACTGCCTTGCcagg | mmu-let-7g-3p | ACTGTACAGGCCACTGCCTTGC | 3' | Diff | gp1a | .......(((.((((.(((.((((((((.(..(((((((((.....((((.((.((((....))))))..)))))))))))))..).))))))))))).))))))) | 99 | 50 | -45.90 | 256 | 220 | 345 | 182 | 336 | 225 | 246 | 382 | 243 | 262 | 309 | 215 | 238 | 514 | 394 | 302.07 | 249.33 | 278.85 | 229.36 | 320.81 | 251.13 | 270.08 | 332.08 | 274.20 | 251.63 | 278.01 | 211.92 | 288.96 | 374.32 | 326.29 | middle |
| 13 | 20 | mmu-let-7c-5p | TGAGGTAGTAGGTTGTATGGTT | 22 | chr15 | + | 85706598 | 85706704 | gactgacggcctttggggTGAGGTAGTAGGTTGTATGGTTttgggctctgccccgctctgcggtaaCTATACAATCTACTGTCTTTCCtgaagtggccgcaatatct | 14 | mmu-let-7c-2,rno-let-7c-2,hsa-let-7a-3,bta-let-7a-3,ppy-let-7a-3,mml-let-7a-3,eca-let-7a-2,ptr-let-7a-3,cfa-let-7a-1,ggo-let-7a,chi-let-7a,gga-let-7a-3,tgu-let-7a-1,xtr-let-7e-2, | mmu-let-7c-2 | acggcctttggggTGAGGTAGTAGGTTGTATGGTTttgggctctgccccgctctgcggtaaCTATACAATCTACTGTCTTTCCtgaagtggccgc | mmu-let-7c-5p | TGAGGTAGTAGGTTGTATGGTT | 5' | Yes | gp1a | ...((.((((((((..((..((..((((((((((((((((..((((...))))(((...)))..))))))))))))))))..))..))..))).)))))))...... | 98 | 51.40 | -47.70 | 256014.92 | 238300.05 | 359463.89 | 224975.42 | 262720.02 | 244497.40 | 249622.12 | 316377.41 | 242901.86 | 278146.57 | 327210.28 | 313292.84 | 220474.06 | 383505.75 | 360616.05 | 302082.94 | 270065.37 | 290544.83 | 283518.88 | 250841.49 | 272894.97 | 274055.40 | 275037.15 | 274091.83 | 267138.89 | 294398.74 | 308804.14 | 267679.76 | 279290.10 | 298643.84 | high |
| 13 | 21 | mmu-let-7c-2-3p | CTATACAATCTACTGTCTTTCC | 22 | chr15 | + | 85706598 | 85706704 | gactgacggcctttggggTGAGGTAGTAGGTTGTATGGTTttgggctctgccccgctctgcggtaaCTATACAATCTACTGTCTTTCCtgaagtggccgcaatatct | 14 | mmu-let-7c-2,rno-let-7c-2,hsa-let-7a-3,bta-let-7a-3,ppy-let-7a-3,mml-let-7a-3,eca-let-7a-2,ptr-let-7a-3,cfa-let-7a-1,ggo-let-7a,chi-let-7a,gga-let-7a-3,tgu-let-7a-1,xtr-let-7e-2, | mmu-let-7c-2 | acggcctttggggTGAGGTAGTAGGTTGTATGGTTttgggctctgccccgctctgcggtaaCTATACAATCTACTGTCTTTCCtgaagtggccgc | mmu-let-7c-2-3p | CTATACAATCTACTGTCTTTCC | 3' | Yes | gp1a | ...((.((((((((..((..((..((((((((((((((((..((((...))))(((...)))..))))))))))))))))..))..))..))).)))))))...... | 98 | 51.40 | -47.70 | 949.50 | 764.50 | 1284.50 | 793 | 1107.50 | 916 | 1000 | 1244 | 888.50 | 1014.50 | 1309.50 | 1024.50 | 740 | 1461.50 | 1270 | 1120.36 | 866.41 | 1038.23 | 999.36 | 1057.43 | 1022.39 | 1097.88 | 1081.45 | 1002.59 | 974.35 | 1178.19 | 1009.82 | 898.44 | 1064.35 | 1051.75 | middle |
| 14 | 22 | mmu-miR-7a-5p_R+1 | TGGAAGACTAGTGATTTTGTTGTT | 24 | chr7 | + | 78888277 | 78888373 | ggtcgggccagccccgttTGGAAGACTAGTGATTTTGTTGTTgtgtctctgtatccaacaacaagtcccagtctgccacatggtgctggtcatttca | 6 | mmu-mir-7a-2,rno-mir-7a-2,eca-mir-7-1,cfa-mir-7-2,ssc-mir-7-1,tch-mir-7-2, | mmu-mir-7a-2 | ggtcgggccagccccgttTGGAAGACTAGTGATTTTGTTGTtgtgtctctgtatccaaCAACAAGTCCCAGTCTGCCACAtggtgctggtcatttca | mmu-miR-7a-5p | TGGAAGACTAGTGATTTTGTTGT | 5' | Diff | gp1a | ((...(((((((.((((.(((.(((((...((.((((((((((..(......)..))))))))))))..))))).))).)))).)))))))...)). | 96 | 50.50 | -40.30 | 1695.50 | 1854.50 | 2230.50 | 1748.50 | 2500 | 1986.50 | 2013.50 | 2702.50 | 1702.50 | 2202.50 | 2243.50 | 2135.50 | 1577 | 3062.50 | 2642.50 | 2000.59 | 2101.70 | 1802.85 | 2203.50 | 2386.97 | 2217.23 | 2210.58 | 2349.37 | 1921.11 | 2115.34 | 2018.53 | 2104.90 | 1914.65 | 2230.28 | 2188.38 | middle |
| 15 | 23 | mmu-let-7c-5p | TGAGGTAGTAGGTTGTATGGTT | 22 | chr16 | + | 77599630 | 77599774 | taaggagtttgaagaaacattggaagctgtgtgcatccgggtTGAGGTAGTAGGTTGTATGGTTtagagttacaccctgggagttaaCTGTACAACCTTCTAGCTTTCCttggagcacacttgagccatcgaggaattctccatc | 21 | mmu-let-7c-1,rno-let-7c-1,cgr-let-7c,hsa-let-7c,bta-let-7c,ppy-let-7c,mml-let-7c,oar-let-7c,gga-let-7c,eca-let-7c,ptr-let-7c,cfa-let-7c,efu-let-7c,oan-let-7c-1,oan-let-7c-2,ssc-let-7c,ggo-let-7c,chi-let-7c,tgu-let-7c-1,tgu-let-7c-2,xtr-let-7c, | mmu-let-7c-1 | tgtgtgcatccgggtTGAGGTAGTAGGTTGTATGGTTtagagttacaccctgggagttaaCTGTACAACCTTCTAGCTTTCCttggagcacact | mmu-let-7c-5p | TGAGGTAGTAGGTTGTATGGTT | 5' | Yes | gp1a | ...((((.............(((.....((((((.(((..(..(((.(((.((((((((..(((..((.(..(.....)..).)))))..)))))))).))).)))..)..))))))))).....)))..........))))... | 108 | 45.50 | -50.60 | 256014.92 | 238300.05 | 359463.89 | 224975.42 | 262720.02 | 244497.40 | 249622.12 | 316377.41 | 242901.86 | 278146.57 | 327210.28 | 313292.84 | 220474.06 | 383505.75 | 360616.05 | 302082.94 | 270065.37 | 290544.83 | 283518.88 | 250841.49 | 272894.97 | 274055.40 | 275037.15 | 274091.83 | 267138.89 | 294398.74 | 308804.14 | 267679.76 | 279290.10 | 298643.84 | high |
| 15 | 24 | mmu-let-7c-1-3p | CTGTACAACCTTCTAGCTTTCC | 22 | chr16 | + | 77599630 | 77599774 | taaggagtttgaagaaacattggaagctgtgtgcatccgggtTGAGGTAGTAGGTTGTATGGTTtagagttacaccctgggagttaaCTGTACAACCTTCTAGCTTTCCttggagcacacttgagccatcgaggaattctccatc | 21 | mmu-let-7c-1,rno-let-7c-1,cgr-let-7c,hsa-let-7c,bta-let-7c,ppy-let-7c,mml-let-7c,oar-let-7c,gga-let-7c,eca-let-7c,ptr-let-7c,cfa-let-7c,efu-let-7c,oan-let-7c-1,oan-let-7c-2,ssc-let-7c,ggo-let-7c,chi-let-7c,tgu-let-7c-1,tgu-let-7c-2,xtr-let-7c, | mmu-let-7c-1 | tgtgtgcatccgggtTGAGGTAGTAGGTTGTATGGTTtagagttacaccctgggagttaaCTGTACAACCTTCTAGCTTTCCttggagcacact | mmu-let-7c-1-3p | CTGTACAACCTTCTAGCTTTCC | 3' | Yes | gp1a | ...((((.............(((.....((((((.(((..(..(((.(((.((((((((..(((..((.(..(.....)..).)))))..)))))))).))).)))..)..))))))))).....)))..........))))... | 108 | 45.50 | -50.60 | 66 | 26 | 172 | 98 | 144 | 109 | 98 | 139 | 81 | 85 | 143 | 113 | 51 | 119 | 96 | 77.88 | 29.47 | 139.02 | 123.50 | 137.49 | 121.66 | 107.59 | 120.84 | 91.40 | 81.64 | 128.66 | 111.38 | 61.92 | 86.66 | 79.50 | middle |
| 16 | 25 | mmu-let-7k_R+1_1ss9GT | TGAGGTAGTAGGTTGTGTGC | 20 | chr5 | - | 147283189 | 147283298 | tagccacagccctaaccctagccTGAGGTAGGAGGTTGTGTGCaagctcaccactaacctatagtacacagagagcctttatcccacaacacaacacaaaacaatacttc | 1 | mmu-let-7k, | mmu-let-7k | tagccacagccctaaccctagccTGAGGTAGGAGGTTGTGTGcaagctcaccactaacctatagtacacagagagcctttatcccacaacacaacacaaaacaatacttc | mmu-let-7k | TGAGGTAGGAGGTTGTGTG | 5' | Diff | gp1a | ..((((((((((..(((.........)))..).))))))).))..((((...((((.....)))).......)))).................................. | 41 | 47.30 | -20.70 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.50 | 0 | 2.50 | 0 | 0 | 3.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.04 | 0 | 2.07 | low |
| 17 | 26 | mmu-let-7f-5p | TGAGGTAGTAGATTGTATAGTT | 22 | chrX | + | 151912346 | 151912428 | tgtgggaTGAGGTAGTAGATTGTATAGTTttagggtcataccccatcttggagataaCTATACAGTCTACTGTCTTTCCcacg | 11 | mmu-let-7f-2,rno-let-7f-2,hsa-let-7f-2,bta-let-7f-2,ppy-let-7f-2,mml-let-7f-2,ssc-let-7f-1,oar-let-7f,ptr-let-7f-2,mdo-let-7f-2,xtr-let-7f, | mmu-let-7f-2 | tgtgggaTGAGGTAGTAGATTGTATAGTTttagggtcataccccatcttggagataaCTATACAGTCTACTGTCTTTCccacg | mmu-let-7f-5p | TGAGGTAGTAGATTGTATAGTT | 5' | Yes | gp1a | .((((((.(((..((((((((((((((((...(((.....))).(((.....)))))))))))))))))))..))))))))). | 81 | 42.20 | -40.70 | 223988.23 | 224054.36 | 310075.11 | 216241.50 | 263199.10 | 228574.61 | 227177.07 | 309683.24 | 224084.71 | 239972.10 | 295836.61 | 253926.48 | 194858.84 | 350808.30 | 318058.70 | 264293.29 | 253920.74 | 250625.22 | 272512.21 | 251298.92 | 255122.81 | 249413.40 | 269217.69 | 252858.46 | 230475.18 | 266171.12 | 250288.34 | 236580.07 | 255478.01 | 263400.01 | high |
| 17 | 27 | mmu-let-7f-2-3p_R+1 | CTATACAGTCTACTGTCTTTCT | 22 | chrX | + | 151912346 | 151912428 | tgtgggaTGAGGTAGTAGATTGTATAGTTttagggtcataccccatcttggagataaCTATACAGTCTACTGTCTTTCCcacg | 11 | mmu-let-7f-2,rno-let-7f-2,hsa-let-7f-2,bta-let-7f-2,ppy-let-7f-2,mml-let-7f-2,ssc-let-7f-1,oar-let-7f,ptr-let-7f-2,mdo-let-7f-2,xtr-let-7f, | mmu-let-7f-2 | tgtgggaTGAGGTAGTAGATTGTATAGTTttagggtcataccccatcttggagataaCTATACAGTCTACTGTCTTTCccacg | mmu-let-7f-2-3p | CTATACAGTCTACTGTCTTTC | 3' | Diff | gp1a | .((((((.(((..((((((((((((((((...(((.....))).(((.....)))))))))))))))))))..))))))))). | 81 | 42.20 | -40.70 | 379.50 | 311.50 | 522 | 309.50 | 425 | 375 | 401.50 | 428.50 | 338.50 | 411.50 | 519.50 | 401 | 312 | 601.50 | 549.50 | 447.79 | 353.02 | 421.92 | 390.04 | 405.78 | 418.56 | 440.80 | 372.51 | 381.97 | 395.21 | 467.41 | 395.25 | 378.80 | 438.05 | 455.07 | middle |
| 18 | 28 | mmu-miR-7a-5p_R+1 | TGGAAGACTAGTGATTTTGTTGTT | 24 | chr13 | - | 58392775 | 58392920 | ttatacagagcctgtagaaaatgtagaagagacattggatgttggcctagttctgtgTGGAAGACTAGTGATTTTGTTGTTtttagataactaaaacgaCAACAAATCACAGTCTGCCATAtggcacaggccacctctacaggaca | 26 | mmu-mir-7a-1,rno-mir-7a-1,hsa-mir-7-1,ppy-mir-7-1,ggo-mir-7-1,ppa-mir-7-1,lla-mir-7,bta-mir-7-2,eca-mir-7-3,ptr-mir-7-1,mml-mir-7-1,mne-mir-7-1,cfa-mir-7-1,tch-mir-7-3,tch-mir-7-4,efu-mir-7b,mdo-mir-7,oan-mir-7-1,ssc-mir-7-2,aja-mir-7,chi-mir-7,sha-mir-7,sla-mir-7,gga-mir-7-1,tgu-mir-7-1,xtr-mir-7-1, | mmu-mir-7a-1 | ttggatgttggcctagttctgtgTGGAAGACTAGTGATTTTGTTGTttttagataactaaaacgaCAACAAATCACAGTCTGCCATAtggcacaggccacctctacag | mmu-miR-7a-5p | TGGAAGACTAGTGATTTTGTTGT | 5' | Diff | gp1a | ..........((((((((.(((((.......)))))......((((((.((.(..(((((.(((((.((((.((((((((((((((....)))))..)))))))))))))))))).)))))..).))))))))..))))))))... | 91 | 40.40 | -58.10 | 1695.50 | 1854.50 | 2230.50 | 1748.50 | 2500 | 1986.50 | 2013.50 | 2702.50 | 1702.50 | 2202.50 | 2243.50 | 2135.50 | 1577 | 3062.50 | 2642.50 | 2000.59 | 2101.70 | 1802.85 | 2203.50 | 2386.97 | 2217.23 | 2210.58 | 2349.37 | 1921.11 | 2115.34 | 2018.53 | 2104.90 | 1914.65 | 2230.28 | 2188.38 | middle |
| 18 | 29 | mmu-miR-7a-1-3p | CAACAAATCACAGTCTGCCATA | 22 | chr13 | - | 58392775 | 58392920 | ttatacagagcctgtagaaaatgtagaagagacattggatgttggcctagttctgtgTGGAAGACTAGTGATTTTGTTGTTtttagataactaaaacgaCAACAAATCACAGTCTGCCATAtggcacaggccacctctacaggaca | 26 | mmu-mir-7a-1,rno-mir-7a-1,hsa-mir-7-1,ppy-mir-7-1,ggo-mir-7-1,ppa-mir-7-1,lla-mir-7,bta-mir-7-2,eca-mir-7-3,ptr-mir-7-1,mml-mir-7-1,mne-mir-7-1,cfa-mir-7-1,tch-mir-7-3,tch-mir-7-4,efu-mir-7b,mdo-mir-7,oan-mir-7-1,ssc-mir-7-2,aja-mir-7,chi-mir-7,sha-mir-7,sla-mir-7,gga-mir-7-1,tgu-mir-7-1,xtr-mir-7-1, | mmu-mir-7a-1 | ttggatgttggcctagttctgtgTGGAAGACTAGTGATTTTGTTGTttttagataactaaaacgaCAACAAATCACAGTCTGCCATAtggcacaggccacctctacag | mmu-miR-7a-1-3p | CAACAAATCACAGTCTGCCATA | 3' | Yes | gp1a | ..........((((((((.(((((.......)))))......((((((.((.(..(((((.(((((.((((.((((((((((((((....)))))..)))))))))))))))))).)))))..).))))))))..))))))))... | 91 | 40.40 | -58.10 | 313 | 350 | 450 | 285 | 405 | 334 | 345 | 418 | 335 | 364 | 433 | 396 | 282 | 513 | 465 | 369.32 | 396.65 | 363.72 | 359.16 | 386.69 | 372.79 | 378.77 | 363.38 | 378.02 | 349.59 | 389.58 | 390.33 | 342.38 | 373.59 | 385.09 | middle |
| 19 | 30 | mmu-let-7a-5p | TGAGGTAGTAGGTTGTATAGTT | 22 | chr13 | - | 48538171 | 48538272 | ttcactgtgggaTGAGGTAGTAGGTTGTATAGTTttagggtcacacccaccactgggagataaCTATACAATCTACTGTCTTTCCtaaggtgatggaaaagt | 14 | mmu-let-7a-1,rno-let-7a-1,cgr-let-7a,hsa-let-7a-1,bta-let-7a-1,ppy-let-7a-1,mml-let-7a-1,ptr-let-7a-1,mdo-let-7a-1,ssc-let-7a-2,oar-let-7a,gga-let-7a-1,tgu-let-7a-3,xtr-let-7e-1, | mmu-let-7a-1 | ttcactgtgggaTGAGGTAGTAGGTTGTATAGTTttagggtcacacccaccactgggagataaCTATACAATCTACTGTCTTTCCtaaggtgat | mmu-let-7a-5p | TGAGGTAGTAGGTTGTATAGTT | 5' | Yes | gp1a | .((((..(((((.(((..((((((((((((((((...(((.....))).((....))....))))))))))))))))..))))))))..))))......... | 92 | 42.20 | -43.20 | 98639.42 | 94202.88 | 137356.73 | 89197.09 | 106817.52 | 96001.56 | 95779.28 | 125896.74 | 96625.36 | 107807.40 | 127633.44 | 118942.68 | 85914.39 | 151662.25 | 139922.05 | 116388.86 | 106760.09 | 111021.68 | 112408.09 | 101987.91 | 107151.83 | 105154.26 | 109446.12 | 109032.61 | 103540.91 | 114834.80 | 117238.52 | 104309.52 | 110448.84 | 115876.32 | high |
| 19 | 31 | mmu-let-7c-2-3p_1ss22CT | CTATACAATCTACTGTCTTTCT | 22 | chr13 | - | 48538171 | 48538272 | ttcactgtgggaTGAGGTAGTAGGTTGTATAGTTttagggtcacacccaccactgggagataaCTATACAATCTACTGTCTTTCCtaaggtgatggaaaagt | 14 | mmu-let-7a-1,rno-let-7a-1,cgr-let-7a,hsa-let-7a-1,bta-let-7a-1,ppy-let-7a-1,mml-let-7a-1,ptr-let-7a-1,mdo-let-7a-1,ssc-let-7a-2,oar-let-7a,gga-let-7a-1,tgu-let-7a-3,xtr-let-7e-1, | mmu-let-7a-1 | ttcactgtgggaTGAGGTAGTAGGTTGTATAGTTttagggtcacacccaccactgggagataaCTATACAATCTACTGTCTTTCCtaaggtgat | mmu-let-7c-2-3p | CTATACAATCTACTGTCTTTCC | 3' | Diff | gp1a | .((((..(((((.(((..((((((((((((((((...(((.....))).((....))....))))))))))))))))..))))))))..))))......... | 92 | 42.20 | -43.20 | 3381 | 2650 | 4267.50 | 2821.50 | 3906.50 | 3154 | 3380.50 | 4303.50 | 2932 | 3536 | 4314 | 3636.50 | 2574 | 5306 | 4422.50 | 3989.39 | 3003.24 | 3449.30 | 3555.72 | 3729.87 | 3520.33 | 3711.39 | 3741.17 | 3308.49 | 3396.06 | 3881.41 | 3584.40 | 3125.12 | 3864.12 | 3662.49 | middle |
| 20 | 32 | mmu-miR-9-5p | TCTTTGGTTATCTAGCTGTATGA | 23 | chr7 | + | 79505240 | 79505369 | gcgcggcagcggtgccggcgaatgggaggcccgtttctcTCTTTGGTTATCTAGCTGTATGAgtgccacagagccgtcaTAAAGCTAGATAACCGAAAGTagaaatgactctcacaacttctgcgtgcga | 14 | mmu-mir-9-3,bta-mir-9-1,ppy-mir-9-3,rno-mir-9a-3,hsa-mir-9-3,mml-mir-9-3,cfa-mir-9-3,tch-mir-9-2,efu-mir-9-2,mdo-mir-9a-1,ssc-mir-9-3,chi-mir-9,tgu-mir-9-1,xtr-mir-9-3, | mmu-mir-9-3 | ggaggcccgtttctcTCTTTGGTTATCTAGCTGTATGAgtgccacagagccgtcATAAAGCTAGATAACCGAAAGTagaaatgactctca | mmu-miR-9-5p | TCTTTGGTTATCTAGCTGTATGA | 5' | Yes | gp1a | ((((.((((..((.(((.....)))((((..(((((((((.(((((((((((((((.(((((..((......))..))))).))))))))))))))))).)))))))..))))...))..)))))))).. | 88 | 53.10 | -55 | 1756.67 | 1886.67 | 2398.67 | 2036 | 2176.33 | 1380 | 1415.67 | 2298.33 | 1731.67 | 1791.67 | 2047.67 | 1864 | 1511 | 3006.67 | 2473.67 | 2072.77 | 2138.16 | 1938.78 | 2565.81 | 2077.93 | 1540.28 | 1554.23 | 1998.02 | 1954.02 | 1720.76 | 1842.33 | 1837.29 | 1834.52 | 2189.62 | 2048.56 | middle |
| 20 | 33 | mmu-miR-9-3p_L-1 | TAAAGCTAGATAACCGAAAGT | 21 | chr7 | + | 79505240 | 79505369 | gcgcggcagcggtgccggcgaatgggaggcccgtttctcTCTTTGGTTATCTAGCTGTATGAgtgccacagagccgtcaTAAAGCTAGATAACCGAAAGTagaaatgactctcacaacttctgcgtgcga | 14 | mmu-mir-9-3,bta-mir-9-1,ppy-mir-9-3,rno-mir-9a-3,hsa-mir-9-3,mml-mir-9-3,cfa-mir-9-3,tch-mir-9-2,efu-mir-9-2,mdo-mir-9a-1,ssc-mir-9-3,chi-mir-9,tgu-mir-9-1,xtr-mir-9-3, | mmu-mir-9-3 | ggaggcccgtttctcTCTTTGGTTATCTAGCTGTATGAgtgccacagagccgtcATAAAGCTAGATAACCGAAAGTagaaatgactctca | mmu-miR-9-3p | ATAAAGCTAGATAACCGAAAGT | 3' | Diff | gp1a | ((((.((((..((.(((.....)))((((..(((((((((.(((((((((((((((.(((((..((......))..))))).))))))))))))))))).)))))))..))))...))..)))))))).. | 88 | 53.10 | -55 | 396.83 | 533.67 | 615.67 | 481.50 | 509.17 | 337.83 | 346.17 | 479.17 | 407.33 | 450.17 | 442.83 | 415 | 365.33 | 667.33 | 525.17 | 468.24 | 604.80 | 497.63 | 606.80 | 486.15 | 377.07 | 380.05 | 416.56 | 459.64 | 432.35 | 398.43 | 409.05 | 443.55 | 485.99 | 434.92 | middle |
| 21 | 34 | mmu-miR-9-5p | TCTTTGGTTATCTAGCTGTATGA | 23 | chr3 | + | 88215585 | 88215702 | ggcggccaggaggcggggttggttgttaTCTTTGGTTATCTAGCTGTATGAgtggtgtggagtcttcaTAAAGCTAGATAACCGAAAGTaaaaataaccccatacactgcgcagaggg | 13 | mmu-mir-9-1,rno-mir-9a-1,hsa-mir-9-1,ppy-mir-9-1,mml-mir-9-1,ssc-mir-9-1,eca-mir-9a,ptr-mir-9-1,cfa-mir-9-1,efu-mir-9-1,mdo-mir-9a-3,tch-mir-9-3,xtr-mir-9a-1, | mmu-mir-9-1 | cggggttggttgttaTCTTTGGTTATCTAGCTGTATGAgtggtgtggagtcttcATAAAGCTAGATAACCGAAAGTaaaaataacccca | mmu-miR-9-5p | TCTTTGGTTATCTAGCTGTATGA | 5' | Yes | gp1a | .(((..(((.....(((((((....(((..(((((((((((((((.((((((.((.......)))))))).)))))))))))))))..)))...))))))).....))))))...... | 111 | 48.30 | -47.50 | 1756.67 | 1886.67 | 2398.67 | 2036 | 2176.33 | 1380 | 1415.67 | 2298.33 | 1731.67 | 1791.67 | 2047.67 | 1864 | 1511 | 3006.67 | 2473.67 | 2072.77 | 2138.16 | 1938.78 | 2565.81 | 2077.93 | 1540.28 | 1554.23 | 1998.02 | 1954.02 | 1720.76 | 1842.33 | 1837.29 | 1834.52 | 2189.62 | 2048.56 | middle |
| 21 | 35 | mmu-miR-9-3p_L-1 | TAAAGCTAGATAACCGAAAGT | 21 | chr3 | + | 88215585 | 88215702 | ggcggccaggaggcggggttggttgttaTCTTTGGTTATCTAGCTGTATGAgtggtgtggagtcttcaTAAAGCTAGATAACCGAAAGTaaaaataaccccatacactgcgcagaggg | 13 | mmu-mir-9-1,rno-mir-9a-1,hsa-mir-9-1,ppy-mir-9-1,mml-mir-9-1,ssc-mir-9-1,eca-mir-9a,ptr-mir-9-1,cfa-mir-9-1,efu-mir-9-1,mdo-mir-9a-3,tch-mir-9-3,xtr-mir-9a-1, | mmu-mir-9-1 | cggggttggttgttaTCTTTGGTTATCTAGCTGTATGAgtggtgtggagtcttcATAAAGCTAGATAACCGAAAGTaaaaataacccca | mmu-miR-9-3p | ATAAAGCTAGATAACCGAAAGT | 3' | Diff | gp1a | .(((..(((.....(((((((....(((..(((((((((((((((.((((((.((.......)))))))).)))))))))))))))..)))...))))))).....))))))...... | 111 | 48.30 | -47.50 | 396.83 | 533.67 | 615.67 | 481.50 | 509.17 | 337.83 | 346.17 | 479.17 | 407.33 | 450.17 | 442.83 | 415 | 365.33 | 667.33 | 525.17 | 468.24 | 604.80 | 497.63 | 606.80 | 486.15 | 377.07 | 380.05 | 416.56 | 459.64 | 432.35 | 398.43 | 409.05 | 443.55 | 485.99 | 434.92 | middle |
| 22 | 36 | mmu-miR-9-5p | TCTTTGGTTATCTAGCTGTATGA | 23 | chr13 | + | 83738801 | 83738894 | gtgagggaagcgagttgttaTCTTTGGTTATCTAGCTGTATGAgtgtattggtcttcaTAAAGCTAGATAACCGAAAGTaaaaactccttcaag | 22 | mmu-mir-9-2,rno-mir-9a-2,hsa-mir-9-2,bta-mir-9-2,ptr-mir-9-2,mml-mir-9-2,ssc-mir-9-2,ggo-mir-9,mne-mir-9,age-mir-9,lla-mir-9,cgr-mir-9,eca-mir-9a-2,ppy-mir-9-2,mdo-mir-9a-2,cfa-mir-9-2,efu-mir-9-3,oan-mir-9-2,tch-mir-9-1,gga-mir-9-2,tgu-mir-9-2,xtr-mir-9a-2, | mmu-mir-9-2 | gttgttaTCTTTGGTTATCTAGCTGTATGAgtgtattggtcttcATAAAGCTAGATAACCGAAAGTaaaaac | mmu-miR-9-5p | TCTTTGGTTATCTAGCTGTATGA | 5' | Yes | gp1a | ......((((.(((((.(((..(((((((((((((((.((((((..(....)..)))))).)))))))))))))))..))).)))))))))... | 85 | 38.30 | -40.10 | 1756.67 | 1886.67 | 2398.67 | 2036 | 2176.33 | 1380 | 1415.67 | 2298.33 | 1731.67 | 1791.67 | 2047.67 | 1864 | 1511 | 3006.67 | 2473.67 | 2072.77 | 2138.16 | 1938.78 | 2565.81 | 2077.93 | 1540.28 | 1554.23 | 1998.02 | 1954.02 | 1720.76 | 1842.33 | 1837.29 | 1834.52 | 2189.62 | 2048.56 | middle |
| 22 | 37 | mmu-miR-9-3p_L-1 | TAAAGCTAGATAACCGAAAGT | 21 | chr13 | + | 83738801 | 83738894 | gtgagggaagcgagttgttaTCTTTGGTTATCTAGCTGTATGAgtgtattggtcttcaTAAAGCTAGATAACCGAAAGTaaaaactccttcaag | 22 | mmu-mir-9-2,rno-mir-9a-2,hsa-mir-9-2,bta-mir-9-2,ptr-mir-9-2,mml-mir-9-2,ssc-mir-9-2,ggo-mir-9,mne-mir-9,age-mir-9,lla-mir-9,cgr-mir-9,eca-mir-9a-2,ppy-mir-9-2,mdo-mir-9a-2,cfa-mir-9-2,efu-mir-9-3,oan-mir-9-2,tch-mir-9-1,gga-mir-9-2,tgu-mir-9-2,xtr-mir-9a-2, | mmu-mir-9-2 | gttgttaTCTTTGGTTATCTAGCTGTATGAgtgtattggtcttcATAAAGCTAGATAACCGAAAGTaaaaac | mmu-miR-9-3p | ATAAAGCTAGATAACCGAAAGT | 3' | Diff | gp1a | ......((((.(((((.(((..(((((((((((((((.((((((..(....)..)))))).)))))))))))))))..))).)))))))))... | 85 | 38.30 | -40.10 | 396.83 | 533.67 | 615.67 | 481.50 | 509.17 | 337.83 | 346.17 | 479.17 | 407.33 | 450.17 | 442.83 | 415 | 365.33 | 667.33 | 525.17 | 468.24 | 604.80 | 497.63 | 606.80 | 486.15 | 377.07 | 380.05 | 416.56 | 459.64 | 432.35 | 398.43 | 409.05 | 443.55 | 485.99 | 434.92 | middle |
| 23 | 38 | mmu-miR-10a-5p_R-1 | TACCCTGTAGATCCGAATTTGT | 22 | chr11 | + | 96317160 | 96317275 | aagaagacctgtctgtcttctgtataTACCCTGTAGATCCGAATTTGTgtaaggaattttgtggtcaCAAATTCGTATCTAGGGGAATatgtagttgacataaacactccgctcat | 20 | mmu-mir-10a,rno-mir-10a,cgr-mir-10a,hsa-mir-10a,ggo-mir-10a,bta-mir-10a,oar-mir-10a,eca-mir-10a,ppy-mir-10a,ptr-mir-10a,mml-mir-10a,cfa-mir-10a,mdo-mir-10a,oan-mir-10a,ssc-mir-10a,chi-mir-10a,ppa-mir-10a,age-mir-10a,sla-mir-10a,gga-mir-10a, | mmu-mir-10a | gacctgtctgtcttctgtataTACCCTGTAGATCCGAATTTGTGtaaggaattttgtggtcaCAAATTCGTATCTAGGGGAATAtgtagttgacataaacactccgctca | mmu-miR-10a-5p | TACCCTGTAGATCCGAATTTGTG | 5' | Diff | gp1a | .(((((((......))))))).(((((.((((.(((((.((((((((((................)))))))))).))))))))).)))))..(((......)))........... | 69 | 38.80 | -33.20 | 944488.50 | 893187.50 | 1071414 | 963528.50 | 1158644.50 | 821312 | 919515.50 | 1090818 | 849627 | 1098807.50 | 1158597 | 960418.50 | 900721.50 | 1549966 | 1221946 | 1114442.35 | 1012249.11 | 865994.61 | 1214259.40 | 1106257.99 | 916704.71 | 1009518.67 | 948283.48 | 958723.90 | 1055322.08 | 1042416.84 | 946658.10 | 1093574.98 | 1128770.96 | 1011953.42 | high |
| 23 | 39 | mmu-miR-10a-3p_R-1 | CAAATTCGTATCTAGGGGAAT | 21 | chr11 | + | 96317160 | 96317275 | aagaagacctgtctgtcttctgtataTACCCTGTAGATCCGAATTTGTgtaaggaattttgtggtcaCAAATTCGTATCTAGGGGAATatgtagttgacataaacactccgctcat | 20 | mmu-mir-10a,rno-mir-10a,cgr-mir-10a,hsa-mir-10a,ggo-mir-10a,bta-mir-10a,oar-mir-10a,eca-mir-10a,ppy-mir-10a,ptr-mir-10a,mml-mir-10a,cfa-mir-10a,mdo-mir-10a,oan-mir-10a,ssc-mir-10a,chi-mir-10a,ppa-mir-10a,age-mir-10a,sla-mir-10a,gga-mir-10a, | mmu-mir-10a | gacctgtctgtcttctgtataTACCCTGTAGATCCGAATTTGTGtaaggaattttgtggtcaCAAATTCGTATCTAGGGGAATAtgtagttgacataaacactccgctca | mmu-miR-10a-3p | CAAATTCGTATCTAGGGGAATA | 3' | Diff | gp1a | .(((((((......))))))).(((((.((((.(((((.((((((((((................)))))))))).))))))))).)))))..(((......)))........... | 69 | 38.80 | -33.20 | 3846 | 3852 | 5966 | 3672 | 5139 | 3601 | 4117 | 4976 | 4282 | 4312 | 4956 | 4461 | 3717 | 6325 | 5639 | 4538.06 | 4365.47 | 4822.15 | 4627.53 | 4906.65 | 4019.24 | 4519.98 | 4325.80 | 4831.83 | 4141.35 | 4459.03 | 4397.09 | 4512.85 | 4606.21 | 4669.93 | middle |
| 24 | 40 | mmu-miR-10b-5p_R-1 | TACCCTGTAGAACCGAATTTGT | 22 | chr2 | + | 74726051 | 74726157 | gaggttgtaacgttgtctatataTACCCTGTAGAACCGAATTTGTgtggtacccacatagtcACAGATTCGATTCTAGGGGAATatatggtcgatgcaaaaacttca | 23 | mmu-mir-10b,rno-mir-10b,cgr-mir-10b,hsa-mir-10b,ppa-mir-10b,bta-mir-10b,eca-mir-10b,ppy-mir-10b,mml-mir-10b,ptr-mir-10b,cfa-mir-10b,mdo-mir-10b,oan-mir-10b,ssc-mir-10b,ggo-mir-10b,chi-mir-10b,tch-mir-10b-1,tch-mir-10b-2,oar-mir-10b,mne-mir-10b,gga-mir-10b,tgu-mir-10a,xtr-mir-10b, | mmu-mir-10b | tataTACCCTGTAGAACCGAATTTGTGtggtacccacatagtcaCAGATTCGATTCTAGGGGAATAta | mmu-miR-10b-5p | TACCCTGTAGAACCGAATTTGTG | 5' | Diff | gp1a | ((((((....(((((.((((((((.((((.(((((.((((((((((..((......))...)))))))))).))))))))).)))))))).)))))....)))))). | 106 | 40.20 | -43.40 | 516479.50 | 516543.50 | 576749 | 558929.50 | 633122.50 | 444558 | 467206.50 | 592326 | 440836 | 587832.50 | 603649 | 528695.50 | 474556.50 | 823388 | 616648 | 609416.24 | 585398.59 | 466170.43 | 704375.01 | 604496.74 | 496191.96 | 512937.18 | 514928.21 | 497441.83 | 564568.97 | 543117.14 | 521120.61 | 576163.79 | 599636.68 | 510676.46 | high |
| 24 | 41 | mmu-miR-10b-3p_L+1R-1 | ACAGATTCGATTCTAGGGGAAT | 22 | chr2 | + | 74726051 | 74726157 | gaggttgtaacgttgtctatataTACCCTGTAGAACCGAATTTGTgtggtacccacatagtcACAGATTCGATTCTAGGGGAATatatggtcgatgcaaaaacttca | 23 | mmu-mir-10b,rno-mir-10b,cgr-mir-10b,hsa-mir-10b,ppa-mir-10b,bta-mir-10b,eca-mir-10b,ppy-mir-10b,mml-mir-10b,ptr-mir-10b,cfa-mir-10b,mdo-mir-10b,oan-mir-10b,ssc-mir-10b,ggo-mir-10b,chi-mir-10b,tch-mir-10b-1,tch-mir-10b-2,oar-mir-10b,mne-mir-10b,gga-mir-10b,tgu-mir-10a,xtr-mir-10b, | mmu-mir-10b | tataTACCCTGTAGAACCGAATTTGTGtggtacccacatagtcaCAGATTCGATTCTAGGGGAATAta | mmu-miR-10b-3p | CAGATTCGATTCTAGGGGAATA | 3' | Diff | gp1a | ((((((....(((((.((((((((.((((.(((((.((((((((((..((......))...)))))))))).))))))))).)))))))).)))))....)))))). | 106 | 40.20 | -43.40 | 1706 | 1753 | 2619 | 1695 | 2481 | 1511 | 1793 | 2256 | 1866 | 1842 | 2261 | 1852 | 1615 | 2643 | 2326 | 2012.98 | 1986.67 | 2116.87 | 2136.08 | 2368.83 | 1686.50 | 1968.50 | 1961.21 | 2105.60 | 1769.10 | 2034.27 | 1825.47 | 1960.79 | 1924.78 | 1926.27 | middle |
| 25 | 42 | mmu-miR-15a-5p_R-1 | TAGCAGCACATAATGGTTTGT | 21 | chr14 | - | 61632017 | 61632110 | cccttggagtaaagTAGCAGCACATAATGGTTTGTggatgttgaaaaggtgCAGGCCATACTGTGCTGCCTCAaaatacaaggacctgatcttc | 23 | mmu-mir-15a,rno-mir-15a,cgr-mir-15a,hsa-mir-15a,bta-mir-15a,ppy-mir-15a,ptr-mir-15a,mml-mir-15a,ggo-mir-15a,ppa-mir-15a,mne-mir-15a,age-mir-15a,lla-mir-15a,sla-mir-15a,lca-mir-15a,eca-mir-15a,cfa-mir-15a,tch-mir-15a,mdo-mir-15a,oan-mir-15a,ssc-mir-15a,chi-mir-15a,xtr-mir-15a, | mmu-mir-15a | cccttggagtaaagTAGCAGCACATAATGGTTTGTGgatgttgaaaaggtgCAGGCCATACTGTGCTGCCTCAaaatacaagga | mmu-miR-15a-5p | TAGCAGCACATAATGGTTTGTG | 5' | Diff | gp1a | .(((((..........((((((((..((((..(((...............)))..))))..)))))))).........)))))........... | 53 | 45.70 | -29 | 12164 | 17094 | 19635 | 12188 | 15316 | 15009 | 13874 | 17556 | 16110 | 18923 | 16141 | 15820 | 13229 | 22255 | 18919 | 14352.82 | 19372.62 | 15870.43 | 15359.58 | 14623.51 | 16752.25 | 15232.00 | 15262.00 | 18178.61 | 18174.12 | 14522.44 | 15593.34 | 16061.46 | 16207.32 | 15667.75 | high |
| 25 | 43 | mmu-miR-15a-3p_1ss22AT | CAGGCCATACTGTGCTGCCTCT | 22 | chr14 | - | 61632017 | 61632110 | cccttggagtaaagTAGCAGCACATAATGGTTTGTggatgttgaaaaggtgCAGGCCATACTGTGCTGCCTCAaaatacaaggacctgatcttc | 23 | mmu-mir-15a,rno-mir-15a,cgr-mir-15a,hsa-mir-15a,bta-mir-15a,ppy-mir-15a,ptr-mir-15a,mml-mir-15a,ggo-mir-15a,ppa-mir-15a,mne-mir-15a,age-mir-15a,lla-mir-15a,sla-mir-15a,lca-mir-15a,eca-mir-15a,cfa-mir-15a,tch-mir-15a,mdo-mir-15a,oan-mir-15a,ssc-mir-15a,chi-mir-15a,xtr-mir-15a, | mmu-mir-15a | cccttggagtaaagTAGCAGCACATAATGGTTTGTGgatgttgaaaaggtgCAGGCCATACTGTGCTGCCTCAaaatacaagga | mmu-miR-15a-3p | CAGGCCATACTGTGCTGCCTCA | 3' | Diff | gp1a | .(((((..........((((((((..((((..(((...............)))..))))..)))))))).........)))))........... | 53 | 45.70 | -29 | 189 | 225 | 286 | 221 | 241 | 250 | 280 | 306 | 243 | 274 | 311 | 243 | 205 | 407 | 379 | 223.01 | 254.99 | 231.17 | 278.51 | 230.10 | 279.04 | 307.41 | 266.02 | 274.20 | 263.16 | 279.81 | 239.52 | 248.89 | 296.40 | 313.87 | middle |
| 26 | 44 | mmu-miR-15b-5p | TAGCAGCACATCATGGTTTACA | 22 | chr3 | + | 69009756 | 69009853 | ttggaaccttaaagtactgTAGCAGCACATCATGGTTTACAtactacagtcaagatgCGAATCATTATTTGCTGCTCTagaaatttaaggaaattcat | 18 | mmu-mir-15b,eca-mir-15b,rno-mir-15b,cgr-mir-15b,hsa-mir-15b,ppy-mir-15b,ptr-mir-15b,ggo-mir-15b,ppa-mir-15b,bta-mir-15b,mml-mir-15b,chi-mir-15b,mne-mir-15b,age-mir-15b,lla-mir-15b,cfa-mir-15b,tch-mir-15b,ssc-mir-15b, | mmu-mir-15b | ctgTAGCAGCACATCATGGTTTACAtactacagtcaagatgCGAATCATTATTTGCTGCTCTAg | mmu-miR-15b-5p | TAGCAGCACATCATGGTTTACA | 5' | Yes | gp1a | .((((.(((((((...((..(((((((.((.((((((..(((.((.......)))))..)))))).)).)))))))..))...)))))))...)))). | 96 | 34.70 | -29.10 | 4534 | 5769 | 6200 | 4334 | 5066 | 4502 | 4282 | 5329 | 4073 | 5702 | 5238 | 5220 | 3827 | 5944 | 5385 | 5349.86 | 6538.01 | 5011.29 | 5461.80 | 4836.95 | 5024.89 | 4701.13 | 4632.67 | 4596.00 | 5476.34 | 4712.75 | 5145.21 | 4646.40 | 4328.75 | 4459.58 | middle |
document location: Final_Report/3_Summary/2_miRNAExpression/Table5_All_Expressed_miRNA.xlsx
Differential expression of miRNAs based on normalized deep-sequencing counts was analyzed by selectively using Fisher exact test, Chi-squared 2X2 test, Chi-squared nXn test, Student t test, or ANOVA based on the experiments design. The significance threshold was set to be 0.01 and 0.05 in each test.
| Index | miR_name | miR_seq | up/down | fold_change(C_12MK(mean)/C_3MK(mean)) | log2(fold_change) | pvalue(t_test) | C_3MK(mean) | C_12MK(mean) | C_12MK/C_12MK17(norm) | C_12MK/C_12MK18(norm) | C_12MK/C_12MK19(norm) | C_12MK/C_12MK20(norm) | C_12MK/C_12MK21(norm) | C_3MK/C_3MK5(norm) | C_3MK/C_3MK6(norm) | C_3MK/C_3MK7(norm) | C_3MK/C_3MK8(norm) | C_3MK/C_3MK9(norm) | C_12MK/C_12MK17(raw) | C_12MK/C_12MK18(raw) | C_12MK/C_12MK19(raw) | C_12MK/C_12MK20(raw) | C_12MK/C_12MK21(raw) | C_3MK/C_3MK5(raw) | C_3MK/C_3MK6(raw) | C_3MK/C_3MK7(raw) | C_3MK/C_3MK8(raw) | C_3MK/C_3MK9(raw) | Expression level |
| 1 | mmu-miR-335-3p | TTTTTCATTATTGCTCCTGACC | down | 0.68 | -0.55 | 0.00 | 479.99 | 326.78 | 313.64 | 332.66 | 336.43 | 322.72 | 328.47 | 455.46 | 502.05 | 424.34 | 501.57 | 516.54 | 281 | 303 | 387 | 286 | 342 | 386 | 443 | 525 | 398 | 541 | middle |
| 2 | mmu-miR-200b-3p_R+1 | TAATACTGCCTGGTAATGATGAC | down | 0.93 | -0.11 | 0.00 | 180528.84 | 167335.83 | 167322.11 | 168956.76 | 169744.12 | 165323.84 | 165332.34 | 180854.54 | 185882.11 | 182410.16 | 178732.82 | 174764.58 | 149910.50 | 153893.50 | 195258 | 146511 | 172145 | 153274 | 164018.50 | 225679 | 141826.50 | 183040.50 | high |
| 3 | mmu-miR-378a-3p_R+1 | ACTGGACTTGGAGTCAGAAGGC | down | 0.90 | -0.16 | 0.00 | 127591.39 | 114354.43 | 111184.21 | 111711.96 | 118075.78 | 119854.17 | 110946.04 | 130103.04 | 127374.57 | 121437.71 | 131806.15 | 127235.47 | 99614.33 | 101752.33 | 135823.50 | 106215.50 | 115517.67 | 110262.17 | 112392.67 | 150243.50 | 104589.67 | 133260.67 | high |
| 4 | efu-miR-9226_L-4_1ss22GT | GTCCCTGTTCGGGCGCCT | up | 7.49 | 2.91 | 0.00 | 0.97 | 7.27 | 7.81 | 6.59 | 9.56 | 5.64 | 6.72 | 0 | 0 | 4.85 | 0 | 0 | 7 | 6 | 11 | 5 | 7 | 0 | 0 | 6 | 0 | 0 | low |
| 5 | mmu-miR-296-5p | AGGGCCCCCCCTCAATCCTGT | down | 0.39 | -1.35 | 0.00 | 29.18 | 11.41 | 20.09 | 12.08 | 8.69 | 5.64 | 10.56 | 27.14 | 27.20 | 23.44 | 28.99 | 39.15 | 18 | 11 | 10 | 5 | 11 | 23 | 24 | 29 | 23 | 41 | middle |
| 6 | mmu-miR-144-3p_R-1 | TACAGTATAGATGATGTAC | down | 0.60 | -0.74 | 0.00 | 10722.51 | 6405.07 | 6775.01 | 4952.54 | 5747.16 | 6949.85 | 7600.80 | 12697.36 | 11963.11 | 8502.22 | 10546.79 | 9903.04 | 6070 | 4511 | 6611 | 6159 | 7914 | 10761 | 10556 | 10519 | 8369 | 10372 | middle |
| 7 | mmu-miR-375-3p | TTTGTTCGTTCGGCTCGCGTGA | up | 1.38 | 0.47 | 0.00 | 1320.72 | 1823.26 | 2009.06 | 1984.97 | 1876.89 | 1658.76 | 1586.62 | 1195.28 | 1478.96 | 1538.14 | 1112.78 | 1278.46 | 1800 | 1808 | 2159 | 1470 | 1652 | 1013 | 1305 | 1903 | 883 | 1339 | middle |
| 8 | mmu-miR-208a-3p | ATAAGACGAGCAAAAAGCTTGT | down | 0.60 | -0.74 | 0.00 | 58.37 | 35.07 | 35.72 | 24.15 | 33.03 | 44.01 | 38.42 | 56.64 | 58.93 | 57.39 | 45.37 | 73.52 | 32 | 22 | 38 | 39 | 40 | 48 | 52 | 71 | 36 | 77 | middle |
| 9 | mmu-miR-124-3p | TAAGGCACGCGGTGAATGCC | up | 31.74 | 4.99 | 0.00 | 14.96 | 474.70 | 263.04 | 600.54 | 313.25 | 593.54 | 603.15 | 17.31 | 13.98 | 10.51 | 31.09 | 1.91 | 235.67 | 547 | 360.33 | 526 | 628 | 14.67 | 12.33 | 13 | 24.67 | 2 | middle |
| 10 | mmu-miR-592-5p_L-1 | TTGTGTCAATATGCGATGATGT | up | 3.31 | 1.73 | 0.00 | 3.32 | 11.00 | 15.63 | 9.88 | 7.82 | 10.16 | 11.53 | 5.90 | 0 | 4.04 | 0 | 6.68 | 14 | 9 | 9 | 9 | 12 | 5 | 0 | 5 | 0 | 7 | middle |
| 11 | mmu-miR-486a-5p | TCCTGTACTGAGCTGCCCCGAG | down | 0.46 | -1.12 | 0.00 | 9162.65 | 4202.38 | 3967.90 | 3559.33 | 3376.49 | 4149.71 | 5958.48 | 9214.76 | 12626.66 | 6721.60 | 8227.99 | 9022.25 | 3555 | 3242 | 3884 | 3677.50 | 6204 | 7809.50 | 11141.50 | 8316 | 6529 | 9449.50 | middle |
| 12 | mmu-miR-3058-5p_R-3 | TCAGCCACGGCTTACCTGGA | down | 0.64 | -0.64 | 0.01 | 98.91 | 63.49 | 62.50 | 53.80 | 66.94 | 75.60 | 58.59 | 100.30 | 70.26 | 104.27 | 110.90 | 108.85 | 56 | 49 | 77 | 67 | 61 | 85 | 62 | 129 | 88 | 114 | middle |
| 13 | mmu-miR-511-3p | AATGTGTAGCAAAAGACAGGAT | up | 1.90 | 0.92 | 0.01 | 141.06 | 267.43 | 299.13 | 323.87 | 297.31 | 232.45 | 184.40 | 97.94 | 117.86 | 192.37 | 107.12 | 190.00 | 268 | 295 | 342 | 206 | 192 | 83 | 104 | 238 | 85 | 199 | middle |
| 14 | mmu-miR-199b-5p_1ss10TC | CCCAGTGTTCAGACTACCTGTTC | up | 1.42 | 0.50 | 0.01 | 28553.94 | 40491.54 | 39260.83 | 50260.26 | 39432.63 | 37686.87 | 35817.13 | 25466.31 | 30048.69 | 33021.44 | 25595.10 | 28638.18 | 35175.33 | 45779.33 | 45359.67 | 33398.33 | 37293 | 21582.67 | 26514.33 | 40854.33 | 20310 | 29994.33 | high |
| 15 | mmu-miR-199a-5p | CCCAGTGTTCAGACTACCTGTTC | up | 1.42 | 0.50 | 0.01 | 28553.94 | 40491.54 | 39260.83 | 50260.26 | 39432.63 | 37686.87 | 35817.13 | 25466.31 | 30048.69 | 33021.44 | 25595.10 | 28638.18 | 35175.33 | 45779.33 | 45359.67 | 33398.33 | 37293 | 21582.67 | 26514.33 | 40854.33 | 20310 | 29994.33 | high |
| 16 | mmu-miR-542-3p_R-2 | TGTGACAGATTGATAACTGA | down | 0.82 | -0.28 | 0.01 | 652.41 | 537.13 | 481.06 | 533.57 | 550.29 | 580.00 | 540.72 | 664.31 | 678.85 | 599.74 | 723.37 | 595.79 | 431 | 486 | 633 | 514 | 563 | 563 | 599 | 742 | 574 | 624 | middle |
| 17 | mmu-miR-335-5p_R-2 | TCAAGAGCAATAACGAAAAAT | down | 0.71 | -0.50 | 0.01 | 4199.32 | 2978.76 | 2837.24 | 2874.25 | 2975.72 | 3015.10 | 3191.49 | 4341.01 | 4220.41 | 3329.27 | 4837.99 | 4267.90 | 2542 | 2618 | 3423 | 2672 | 3323 | 3679 | 3724 | 4119 | 3839 | 4470 | middle |
| 18 | mmu-miR-29b-2-5p_R-2 | CTGGTTTCACATGGTGGCTTAGA | up | 1.21 | 0.28 | 0.01 | 288.73 | 349.88 | 382.84 | 305.21 | 351.21 | 350.93 | 359.20 | 276.11 | 291.26 | 282.90 | 297.41 | 295.98 | 343 | 278 | 404 | 311 | 374 | 234 | 257 | 350 | 236 | 310 | middle |
| 19 | hsa-miR-378c_R-2_2ss21AG22GC | ACTGGACTTGGAGTCAGAAGGCT | down | 0.88 | -0.18 | 0.01 | 9067.98 | 7984.80 | 7204.73 | 8129.81 | 8058.71 | 8160.63 | 8370.10 | 9938.66 | 8592.68 | 8967.78 | 9008.06 | 8832.73 | 6455 | 7405 | 9270 | 7232 | 8715 | 8423 | 7582 | 11095 | 7148 | 9251 | middle |
| 20 | hsa-miR-4508_L+2R-1 | AAGCGGGGCTGGGCGCGC | down | 0.18 | -2.44 | 0.01 | 5.96 | 1.10 | 0 | 5.49 | 0 | 0 | 0 | 7.08 | 6.80 | 4.85 | 6.30 | 4.77 | 0 | 5 | 0 | 0 | 0 | 6 | 6 | 6 | 5 | 5 | low |
| 21 | mmu-miR-200b-5p | CATCTTACTGGGCAGCATTGGA | down | 0.90 | -0.15 | 0.01 | 1819.32 | 1634.47 | 1574.88 | 1743.44 | 1615.22 | 1705.02 | 1533.80 | 1723.90 | 1755.48 | 1916.41 | 1839.92 | 1860.88 | 1411 | 1588 | 1858 | 1511 | 1597 | 1461 | 1549 | 2371 | 1460 | 1949 | middle |
| 22 | mmu-miR-199b-3p_R-1 | ACAGTAGTCTGCACATTGGTT | up | 1.39 | 0.48 | 0.01 | 35629.42 | 49620.83 | 51071.34 | 56322.21 | 55201.89 | 46249.40 | 39259.29 | 28520.00 | 37443.28 | 41244.00 | 31668.53 | 39271.32 | 45756.83 | 51300.83 | 63499.17 | 40986.50 | 40877 | 24170.67 | 33039.17 | 51027.33 | 25129.33 | 41131 | high |
| 23 | mmu-miR-144-5p | GGATATCATCATATACTGTAAGT | down | 0.55 | -0.87 | 0.01 | 2808.58 | 1534.50 | 1695.43 | 1033.11 | 1410.93 | 1481.60 | 2051.47 | 3636.58 | 3252.57 | 1990.78 | 2802.73 | 2360.23 | 1519 | 941 | 1623 | 1313 | 2136 | 3082 | 2870 | 2463 | 2224 | 2472 | middle |
| 24 | mmu-miR-574-5p | TGAGTGTGTGTGTGTGAGTGTGT | up | 1.25 | 0.32 | 0.01 | 214.43 | 268.31 | 264.53 | 306.31 | 273.84 | 227.94 | 268.92 | 223.01 | 206.26 | 217.43 | 223.06 | 202.41 | 237 | 279 | 315 | 202 | 280 | 189 | 182 | 269 | 177 | 212 | middle |
| 25 | mmu-miR-147-3p_R-1 | GTGTGCGGAAATGCTTCTGCT | up | 4.07 | 2.03 | 0.01 | 5.37 | 21.86 | 20.09 | 30.74 | 25.21 | 16.93 | 16.33 | 0 | 6.80 | 0 | 0 | 20.05 | 18 | 28 | 29 | 15 | 17 | 0 | 6 | 0 | 0 | 21 | middle |
| 26 | xtr-miR-200b_R+1_1ss23TA | TAATACTGCCTGGTAATGATGAAT | down | 0.92 | -0.12 | 0.01 | 360.10 | 330.37 | 344.89 | 348.03 | 310.35 | 318.21 | 330.39 | 366.96 | 371.72 | 360.49 | 356.64 | 344.68 | 309 | 317 | 357 | 282 | 344 | 311 | 328 | 446 | 283 | 361 | middle |
| 27 | mmu-miR-139-5p_R+1 | TCTACAGTGCACGTGTCTCCAGT | up | 1.11 | 0.15 | 0.01 | 6358.36 | 7050.53 | 6982.61 | 7011.07 | 7223.28 | 6967.90 | 7067.77 | 6489.69 | 6517.61 | 5767.03 | 6759.83 | 6257.67 | 6256 | 6386 | 8309 | 6175 | 7359 | 5500 | 5751 | 7135 | 5364 | 6554 | middle |
| 28 | mmu-miR-9-3p_L-1 | TAAAGCTAGATAACCGAAAGT | down | 0.78 | -0.37 | 0.01 | 532.72 | 413.13 | 377.07 | 380.05 | 416.56 | 459.64 | 432.35 | 468.24 | 604.80 | 497.63 | 606.80 | 486.15 | 337.83 | 346.17 | 479.17 | 407.33 | 450.17 | 396.83 | 533.67 | 615.67 | 481.50 | 509.17 | middle |
| 29 | mmu-miR-190b-5p_R+2 | TGATATGTTTGATATTGGGTTGT | down | 0.66 | -0.59 | 0.01 | 54.84 | 36.33 | 23.44 | 50.50 | 38.25 | 40.62 | 28.81 | 54.28 | 48.73 | 49.30 | 61.75 | 60.15 | 21 | 46 | 44 | 36 | 30 | 46 | 43 | 61 | 49 | 63 | middle |
| 30 | mmu-miR-615-3p_R-1 | TCCGAGCCTGGGTCTCCCTCT | down | 0.83 | -0.26 | 0.01 | 2846.97 | 2372.79 | 2269.13 | 2684.32 | 2401.97 | 2440.74 | 2067.79 | 3112.69 | 2577.12 | 3098.92 | 2686.79 | 2759.33 | 2033 | 2445 | 2763 | 2163 | 2153 | 2638 | 2274 | 3834 | 2132 | 2890 | middle |
| 31 | pma-miR-27a_R-1_1ss19CA | TTCACAGTGGCTAAGTTCAA | up | 1.32 | 0.40 | 0.01 | 53.20 | 70.15 | 74.78 | 71.36 | 60.85 | 68.83 | 74.91 | 37.76 | 53.27 | 58.20 | 64.27 | 52.51 | 67 | 65 | 70 | 61 | 78 | 32 | 47 | 72 | 51 | 55 | middle |
| 32 | mmu-miR-34c-5p | AGGCAGTGTAGTTAGCTGATTGC | up | 1.24 | 0.31 | 0.01 | 2926.15 | 3632.16 | 3945.58 | 3368.30 | 3488.63 | 3951.68 | 3406.63 | 2869.62 | 2592.99 | 2500.80 | 3400.08 | 3267.28 | 3535 | 3068 | 4013 | 3502 | 3547 | 2432 | 2288 | 3094 | 2698 | 3422 | middle |
| 33 | mmu-miR-155-5p | TTAATGCTAATTGTGATAGGGGT | up | 1.36 | 0.44 | 0.01 | 1394.43 | 1890.04 | 2300.38 | 1843.34 | 1596.09 | 1705.02 | 2005.37 | 1612.98 | 1109.50 | 1501.77 | 1217.37 | 1530.52 | 2061 | 1679 | 1836 | 1511 | 2088 | 1367 | 979 | 1858 | 966 | 1603 | middle |
| 34 | mmu-miR-30c-2-3p | CTGGGAGAAGGCTGTTTACTCT | down | 0.89 | -0.17 | 0.01 | 4034.10 | 3583.60 | 3409.83 | 3577.99 | 3638.16 | 3628.95 | 3663.06 | 4388.21 | 3779.55 | 3791.61 | 4195.28 | 4015.83 | 3055 | 3259 | 4185 | 3216 | 3814 | 3719 | 3335 | 4691 | 3329 | 4206 | middle |
| 35 | mmu-miR-30e-3p | CTTTCAGTCGGATGTTTACAGC | down | 0.92 | -0.12 | 0.02 | 23711.71 | 21799.98 | 19903.69 | 22027.89 | 22768.25 | 22242.00 | 22058.08 | 23213.01 | 24459.44 | 23659.76 | 24523.91 | 22702.43 | 17832.50 | 20064 | 26190.50 | 19711 | 22967 | 19673 | 21582.50 | 29272 | 19460 | 23777.50 | high |
| 36 | mmu-miR-142a-3p_L-1 | GTAGTGTTTCCTACTTTATGGA | up | 1.44 | 0.53 | 0.02 | 5606.56 | 8096.36 | 9771.86 | 6816.74 | 7499.73 | 7303.04 | 9090.42 | 5130.39 | 4670.33 | 5926.25 | 4544.36 | 7761.46 | 8755 | 6209 | 8627 | 6472 | 9465 | 4348 | 4121 | 7332 | 3606 | 8129 | middle |
| 37 | mmu-miR-141-5p | CATCTTCCAGTGCAGTGTTGGA | down | 0.72 | -0.47 | 0.02 | 74.73 | 54.13 | 55.81 | 60.38 | 43.47 | 55.29 | 55.70 | 77.88 | 53.27 | 81.64 | 76.87 | 84.02 | 50 | 55 | 50 | 49 | 58 | 66 | 47 | 101 | 61 | 88 | middle |
| 38 | mmu-miR-200c-3p | TAATACTGCCGGGTAATGATGGA | down | 0.87 | -0.20 | 0.02 | 13695.28 | 11945.85 | 12554.42 | 12255.65 | 10542.39 | 12011.31 | 12365.47 | 13124.50 | 14391.77 | 12691.50 | 15061.54 | 13207.08 | 11248 | 11163 | 12127 | 10644.50 | 12875 | 11123 | 12699 | 15702 | 11951.50 | 13832.50 | middle |
| 39 | mmu-miR-467d-3p | ATATACATACACACACCTACAC | up | 1.34 | 0.42 | 0.02 | 12.87 | 17.22 | 18.14 | 17.57 | 18.04 | 17.21 | 15.13 | 10.03 | 13.03 | 15.36 | 10.40 | 15.52 | 16.25 | 16 | 20.75 | 15.25 | 15.75 | 8.50 | 11.50 | 19 | 8.25 | 16.25 | middle |
| 40 | PC-3p-12776_151 | ACTGTGCCTCTCTGTTTTCAGT | up | 2.61 | 1.39 | 0.02 | 6.63 | 17.33 | 14.51 | 8.78 | 26.08 | 18.05 | 19.21 | 10.62 | 6.80 | 5.66 | 10.08 | 0 | 13 | 8 | 30 | 16 | 20 | 9 | 6 | 7 | 8 | 0 | middle |
| 41 | mmu-miR-451a_R+1 | AAACCGTTACCATTACTGAGTTT | down | 0.55 | -0.87 | 0.02 | 59802.86 | 32742.29 | 33628.38 | 22237.58 | 27104.05 | 32370.57 | 48370.84 | 75248.49 | 77585.70 | 40112.95 | 56664.60 | 49402.56 | 30129 | 20255 | 31178 | 28687 | 50364 | 63773 | 68460 | 49628 | 44964 | 51742 | high |
| 42 | mmu-miR-135a-5p | TATGGCTTTTTATTCCTATGTGA | up | 2.67 | 1.42 | 0.02 | 5.36 | 14.33 | 11.72 | 11.53 | 13.04 | 11.85 | 23.53 | 5.90 | 0 | 5.66 | 3.78 | 11.46 | 10.50 | 10.50 | 15 | 10.50 | 24.50 | 5 | 0 | 7 | 3 | 12 | middle |
| 43 | mmu-mir-653-p5 | TTGAAACAATCTCTACTGAACC | up | 1.46 | 0.54 | 0.02 | 337.76 | 491.77 | 504.50 | 499.54 | 502.47 | 468.29 | 484.05 | 285.55 | 316.19 | 282.09 | 303.71 | 501.26 | 452 | 455 | 578 | 415 | 504 | 242 | 279 | 349 | 241 | 525 | middle |
| 44 | mmu-miR-124-5p | CGTGTTCACAGCGGACCTTGAT | up | inf | inf | 0.02 | 0 | 6.62 | 3.35 | 7.69 | 2.61 | 12.41 | 7.04 | 0 | 0 | 0 | 0 | 0 | 3 | 7 | 3 | 11 | 7.33 | 0 | 0 | 0 | 0 | 0 | middle |
| 45 | mmu-miR-1968-5p_R-1 | TGCAGCTGTTAAGGATGGTGGAC | down | 0.82 | -0.29 | 0.02 | 189.19 | 154.70 | 175.24 | 135.04 | 172.13 | 129.77 | 161.35 | 204.13 | 190.39 | 203.68 | 170.13 | 177.59 | 157 | 123 | 198 | 115 | 168 | 173 | 168 | 252 | 135 | 186 | middle |
| 46 | bta-miR-2478_L+2 | TCGTATCCCACTTCTGACACCA | up | 1.41 | 0.49 | 0.02 | 97.32 | 137.12 | 148.45 | 122.96 | 140.83 | 152.33 | 121.01 | 69.62 | 70.26 | 109.93 | 122.24 | 114.57 | 133 | 112 | 162 | 135 | 126 | 59 | 62 | 136 | 97 | 120 | middle |
| 47 | mmu-miR-574-3p | CACGCTCATGCACACACCCACA | up | 1.09 | 0.12 | 0.02 | 867.80 | 943.46 | 973.28 | 994.68 | 950.18 | 904.98 | 894.16 | 834.22 | 874.91 | 871.32 | 826.71 | 931.87 | 872 | 906 | 1093 | 802 | 931 | 707 | 772 | 1078 | 656 | 976 | middle |
| 48 | mmu-miR-9-5p | TCTTTGGTTATCTAGCTGTATGA | down | 0.81 | -0.30 | 0.02 | 2158.69 | 1753.46 | 1540.28 | 1554.23 | 1998.02 | 1954.02 | 1720.76 | 2072.77 | 2138.16 | 1938.78 | 2565.81 | 2077.93 | 1380 | 1415.67 | 2298.33 | 1731.67 | 1791.67 | 1756.67 | 1886.67 | 2398.67 | 2036 | 2176.33 | middle |
| 49 | mmu-miR-5621-3p | TGGGCCCTCCAGACCTCATGC | up | 2.98 | 1.57 | 0.02 | 3.91 | 11.64 | 8.93 | 5.49 | 11.30 | 18.05 | 14.41 | 7.08 | 6.80 | 5.66 | 0 | 0 | 8 | 5 | 13 | 16 | 15 | 6 | 6 | 7 | 0 | 0 | middle |
| 50 | mmu-miR-142a-5p | CATAAAGTAGAAAGCACTACT | up | 1.39 | 0.48 | 0.02 | 15352.16 | 21342.98 | 23845.36 | 21664.49 | 21402.53 | 18459.02 | 21343.52 | 14622.44 | 10748.78 | 19721.45 | 12560.00 | 19108.14 | 21364 | 19733 | 24619.50 | 16358.50 | 22223 | 12392.50 | 9484.50 | 24399.50 | 9966.50 | 20013 | high |
| 51 | mmu-miR-339-5p_R-2 | TCCCTGTCCTCCAGGAGCTCA | up | 1.13 | 0.18 | 0.02 | 6732.81 | 7626.10 | 7863.25 | 6893.60 | 7793.57 | 8394.21 | 7185.90 | 6316.23 | 6710.27 | 7024.70 | 6864.43 | 6748.43 | 7045 | 6279 | 8965 | 7439 | 7482 | 5353 | 5921 | 8691 | 5447 | 7068 | middle |
| 52 | PC-3p-5037_668 | CAGTCGGTCCTGAGAGATG | up | 1.25 | 0.32 | 0.02 | 41.57 | 51.77 | 49.11 | 54.89 | 44.34 | 51.91 | 58.59 | 35.40 | 48.73 | 34.76 | 44.11 | 44.87 | 44 | 50 | 51 | 46 | 61 | 30 | 43 | 43 | 35 | 47 | middle |
| 53 | mmu-miR-378a-5p | CTCCTGACTCCAGGTCCTGTGT | down | 0.92 | -0.13 | 0.02 | 3309.30 | 3029.24 | 3003.55 | 3003.80 | 2774.91 | 3220.47 | 3143.47 | 3497.35 | 3367.03 | 3368.07 | 3183.32 | 3130.74 | 2691 | 2736 | 3192 | 2854 | 3273 | 2964 | 2971 | 4167 | 2526 | 3279 | middle |
| 54 | mmu-miR-7667-5p | GAGCCATCTCTCTAGCCCCTGA | up | 2.39 | 1.26 | 0.03 | 3.45 | 8.24 | 7.81 | 6.59 | 7.82 | 11.28 | 7.68 | 0 | 6.80 | 5.66 | 0 | 4.77 | 7 | 6 | 9 | 10 | 8 | 0 | 6 | 7 | 0 | 5 | middle |
| 55 | mmu-miR-214-3p | ACAGCAGGCACAGACAGGCAGT | up | 1.45 | 0.54 | 0.03 | 3250.49 | 4721.29 | 4647.63 | 6274.39 | 4783.07 | 4031.79 | 3869.55 | 2536.88 | 3387.43 | 4287.89 | 2565.81 | 3474.47 | 4164 | 5715 | 5502 | 3573 | 4029 | 2150 | 2989 | 5305 | 2036 | 3639 | middle |
| 56 | mmu-miR-30d-5p_R-2 | TGTAAACATCCCCGACTGGA | down | 0.92 | -0.11 | 0.03 | 330754.51 | 305807.78 | 287849.78 | 309716.64 | 299268.13 | 314131.77 | 318072.56 | 331586.92 | 336979.86 | 314761.97 | 354185.90 | 316257.87 | 257896 | 282104 | 344250.50 | 278385.50 | 331179 | 281019.50 | 297344 | 389425.50 | 281050.50 | 331234.17 | high |
| 57 | mmu-miR-130a-5p | GCTCTTTTCACATTGTGCTACT | up | 1.21 | 0.28 | 0.03 | 54.40 | 65.87 | 60.27 | 66.97 | 63.46 | 73.35 | 65.31 | 51.92 | 51.00 | 67.09 | 46.63 | 55.38 | 54 | 61 | 73 | 65 | 68 | 44 | 45 | 83 | 37 | 58 | middle |
| 58 | mmu-miR-29a-5p_R+1 | ACTGATTTCTTTTGGTGTTCAGA | up | 1.14 | 0.19 | 0.03 | 641.01 | 731.26 | 692.01 | 703.74 | 709.38 | 742.49 | 808.68 | 619.47 | 602.92 | 577.91 | 694.38 | 710.36 | 620 | 641 | 816 | 658 | 842 | 525 | 532 | 715 | 551 | 744 | middle |
| 59 | mmu-miR-214-5p | TGCCTGTCTACACTTGCTGTGC | up | 1.34 | 0.43 | 0.03 | 491.98 | 661.66 | 661.88 | 782.79 | 664.17 | 644.32 | 555.13 | 352.80 | 570.05 | 637.73 | 413.35 | 485.99 | 593 | 713 | 764 | 571 | 578 | 299 | 503 | 789 | 328 | 509 | middle |
| 60 | mmu-miR-29c-3p_R-1 | TAGCACCATTTGAAATCGGTT | up | 1.15 | 0.20 | 0.03 | 18149.44 | 20916.40 | 21512.24 | 18801.21 | 19635.90 | 22781.29 | 21851.35 | 16929.52 | 20939.13 | 16676.21 | 18142.15 | 18060.18 | 19273.67 | 17125 | 22587.33 | 20188.92 | 22751.75 | 14347.75 | 18476.25 | 20631.92 | 14396 | 18915.42 | high |
| 61 | mmu-miR-15a-3p_1ss22AT | CAGGCCATACTGTGCTGCCTCT | up | 1.14 | 0.19 | 0.03 | 243.56 | 277.96 | 279.04 | 307.41 | 266.02 | 274.20 | 263.16 | 223.01 | 254.99 | 231.17 | 278.51 | 230.10 | 250 | 280 | 306 | 243 | 274 | 189 | 225 | 286 | 221 | 241 | middle |
| 62 | mmu-miR-676-3p | CCGTCCTGAGGTTGTTGAGCT | up | 1.14 | 0.18 | 0.03 | 748.09 | 850.39 | 842.69 | 914.53 | 869.33 | 828.25 | 797.15 | 657.23 | 839.78 | 796.96 | 720.85 | 725.64 | 755 | 833 | 1000 | 734 | 830 | 557 | 741 | 986 | 572 | 760 | middle |
| 63 | bta-miR-339b_R+3 | TCCCTGTCCTCCAGGAGCTCATT | up | 1.12 | 0.16 | 0.03 | 423.49 | 474.73 | 476.59 | 417.19 | 497.26 | 490.86 | 491.74 | 435.40 | 446.52 | 413.84 | 443.60 | 378.10 | 427 | 380 | 572 | 435 | 512 | 369 | 394 | 512 | 352 | 396 | middle |
| 64 | mmu-miR-23a-3p | ATCACATTGCCAGGGATTTCC | up | 1.09 | 0.13 | 0.03 | 47288.41 | 51714.59 | 48176.80 | 51149.73 | 51774.40 | 52209.64 | 55262.37 | 49509.81 | 46146.83 | 43511.34 | 46721.45 | 50552.60 | 43163.50 | 46589.50 | 59556.50 | 46268.50 | 57539.50 | 41959.50 | 40719 | 53832.50 | 37074 | 52946.50 | high |
| 65 | mmu-miR-153-3p | TTGCATAGTCACAAAAGTGATC | up | 1.61 | 0.68 | 0.03 | 13.72 | 22.05 | 22.32 | 28.54 | 24.34 | 22.57 | 12.49 | 12.98 | 11.33 | 12.93 | 15.12 | 16.23 | 20 | 26 | 28 | 20 | 13 | 11 | 10 | 16 | 12 | 17 | middle |
| 66 | mmu-miR-16-2-3p | ACCAATATTATTGTGCTGCTTT | down | 0.87 | -0.19 | 0.03 | 383.30 | 335.15 | 370.56 | 298.62 | 328.61 | 328.37 | 349.59 | 387.02 | 402.32 | 341.90 | 364.20 | 421.06 | 332 | 272 | 378 | 291 | 364 | 328 | 355 | 423 | 289 | 441 | middle |
| 67 | mmu-miR-652-3p_R+1 | AATGGCGCCACTAGGGTTGTGT | down | 0.94 | -0.08 | 0.03 | 7606.12 | 7174.39 | 7240.44 | 7152.70 | 7118.96 | 7132.65 | 7227.20 | 7520.96 | 8061.16 | 7634.94 | 7595.36 | 7218.19 | 6487 | 6515 | 8189 | 6321 | 7525 | 6374 | 7113 | 9446 | 6027 | 7560 | middle |
| 68 | mmu-miR-146b-3p | GCCCTAGGGACTCAGTTCTGGT | up | 3.09 | 1.63 | 0.03 | 2.23 | 6.89 | 7.81 | 10.98 | 5.22 | 5.64 | 4.80 | 0 | 0 | 4.85 | 6.30 | 0 | 7 | 10 | 6 | 5 | 5 | 0 | 0 | 6 | 5 | 0 | middle |
| 69 | mmu-miR-15b-3p_R-1 | CGAATCATTATTTGCTGCTCT | up | 1.21 | 0.28 | 0.03 | 366.59 | 444.76 | 425.25 | 454.52 | 488.56 | 391.56 | 463.89 | 400.00 | 349.06 | 441.32 | 342.78 | 299.80 | 381 | 414 | 562 | 347 | 483 | 339 | 308 | 546 | 272 | 314 | middle |
| 70 | mmu-miR-503-3p | GAGTATTGTTTCCACTGCCTGG | down | 0.78 | -0.36 | 0.03 | 796.34 | 621.56 | 646.25 | 562.12 | 643.31 | 625.14 | 631.00 | 765.78 | 876.04 | 704.01 | 970.37 | 665.49 | 579 | 512 | 740 | 554 | 657 | 649 | 773 | 871 | 770 | 697 | middle |
| 71 | mmu-miR-455-5p_R+1 | TATGTGCCTTTGGACTACATCGT | down | 0.88 | -0.18 | 0.03 | 3006.13 | 2652.93 | 2717.82 | 2768.86 | 2782.73 | 2658.52 | 2336.71 | 2764.61 | 3143.77 | 3363.22 | 2898.51 | 2860.54 | 2435 | 2522 | 3201 | 2356 | 2433 | 2343 | 2774 | 4161 | 2300 | 2996 | middle |
| 72 | rno-miR-203b-3p_1ss10TC | TTGAACTGTCAAGAACCACTGG | up | 1.34 | 0.42 | 0.03 | 419.03 | 561.54 | 507.85 | 486.36 | 512.04 | 742.49 | 558.97 | 448.38 | 447.65 | 414.64 | 439.82 | 344.68 | 455 | 443 | 589 | 658 | 582 | 380 | 395 | 513 | 349 | 361 | middle |
| 73 | mmu-miR-137-3p | TTATTGCTTAAGAATACGCGTAG | up | 2.59 | 1.37 | 0.03 | 9.40 | 24.36 | 23.44 | 32.94 | 24.34 | 18.05 | 23.05 | 0 | 14.73 | 6.47 | 0 | 25.78 | 21 | 30 | 28 | 16 | 24 | 0 | 13 | 8 | 0 | 27 | middle |
| 74 | mmu-miR-34a-5p | TGGCAGTGTCTTAGCTGGTTGT | up | 1.30 | 0.38 | 0.04 | 17249.57 | 22379.13 | 24741.62 | 21087.00 | 22456.60 | 22919.05 | 20691.39 | 19010.06 | 13961.12 | 14809.98 | 15388.57 | 23078.14 | 22167 | 19207 | 25832 | 20311 | 21544 | 16111 | 12319 | 18323 | 12211 | 24171 | high |
| 75 | mmu-miR-350-3p | TTCACAAAGCCCATACACTTTC | up | 1.11 | 0.15 | 0.04 | 791.28 | 880.09 | 901.85 | 917.83 | 902.37 | 784.24 | 894.16 | 723.30 | 776.31 | 859.19 | 757.39 | 840.21 | 808 | 836 | 1038 | 695 | 931 | 613 | 685 | 1063 | 601 | 880 | middle |
| 76 | mdo-miR-219-5p_R+3 | TGATTGTCCAAACGCAATTCTCGT | up | 1.36 | 0.44 | 0.04 | 6.90 | 9.35 | 11.16 | 7.69 | 9.13 | 10.16 | 8.64 | 5.31 | 9.07 | 5.25 | 8.19 | 6.68 | 10 | 7 | 10.50 | 9 | 9 | 4.50 | 8 | 6.50 | 6.50 | 7 | middle |
| 77 | mmu-miR-488-3p_R+1 | TTGAAAGGCTGTTTCTTGGTCT | up | 1.65 | 0.72 | 0.04 | 14.88 | 24.49 | 27.90 | 28.54 | 19.13 | 18.05 | 28.81 | 17.70 | 5.67 | 23.44 | 11.34 | 16.23 | 25 | 26 | 22 | 16 | 30 | 15 | 5 | 29 | 9 | 17 | middle |
| 78 | mmu-miR-467e-5p | ATAAGTGTGAGCATGTATATGT | up | 1.41 | 0.49 | 0.04 | 80.03 | 112.68 | 103.80 | 111.98 | 118.23 | 134.28 | 95.08 | 47.20 | 87.26 | 98.61 | 63.01 | 104.07 | 93 | 102 | 136 | 119 | 99 | 40 | 77 | 122 | 50 | 109 | middle |
| 79 | mmu-miR-27a-3p | TTCACAGTGGCTAAGTTCCGC | up | 1.05 | 0.07 | 0.04 | 81099.97 | 85201.42 | 84400.23 | 86740.29 | 86473.37 | 87854.84 | 80538.35 | 79237.87 | 80849.60 | 78930.65 | 84652.23 | 81829.49 | 75617.50 | 79007 | 99471 | 77857.50 | 83857 | 67154 | 71340 | 97653.50 | 67172.50 | 85704.50 | high |
| 80 | mmu-miR-30c-5p_R+1 | TGTAAACATCCTACACTCTCAGCT | down | 0.92 | -0.12 | 0.04 | 576083.50 | 530327.37 | 514997.36 | 505210.65 | 533369.65 | 528127.51 | 569931.66 | 590172.75 | 607291.48 | 535195.84 | 600982.45 | 546774.97 | 461406.50 | 460168.83 | 613539.33 | 468029.83 | 593416.17 | 500170.67 | 535861.33 | 662147.67 | 476886.33 | 572667.33 | high |
| 81 | mmu-miR-183-3p_L-1R+1 | TGAATTACCGAAGGGCCATAAT | down | 0.82 | -0.28 | 0.04 | 37.62 | 30.95 | 32.37 | 35.13 | 23.47 | 34.98 | 28.81 | 34.22 | 43.07 | 37.99 | 36.55 | 36.28 | 29 | 32 | 27 | 31 | 30 | 29 | 38 | 47 | 29 | 38 | middle |
| 82 | mmu-miR-409-5p | AGGTTACCCGAGCAACTTTGCAT | down | 0.61 | -0.71 | 0.04 | 41.25 | 25.17 | 33.48 | 32.94 | 25.21 | 16.93 | 17.29 | 60.18 | 41.93 | 27.48 | 36.55 | 40.10 | 30 | 30 | 29 | 15 | 18 | 51 | 37 | 34 | 29 | 42 | middle |
| 83 | mmu-miR-380-3p_R-1 | TATGTAGTATGGTCCACATCT | up | 4.43 | 2.15 | 0.04 | 1.94 | 8.59 | 5.58 | 15.37 | 10.43 | 6.77 | 4.80 | 0 | 0 | 9.70 | 0 | 0 | 5 | 14 | 12 | 6 | 5 | 0 | 0 | 12 | 0 | 0 | middle |
| 84 | xtr-miR-187_R+1 | TCGTGTCTTGTGTTGCAGCCAT | up | 1.90 | 0.93 | 0.04 | 7.02 | 13.34 | 14.51 | 8.78 | 8.69 | 20.31 | 14.41 | 5.90 | 9.07 | 4.04 | 11.34 | 4.77 | 13 | 8 | 10 | 18 | 15 | 5 | 8 | 5 | 9 | 5 | middle |
| 85 | mmu-miR-150-5p | TCTCCCAACCCTTGTACCAGTG | up | 1.30 | 0.37 | 0.04 | 2192.77 | 2842.73 | 3062.71 | 2376.91 | 2477.60 | 2676.58 | 3619.84 | 2074.34 | 2158.94 | 2322.98 | 2128.51 | 2279.08 | 2744 | 2165 | 2850 | 2372 | 3769 | 1758 | 1905 | 2874 | 1689 | 2387 | middle |
| 86 | mmu-miR-542-5p | CTCGGGGATCATCATGTCACGA | down | 0.71 | -0.49 | 0.05 | 54.13 | 38.52 | 27.90 | 39.52 | 32.17 | 44.01 | 48.98 | 40.12 | 65.73 | 49.30 | 66.79 | 48.69 | 25 | 36 | 37 | 39 | 51 | 34 | 58 | 61 | 53 | 51 | middle |
| 87 | mmu-miR-33-5p_R-1 | GTGCATTGTAGTTGCATTGC | up | 1.18 | 0.24 | 0.05 | 732.32 | 867.57 | 924.17 | 758.64 | 858.90 | 1000.90 | 795.23 | 637.17 | 794.44 | 652.28 | 805.28 | 772.42 | 828 | 691 | 988 | 887 | 828 | 540 | 701 | 807 | 639 | 809 | middle |
| 88 | mmu-miR-130b-5p | ACTCTTTCCCTGTTGCACTACT | up | 1.47 | 0.56 | 0.05 | 28.50 | 41.97 | 43.53 | 47.21 | 55.64 | 32.72 | 30.73 | 24.78 | 19.27 | 36.37 | 27.72 | 34.37 | 39 | 43 | 64 | 29 | 32 | 21 | 17 | 45 | 22 | 36 | middle |
| 89 | PC-3p-6005_506 | TCCGGTGTCCTTTACTCCAGT | up | 1.27 | 0.34 | 0.05 | 27.71 | 35.05 | 36.83 | 29.64 | 36.51 | 33.85 | 38.42 | 21.24 | 36.27 | 27.48 | 23.94 | 29.60 | 33 | 27 | 42 | 30 | 40 | 18 | 32 | 34 | 19 | 31 | middle |
| 90 | mmu-miR-223-3p_R+1 | TGTCAGTTTGTCAAATACCCCAT | up | 1.45 | 0.54 | 0.05 | 1423.62 | 2063.49 | 2077.15 | 2475.72 | 2326.33 | 1721.95 | 1716.28 | 2089.68 | 839.78 | 1660.19 | 1076.23 | 1452.23 | 1861 | 2255 | 2676 | 1526 | 1787 | 1771 | 741 | 2054 | 854 | 1521 | middle |
| 91 | mmu-miR-148a-5p | AAAGTTCTGAGACACTCCGACT | up | 1.53 | 0.61 | 0.05 | 38.26 | 58.40 | 66.97 | 66.97 | 57.38 | 69.96 | 30.73 | 36.58 | 26.07 | 41.22 | 37.81 | 49.65 | 60 | 61 | 66 | 62 | 32 | 31 | 23 | 51 | 30 | 52 | middle |
document location: Final_Report/3_Summary/3_DifferentiallymiRNAs/Table8.*_*vs*.xlsx
Heatmap is a graphical representation of data where the individual z values (repeated) or Log10 (non-repeated) contained in a matrix are represented as color scheme. Calculation formula of z value is shown below. Sample-i means expression level (the value after normalization).
document location: Final_Report/3_Summary/3_DifferentiallymiRNAs/Fig6.1_heatmap_of_differentially_expressed_miRNAs.pdf
document location: Final_Report/3_Summary/3_DifferentiallymiRNAs/Fig6.2_volcano_of_differentially_expressed_miRNAs.pdf
Animal: To predict the genes targeted by most aboundant miRNAs, two computational target prediction algorithms TargetScan (http://www.targetscan.org/) and Miranda 3.3a (http://www.microrna.org/) were used to identify miRNA binding sites. Finally, the data predicted by both algorithms were combined and the overlaps were calculated. The GO terms and KEGG pathways of these most aboundant miRNAs, miRNA targets were also annotated.
Plant: To predict the genes targeted by most aboundant miRNAs, computational target prediction algorithms TargetFinder (https://github.com/carringtonlab/TargetFinder/) were used to identify miRNA binding sites. The GO terms and KEGG pathways of most aboundant miRNA targets were also annotated.
| Transcript ID | Species ID | Gene ID | Symbol | Gene Annoation | miRNA ID | TargetScan | miRanda | Total | GO Term | KEGG pathways |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | PC-3p-10415_211 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | efu-miR-9226_L-4_1ss22GT | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mdo-miR-26-5p_L+1R+1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-101a-3p_L+1R-1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-101a-5p | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-101c_L+2R+1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-10b-3p_L+1R-1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-124-3p | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-139-5p_R+1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-143-3p_R+1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-148a-5p | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-153-3p | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-192-3p_R-1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-195a-5p_R+1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-200b-3p_R+1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-200c-3p | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-29a-5p_R+1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-3058-3p_R+1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-3098-5p | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-33-5p_R-1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-338-5p_R-1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-345-5p_L+1R-1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-378a-5p | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-429-3p | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-5113_L+1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | mmu-miR-615-3p_R-1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | pma-miR-15a_R+1_1ss10GA | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | pma-miR-200b-3p_R-1 | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | rno-miR-101b-3p_L+1R-1_1ss17GA | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000001 | mmu | ENSMUSG00000000001 | Gnai3 | guanine nucleotide binding protein (G protein), alpha inhibiting 3 [Source:MGI Symbol;Acc:MGI:95773] | xtr-miR-200b_R+1_1ss23TA | 1 | 1 | 2 | GO:0000166(nucleotide binding);GO:0001664(G-protein coupled receptor binding);GO:0003924(GTPase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0019001(guanyl nucleotide binding);GO:0019003(GDP binding);GO:0019904(protein domain specific binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031821(G-protein coupled serotonin receptor binding);GO:0032794(GTPase activating protein binding);GO:0046872(metal ion binding);GO:0006906(vesicle fusion);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0046039(GTP metabolic process);GO:0051301(cell division);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005834(heterotrimeric G-protein complex);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0030496(midbody);GO:0042588(zymogen granule);GO:0045121(membrane raft);GO:0070062(extracellular exosome) | ko04015(Rap1 signaling pathway);ko04022(cGMP - PKG signaling pathway);ko04024(cAMP signaling pathway);ko04062(Chemokine signaling pathway);ko04071(Sphingolipid signaling pathway);ko04261(Adrenergic signaling in cardiomyocytes);ko04360(Axon guidance);ko04530(Tight junction);ko04540(Gap junction);ko04611(Platelet activation);ko04670(Leukocyte transendothelial migration);ko04713(Circadian entrainment);ko04723(Retrograde endocannabinoid signaling);ko04724(Glutamatergic synapse);ko04725(Cholinergic synapse);ko04726(Serotonergic synapse);ko04727(GABAergic synapse);ko04728(Dopaminergic synapse);ko04730(Long-term depression);ko04914(Progesterone-mediated oocyte maturation);ko04915(Estrogen signaling pathway);ko04916(Melanogenesis);ko04921(Oxytocin signaling pathway);ko04923(Regulation of lipolysis in adipocyte);ko04971(Gastric acid secretion);ko05012(Parkinson's disease);ko05030(Cocaine addiction);ko05032(Morphine addiction);ko05034(Alcoholism);ko05133(Pertussis);ko05142(Chagas disease (American trypanosomiasis));ko05145(Toxoplasmosis);ko05200(Pathways in cancer) |
| ENSMUST00000000003 | mmu | ENSMUSG00000000003 | Pbsn | probasin [Source:MGI Symbol;Acc:MGI:1860484] | mmu-miR-155-5p | 1 | 1 | 2 | GO:0005215(transporter activity);GO:0005549(odorant binding);GO:0006810(transport);GO:0005576(extracellular region) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | PC-3p-10415_211 | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | hsa-miR-378c_R-2_2ss21AG22GC | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | hsa-miR-4286_R+1 | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | hsa-mir-6087-p3 | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-130b-5p | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-141-5p | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-148a-5p | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-15a-3p_1ss22AT | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-190a-5p_R+1 | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-190b-5p_R+2 | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-195a-5p_R+1 | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-3058-5p_R-3 | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-30b-3p | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-30c-2-3p | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-3473a_1ss18AC | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-350-3p | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-365-2-5p | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-378a-3p_R+1 | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-378d_1ss6CA | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-6516-5p_R+3 | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-7085-3p | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-miR-9769-3p_1ss22CT | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-mir-3473f-p3_1ss18GC | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | mmu-mir-690-p3_1ss18TC | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | pma-miR-15a_R+1_1ss10GA | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000010 | mmu | ENSMUSG00000020875 | Hoxb9 | homeobox B9 [Source:MGI Symbol;Acc:MGI:96190] | rno-miR-181a-2-3p_R+3_1ss7AG | 1 | 1 | 2 | GO:0003677(DNA binding);GO:0043565(sequence-specific DNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048706(embryonic skeletal system development);GO:0060070(canonical Wnt signaling pathway);GO:0060326(cell chemotaxis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion) | |
| ENSMUST00000000028 | mmu | ENSMUSG00000000028 | Cdc45 | cell division cycle 45 [Source:MGI Symbol;Acc:MGI:1338073] | mmu-miR-200a-5p | 1 | 1 | 2 | GO:0006270(DNA replication initiation);GO:0051301(cell division);GO:0005634(nucleus);GO:0005813(centrosome);GO:0003682(chromatin binding);GO:0003688(DNA replication origin binding);GO:0003697(single-stranded DNA binding);GO:0043138(3'-5' DNA helicase activity);GO:0000727(double-strand break repair via break-induced replication);GO:0006260(DNA replication);GO:0006267(pre-replicative complex assembly involved in nuclear cell cycle DNA replication);GO:0007049(cell cycle);GO:0031938(regulation of chromatin silencing at telomere);GO:0032508(DNA duplex unwinding);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1902977(mitotic DNA replication preinitiation complex assembly);GO:0005656(nuclear pre-replicative complex);GO:0031261(DNA replication preinitiation complex);GO:0031298(replication fork protection complex) | ko04110(Cell cycle) |
| ENSMUST00000000028 | mmu | ENSMUSG00000000028 | Cdc45 | cell division cycle 45 [Source:MGI Symbol;Acc:MGI:1338073] | mmu-miR-200b-5p | 1 | 1 | 2 | GO:0006270(DNA replication initiation);GO:0051301(cell division);GO:0005634(nucleus);GO:0005813(centrosome);GO:0003682(chromatin binding);GO:0003688(DNA replication origin binding);GO:0003697(single-stranded DNA binding);GO:0043138(3'-5' DNA helicase activity);GO:0000727(double-strand break repair via break-induced replication);GO:0006260(DNA replication);GO:0006267(pre-replicative complex assembly involved in nuclear cell cycle DNA replication);GO:0007049(cell cycle);GO:0031938(regulation of chromatin silencing at telomere);GO:0032508(DNA duplex unwinding);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1902977(mitotic DNA replication preinitiation complex assembly);GO:0005656(nuclear pre-replicative complex);GO:0031261(DNA replication preinitiation complex);GO:0031298(replication fork protection complex) | ko04110(Cell cycle) |
| ENSMUST00000000028 | mmu | ENSMUSG00000000028 | Cdc45 | cell division cycle 45 [Source:MGI Symbol;Acc:MGI:1338073] | mmu-miR-23a-3p | 1 | 1 | 2 | GO:0006270(DNA replication initiation);GO:0051301(cell division);GO:0005634(nucleus);GO:0005813(centrosome);GO:0003682(chromatin binding);GO:0003688(DNA replication origin binding);GO:0003697(single-stranded DNA binding);GO:0043138(3'-5' DNA helicase activity);GO:0000727(double-strand break repair via break-induced replication);GO:0006260(DNA replication);GO:0006267(pre-replicative complex assembly involved in nuclear cell cycle DNA replication);GO:0007049(cell cycle);GO:0031938(regulation of chromatin silencing at telomere);GO:0032508(DNA duplex unwinding);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1902977(mitotic DNA replication preinitiation complex assembly);GO:0005656(nuclear pre-replicative complex);GO:0031261(DNA replication preinitiation complex);GO:0031298(replication fork protection complex) | ko04110(Cell cycle) |
| ENSMUST00000000028 | mmu | ENSMUSG00000000028 | Cdc45 | cell division cycle 45 [Source:MGI Symbol;Acc:MGI:1338073] | mmu-miR-23b-3p | 1 | 1 | 2 | GO:0006270(DNA replication initiation);GO:0051301(cell division);GO:0005634(nucleus);GO:0005813(centrosome);GO:0003682(chromatin binding);GO:0003688(DNA replication origin binding);GO:0003697(single-stranded DNA binding);GO:0043138(3'-5' DNA helicase activity);GO:0000727(double-strand break repair via break-induced replication);GO:0006260(DNA replication);GO:0006267(pre-replicative complex assembly involved in nuclear cell cycle DNA replication);GO:0007049(cell cycle);GO:0031938(regulation of chromatin silencing at telomere);GO:0032508(DNA duplex unwinding);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1902977(mitotic DNA replication preinitiation complex assembly);GO:0005656(nuclear pre-replicative complex);GO:0031261(DNA replication preinitiation complex);GO:0031298(replication fork protection complex) | ko04110(Cell cycle) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | PC-3p-12776_151 | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | PC-3p-5198_638 | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-101a-5p | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-1198-5p | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-148a-5p | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-183-3p_L-1R+1 | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-192-3p_R-1 | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-195a-5p_R+1 | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-22-5p_R-1 | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-3058-5p_R-3 | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-30b-3p | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-34a-5p | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-34b-5p | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-34c-5p | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-361-3p_R-3 | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-3968_L-3_1ss14AT | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-450a-5p | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-674-5p_R-1 | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000033 | mmu | ENSMUSG00000048583 | Igf2 | insulin-like growth factor 2 [Source:MGI Symbol;Acc:MGI:96434] | mmu-miR-744-5p_R-1 | 1 | 1 | 2 | GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0008083(growth factor activity);GO:0030546(receptor activator activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0001934(positive regulation of protein phosphorylation);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0009887(animal organ morphogenesis);GO:0031017(exocrine pancreas development);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase);GO:0040018(positive regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043085(positive regulation of catalytic activity);GO:0043410(positive regulation of MAPK cascade);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051146(striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0051897(positive regulation of protein kinase B signaling);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000273(positive regulation of receptor activity);GO:2000467(positive regulation of glycogen (starch) synthase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0070062(extracellular exosome) | ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-101a-3p_L+1R-1 | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-101a-5p | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-101c_L+2R+1 | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-144-3p_R-1 | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-152-5p | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-183-3p_L-1R+1 | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-192-3p_R-1 | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-195a-5p_R+1 | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-199b-3p_R-1 | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-21a-5p | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-23a-3p | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-23b-3p | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-27a-3p | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-29b-3p | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-29c-3p_R-1 | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-30a-5p_R+2 | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-30c-5p_R+1 | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-30d-5p_R-2 | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
| ENSMUST00000000058 | mmu | ENSMUSG00000000058 | Cav2 | caveolin 2 [Source:MGI Symbol;Acc:MGI:107571] | mmu-miR-30e-3p | 1 | 1 | 2 | GO:0005925(focal adhesion);GO:0019901(protein kinase binding);GO:0030674(protein binding, bridging);GO:0031748(D1 dopamine receptor binding);GO:0032947(protein complex scaffold);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0097110(scaffold protein binding);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0007005(mitochondrion organization);GO:0007029(endoplasmic reticulum organization);GO:0007088(regulation of mitotic nuclear division);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016050(vesicle organization);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043547(positive regulation of GTPase activity);GO:0044791(positive regulation by host of viral release from host cell);GO:0044794(positive regulation by host of viral process);GO:0048278(vesicle docking);GO:0048741(skeletal muscle fiber development);GO:0051259(protein oligomerization);GO:0060161(positive regulation of dopamine receptor signaling pathway);GO:0070836(caveola assembly);GO:0000139(Golgi membrane);GO:0002080(acrosomal membrane);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005901(caveola);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0016021(integral component of membrane) | ko04144(Endocytosis);ko04510(Focal adhesion);ko05100(Bacterial invasion of epithelial cells);ko05205(Proteoglycans in cancer) |
document location: Final_Report/Target_Enrichment_Analysis/Target_Enrichment/2_Target_predict_annotation.xlsx
Gene ontology (GO) (http://www.geneontology.org) is a major bioinformatics initiative to unify the representation of gene and gene product attributes across all species. More specifically, the project aims to: 1) maintain and develop its controlled vocabulary of gene and gene product attributes; 2) annotate genes and gene products, and assimilate and disseminate annotation data; and 3) provide tools for easy access to all aspects of the data provided by the project, and to enable functional interpretation of experimental data using the GO, for example via enrichment analysis.
GO is part of a larger classification effort, the Open Biomedical Ontologies (OBO).
Although gene nomenclature itself aims to maintain and develop controlled vocabulary of gene and gene products, the Gene Ontology extends the effort by using markup language to make the data (not only of the genes and their products but also of all their attributes) machine readable, and to do so in a way that is unified across all species (whereas gene nomenclature conventions vary by biologic taxon).
Significant GO terms were calculated by Hypergeometric equation as shown below. TB gene number=number of total genes; TS gene number=number of target genes in total genes; B gene number=total number of gene in all GO terms; S gene number=number of target genes in this GO term. Those GO terms with p value<0.05 were defined as significant GO terms.
Significant GO terms:
| GO Id | Function | GO_term | S gene number | TS gene number | B gene number | TB gene number | Pvalue of Fisher's Exact Test |
| GO:0005737 | cellular_component | cytoplasm | 5396 | 19034 | 5699 | 21754 | 2.94e-94 |
| GO:0005515 | molecular_function | protein binding | 3837 | 19034 | 4030 | 21754 | 7.28e-73 |
| GO:0005829 | cellular_component | cytosol | 2891 | 19034 | 3033 | 21754 | 9.64e-55 |
| GO:0005634 | cellular_component | nucleus | 5320 | 19034 | 5741 | 21754 | 1.11e-47 |
| GO:0006351 | biological_process | transcription, DNA-templated | 1674 | 19034 | 1745 | 21754 | 2.67e-36 |
| GO:0005654 | cellular_component | nucleoplasm | 1968 | 19034 | 2072 | 21754 | 3.08e-33 |
| GO:0016740 | molecular_function | transferase activity | 1601 | 19034 | 1676 | 21754 | 3.19e-31 |
| GO:0046872 | molecular_function | metal ion binding | 3160 | 19034 | 3406 | 21754 | 3.33e-27 |
| GO:0005794 | cellular_component | Golgi apparatus | 1092 | 19034 | 1132 | 21754 | 4.15e-27 |
| GO:0045944 | biological_process | positive regulation of transcription from RNA polymerase II promoter | 966 | 19034 | 997 | 21754 | 1.22e-26 |
| GO:0006810 | biological_process | transport | 1677 | 19034 | 1770 | 21754 | 1.84e-26 |
| GO:0006355 | biological_process | regulation of transcription, DNA-templated | 2099 | 19034 | 2236 | 21754 | 1.20e-25 |
| GO:0005524 | molecular_function | ATP binding | 1405 | 19034 | 1478 | 21754 | 3.25e-24 |
| GO:0000166 | molecular_function | nucleotide binding | 1852 | 19034 | 1973 | 21754 | 1.47e-22 |
| GO:0005783 | cellular_component | endoplasmic reticulum | 1217 | 19034 | 1279 | 21754 | 1.44e-21 |
| GO:0016310 | biological_process | phosphorylation | 648 | 19034 | 664 | 21754 | 2.39e-21 |
| GO:0016301 | molecular_function | kinase activity | 645 | 19034 | 661 | 21754 | 3.35e-21 |
| GO:0006468 | biological_process | protein phosphorylation | 601 | 19034 | 617 | 21754 | 4.63e-19 |
| GO:0000139 | cellular_component | Golgi membrane | 403 | 19034 | 408 | 21754 | 8.19e-18 |
| GO:0043231 | cellular_component | intracellular membrane-bounded organelle | 700 | 19034 | 728 | 21754 | 2.01e-16 |
| GO:0005768 | cellular_component | endosome | 500 | 19034 | 513 | 21754 | 2.94e-16 |
| GO:0008270 | molecular_function | zinc ion binding | 974 | 19034 | 1027 | 21754 | 4.92e-16 |
| GO:0007049 | biological_process | cell cycle | 549 | 19034 | 566 | 21754 | 5.99e-16 |
| GO:0045893 | biological_process | positive regulation of transcription, DNA-templated | 530 | 19034 | 546 | 21754 | 1.07e-15 |
| GO:0007275 | biological_process | multicellular organismal development | 897 | 19034 | 944 | 21754 | 1.40e-15 |
| GO:0000122 | biological_process | negative regulation of transcription from RNA polymerase II promoter | 692 | 19034 | 721 | 21754 | 1.42e-15 |
| GO:0004672 | molecular_function | protein kinase activity | 527 | 19034 | 543 | 21754 | 1.48e-15 |
| GO:0005856 | cellular_component | cytoskeleton | 990 | 19034 | 1046 | 21754 | 1.88e-15 |
| GO:0042803 | molecular_function | protein homodimerization activity | 674 | 19034 | 702 | 21754 | 2.54e-15 |
| GO:0005886 | cellular_component | plasma membrane | 4215 | 19034 | 4644 | 21754 | 3.22e-15 |
| GO:0006915 | biological_process | apoptotic process | 515 | 19034 | 531 | 21754 | 5.33e-15 |
| GO:0030054 | cellular_component | cell junction | 665 | 19034 | 693 | 21754 | 6.05e-15 |
| GO:0015031 | biological_process | protein transport | 550 | 19034 | 569 | 21754 | 8.55e-15 |
| GO:0005730 | cellular_component | nucleolus | 742 | 19034 | 777 | 21754 | 9.37e-15 |
| GO:0048471 | cellular_component | perinuclear region of cytoplasm | 568 | 19034 | 589 | 21754 | 1.83e-14 |
| GO:0004674 | molecular_function | protein serine/threonine kinase activity | 392 | 19034 | 401 | 21754 | 7.59e-14 |
| GO:0016787 | molecular_function | hydrolase activity | 1479 | 19034 | 1592 | 21754 | 2.94e-13 |
| GO:0016567 | biological_process | protein ubiquitination | 485 | 19034 | 502 | 21754 | 4.79e-13 |
| GO:0005789 | cellular_component | endoplasmic reticulum membrane | 702 | 19034 | 738 | 21754 | 9.18e-13 |
| GO:0042802 | molecular_function | identical protein binding | 748 | 19034 | 789 | 21754 | 1.88e-12 |
| GO:0043565 | molecular_function | sequence-specific DNA binding | 557 | 19034 | 581 | 21754 | 1.93e-12 |
| GO:0003677 | molecular_function | DNA binding | 1637 | 19034 | 1771 | 21754 | 2.30e-12 |
| GO:0005739 | cellular_component | mitochondrion | 1496 | 19034 | 1616 | 21754 | 5.85e-12 |
| GO:0000978 | molecular_function | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 350 | 19034 | 359 | 21754 | 8.44e-12 |
| GO:0007399 | biological_process | nervous system development | 359 | 19034 | 369 | 21754 | 1.48e-11 |
| GO:0070062 | cellular_component | extracellular vesicular exosome | 2407 | 19034 | 2635 | 21754 | 1.83e-11 |
| GO:0006811 | biological_process | ion transport | 572 | 19034 | 600 | 21754 | 3.40e-11 |
| GO:0007155 | biological_process | cell adhesion | 489 | 19034 | 510 | 21754 | 4.17e-11 |
| GO:0051301 | biological_process | cell division | 335 | 19034 | 344 | 21754 | 4.40e-11 |
| GO:0000977 | molecular_function | RNA polymerase II regulatory region sequence-specific DNA binding | 199 | 19034 | 200 | 21754 | 6.55e-11 |
| GO:0019901 | molecular_function | protein kinase binding | 370 | 19034 | 382 | 21754 | 8.30e-11 |
| GO:0045202 | cellular_component | synapse | 431 | 19034 | 448 | 21754 | 1.06e-10 |
| GO:0006366 | biological_process | transcription from RNA polymerase II promoter | 414 | 19034 | 430 | 21754 | 1.69e-10 |
| GO:0004842 | molecular_function | ubiquitin-protein transferase activity | 330 | 19034 | 340 | 21754 | 3.36e-10 |
| GO:0030154 | biological_process | cell differentiation | 684 | 19034 | 725 | 21754 | 3.50e-10 |
| GO:0055085 | biological_process | transmembrane transport | 465 | 19034 | 486 | 21754 | 3.94e-10 |
| GO:0042995 | cellular_component | cell projection | 637 | 19034 | 674 | 21754 | 5.39e-10 |
| GO:0035556 | biological_process | intracellular signal transduction | 397 | 19034 | 413 | 21754 | 8.92e-10 |
| GO:0008134 | molecular_function | transcription factor binding | 306 | 19034 | 315 | 21754 | 1.01e-09 |
| GO:0031410 | cellular_component | cytoplasmic vesicle | 576 | 19034 | 608 | 21754 | 1.04e-09 |
| GO:0043005 | cellular_component | neuron projection | 301 | 19034 | 310 | 21754 | 1.73e-09 |
| GO:0003700 | molecular_function | sequence-specific DNA binding transcription factor activity | 806 | 19034 | 862 | 21754 | 2.79e-09 |
| GO:0016569 | biological_process | covalent chromatin modification | 238 | 19034 | 243 | 21754 | 3.28e-09 |
| GO:0005096 | molecular_function | GTPase activator activity | 220 | 19034 | 224 | 21754 | 4.35e-09 |
| GO:0003824 | molecular_function | catalytic activity | 483 | 19034 | 508 | 21754 | 4.49e-09 |
| GO:0016020 | cellular_component | membrane | 8036 | 19034 | 9029 | 21754 | 7.29e-09 |
| GO:0007067 | biological_process | mitotic nuclear division | 245 | 19034 | 251 | 21754 | 8.00e-09 |
| GO:0045892 | biological_process | negative regulation of transcription, DNA-templated | 511 | 19034 | 540 | 21754 | 1.60e-08 |
| GO:0006974 | biological_process | cellular response to DNA damage stimulus | 390 | 19034 | 408 | 21754 | 1.60e-08 |
| GO:0016055 | biological_process | Wnt signaling pathway | 184 | 19034 | 187 | 21754 | 4.56e-08 |
| GO:0006629 | biological_process | lipid metabolic process | 432 | 19034 | 455 | 21754 | 5.43e-08 |
| GO:0001077 | molecular_function | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 255 | 19034 | 263 | 21754 | 5.46e-08 |
| GO:0001701 | biological_process | in utero embryonic development | 241 | 19034 | 248 | 21754 | 5.77e-08 |
| GO:0043547 | biological_process | positive regulation of GTPase activity | 420 | 19034 | 442 | 21754 | 5.97e-08 |
| GO:0006357 | biological_process | regulation of transcription from RNA polymerase II promoter | 373 | 19034 | 391 | 21754 | 7.45e-08 |
| GO:0046777 | biological_process | protein autophosphorylation | 159 | 19034 | 161 | 21754 | 1.22e-07 |
| GO:0044212 | molecular_function | transcription regulatory region DNA binding | 220 | 19034 | 226 | 21754 | 1.26e-07 |
| GO:0014069 | cellular_component | postsynaptic density | 190 | 19034 | 194 | 21754 | 1.41e-07 |
| GO:0046983 | molecular_function | protein dimerization activity | 188 | 19034 | 192 | 21754 | 1.78e-07 |
| GO:0030182 | biological_process | neuron differentiation | 115 | 19034 | 115 | 21754 | 2.04e-07 |
| GO:0031625 | molecular_function | ubiquitin protein ligase binding | 280 | 19034 | 291 | 21754 | 2.07e-07 |
| GO:0009986 | cellular_component | cell surface | 499 | 19034 | 530 | 21754 | 2.14e-07 |
| GO:0043065 | biological_process | positive regulation of apoptotic process | 265 | 19034 | 275 | 21754 | 2.70e-07 |
| GO:0001525 | biological_process | angiogenesis | 212 | 19034 | 218 | 21754 | 2.99e-07 |
| GO:0016323 | cellular_component | basolateral plasma membrane | 168 | 19034 | 171 | 21754 | 3.03e-07 |
| GO:0008283 | biological_process | cell proliferation | 195 | 19034 | 200 | 21754 | 4.18e-07 |
| GO:0019904 | molecular_function | protein domain specific binding | 222 | 19034 | 229 | 21754 | 4.33e-07 |
| GO:0031965 | cellular_component | nuclear membrane | 222 | 19034 | 229 | 21754 | 4.33e-07 |
| GO:0032403 | molecular_function | protein complex binding | 233 | 19034 | 241 | 21754 | 5.34e-07 |
| GO:0005667 | cellular_component | transcription factor complex | 220 | 19034 | 227 | 21754 | 5.34e-07 |
| GO:0010468 | biological_process | regulation of gene expression | 245 | 19034 | 254 | 21754 | 5.72e-07 |
| GO:0003682 | molecular_function | chromatin binding | 392 | 19034 | 414 | 21754 | 6.25e-07 |
| GO:0050821 | biological_process | protein stabilization | 127 | 19034 | 128 | 21754 | 6.91e-07 |
| GO:0006897 | biological_process | endocytosis | 160 | 19034 | 163 | 21754 | 7.76e-07 |
| GO:0018105 | biological_process | peptidyl-serine phosphorylation | 142 | 19034 | 144 | 21754 | 9.73e-07 |
| GO:0007507 | biological_process | heart development | 227 | 19034 | 235 | 21754 | 9.85e-07 |
| GO:0005509 | molecular_function | calcium ion binding | 643 | 19034 | 691 | 21754 | 1.00e-06 |
| GO:0008017 | molecular_function | microtubule binding | 198 | 19034 | 204 | 21754 | 1.34e-06 |
| GO:0030425 | cellular_component | dendrite | 328 | 19034 | 345 | 21754 | 1.45e-06 |
document location: Final_Report/Target_Enrichment_Analysis/Target_Enrichment/3_GO_significant.xlsx
Target gene of GO enrichment analysis:
| GO ID | Transcript ID | Gene ID | Symbol | Gene_Annoation | miRNA | GO Function | GO name | Pvalue of Fisher's Exact Test |
| GO:0005737 | ENSMUST00000148602 | ENSMUSG00000000416 | Cttnbp2 | cortactin binding protein 2 [Source:MGI Symbol;Acc:MGI:1353467] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000088546 | ENSMUSG00000000838 | Fmr1 | fragile X mental retardation syndrome 1 [Source:MGI Symbol;Acc:MGI:95564] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000114653 | ENSMUSG00000000838 | Fmr1 | fragile X mental retardation syndrome 1 [Source:MGI Symbol;Acc:MGI:95564] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000114654 | ENSMUSG00000000838 | Fmr1 | fragile X mental retardation syndrome 1 [Source:MGI Symbol;Acc:MGI:95564] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000114655 | ENSMUSG00000000838 | Fmr1 | fragile X mental retardation syndrome 1 [Source:MGI Symbol;Acc:MGI:95564] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000114656 | ENSMUSG00000000838 | Fmr1 | fragile X mental retardation syndrome 1 [Source:MGI Symbol;Acc:MGI:95564] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000114657 | ENSMUSG00000000838 | Fmr1 | fragile X mental retardation syndrome 1 [Source:MGI Symbol;Acc:MGI:95564] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000001326 | ENSMUSG00000001280 | Sp1 | trans-acting transcription factor 1 [Source:MGI Symbol;Acc:MGI:98372] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000163709 | ENSMUSG00000001280 | Sp1 | trans-acting transcription factor 1 [Source:MGI Symbol;Acc:MGI:98372] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000165924 | ENSMUSG00000001280 | Sp1 | trans-acting transcription factor 1 [Source:MGI Symbol;Acc:MGI:98372] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000215474 | ENSMUSG00000001942 | Siae | sialic acid acetylesterase [Source:MGI Symbol;Acc:MGI:104803] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000002292 | ENSMUSG00000002222 | Rmnd5a | required for meiotic nuclear division 5 homolog A [Source:MGI Symbol;Acc:MGI:1915727] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000149415 | ENSMUSG00000002222 | Rmnd5a | required for meiotic nuclear division 5 homolog A [Source:MGI Symbol;Acc:MGI:1915727] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000172450 | ENSMUSG00000003131 | Pafah1b2 | platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 [Source:MGI Symbol;Acc:MGI:108415] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000003320 | ENSMUSG00000003235 | Eif2b5 | eukaryotic translation initiation factor 2B, subunit 5 epsilon [Source:MGI Symbol;Acc:MGI:2446176] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000049567 | ENSMUSG00000003308 | Keap1 | kelch-like ECH-associated protein 1 [Source:MGI Symbol;Acc:MGI:1858732] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000164812 | ENSMUSG00000003308 | Keap1 | kelch-like ECH-associated protein 1 [Source:MGI Symbol;Acc:MGI:1858732] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000194542 | ENSMUSG00000003308 | Keap1 | kelch-like ECH-associated protein 1 [Source:MGI Symbol;Acc:MGI:1858732] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000212297 | ENSMUSG00000003657 | Calb2 | calbindin 2 [Source:MGI Symbol;Acc:MGI:101914] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000077440 | ENSMUSG00000003847 | Nfat5 | nuclear factor of activated T cells 5 [Source:MGI Symbol;Acc:MGI:1859333] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000133026 | ENSMUSG00000003847 | Nfat5 | nuclear factor of activated T cells 5 [Source:MGI Symbol;Acc:MGI:1859333] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000169453 | ENSMUSG00000003847 | Nfat5 | nuclear factor of activated T cells 5 [Source:MGI Symbol;Acc:MGI:1859333] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000043812 | ENSMUSG00000004591 | Pkn2 | protein kinase N2 [Source:MGI Symbol;Acc:MGI:109211] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000006367 | ENSMUSG00000006205 | Htra1 | HtrA serine peptidase 1 [Source:MGI Symbol;Acc:MGI:1929076] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000113229 | ENSMUSG00000006262 | Mob1b | MOB kinase activator 1B [Source:MGI Symbol;Acc:MGI:1915723] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000067692 | ENSMUSG00000007646 | Rad51c | RAD51 paralog C [Source:MGI Symbol;Acc:MGI:2150020] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000040599 | ENSMUSG00000009418 | Nav1 | neuron navigator 1 [Source:MGI Symbol;Acc:MGI:2183683] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000067414 | ENSMUSG00000009418 | Nav1 | neuron navigator 1 [Source:MGI Symbol;Acc:MGI:2183683] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000190298 | ENSMUSG00000009418 | Nav1 | neuron navigator 1 [Source:MGI Symbol;Acc:MGI:2183683] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000009972 | ENSMUSG00000009828 | Ick | intestinal cell kinase [Source:MGI Symbol;Acc:MGI:1934157] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000010191 | ENSMUSG00000010047 | Hyal2 | hyaluronoglucosaminidase 2 [Source:MGI Symbol;Acc:MGI:1196334] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000195681 | ENSMUSG00000010047 | Hyal2 | hyaluronoglucosaminidase 2 [Source:MGI Symbol;Acc:MGI:1196334] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000195752 | ENSMUSG00000010047 | Hyal2 | hyaluronoglucosaminidase 2 [Source:MGI Symbol;Acc:MGI:1196334] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000074366 | ENSMUSG00000010461 | Eya4 | EYA transcriptional coactivator and phosphatase 4 [Source:MGI Symbol;Acc:MGI:1337104] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000220299 | ENSMUSG00000010461 | Eya4 | EYA transcriptional coactivator and phosphatase 4 [Source:MGI Symbol;Acc:MGI:1337104] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000010736 | ENSMUSG00000010592 | Dazl | deleted in azoospermia-like [Source:MGI Symbol;Acc:MGI:1342328] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000170350 | ENSMUSG00000012535 | Tnpo3 | transportin 3 [Source:MGI Symbol;Acc:MGI:1196412] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000059849 | ENSMUSG00000013465 | Nelfb | negative elongation factor complex member B [Source:MGI Symbol;Acc:MGI:1931035] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000205741 | ENSMUSG00000013465 | Nelfb | negative elongation factor complex member B [Source:MGI Symbol;Acc:MGI:1931035] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000013842 | ENSMUSG00000013698 | Pea15a | phosphoprotein enriched in astrocytes 15A [Source:MGI Symbol;Acc:MGI:104799] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000111247 | ENSMUSG00000013698 | Pea15a | phosphoprotein enriched in astrocytes 15A [Source:MGI Symbol;Acc:MGI:104799] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000111289 | ENSMUSG00000013997 | Nit1 | nitrilase 1 [Source:MGI Symbol;Acc:MGI:1350916] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000111295 | ENSMUSG00000013997 | Nit1 | nitrilase 1 [Source:MGI Symbol;Acc:MGI:1350916] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000114017 | ENSMUSG00000015222 | Map2 | microtubule-associated protein 2 [Source:MGI Symbol;Acc:MGI:97175] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000016088 | ENSMUSG00000015944 | Gatsl2 | GATS protein-like 2 [Source:MGI Symbol;Acc:MGI:1933384] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000056177 | ENSMUSG00000016664 | Pacsin2 | protein kinase C and casein kinase substrate in neurons 2 [Source:MGI Symbol;Acc:MGI:1345153] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000165095 | ENSMUSG00000016664 | Pacsin2 | protein kinase C and casein kinase substrate in neurons 2 [Source:MGI Symbol;Acc:MGI:1345153] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000171436 | ENSMUSG00000016664 | Pacsin2 | protein kinase C and casein kinase substrate in neurons 2 [Source:MGI Symbol;Acc:MGI:1345153] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000110391 | ENSMUSG00000016756 | Cmah | cytidine monophospho-N-acetylneuraminic acid hydroxylase [Source:MGI Symbol;Acc:MGI:103227] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000167746 | ENSMUSG00000016756 | Cmah | cytidine monophospho-N-acetylneuraminic acid hydroxylase [Source:MGI Symbol;Acc:MGI:103227] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000123726 | ENSMUSG00000017421 | Zfp207 | zinc finger protein 207 [Source:MGI Symbol;Acc:MGI:1340045] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000076817 | ENSMUSG00000019820 | Utrn | utrophin [Source:MGI Symbol;Acc:MGI:104631] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000218635 | ENSMUSG00000019820 | Utrn | utrophin [Source:MGI Symbol;Acc:MGI:104631] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000219003 | ENSMUSG00000019820 | Utrn | utrophin [Source:MGI Symbol;Acc:MGI:104631] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000019997 | ENSMUSG00000019850 | Tnfaip3 | tumor necrosis factor, alpha-induced protein 3 [Source:MGI Symbol;Acc:MGI:1196377] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000105527 | ENSMUSG00000019850 | Tnfaip3 | tumor necrosis factor, alpha-induced protein 3 [Source:MGI Symbol;Acc:MGI:1196377] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000020008 | ENSMUSG00000019861 | Gopc | golgi associated PDZ and coiled-coil motif containing [Source:MGI Symbol;Acc:MGI:2149946] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000105475 | ENSMUSG00000019861 | Gopc | golgi associated PDZ and coiled-coil motif containing [Source:MGI Symbol;Acc:MGI:2149946] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000217753 | ENSMUSG00000019861 | Gopc | golgi associated PDZ and coiled-coil motif containing [Source:MGI Symbol;Acc:MGI:2149946] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000105283 | ENSMUSG00000019966 | Kitl | kit ligand [Source:MGI Symbol;Acc:MGI:96974] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000020208 | ENSMUSG00000020021 | Fgd6 | FYVE, RhoGEF and PH domain containing 6 [Source:MGI Symbol;Acc:MGI:1261419] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000020288 | ENSMUSG00000020091 | Eif4ebp2 | eukaryotic translation initiation factor 4E binding protein 2 [Source:MGI Symbol;Acc:MGI:109198] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000020329 | ENSMUSG00000020122 | Egfr | epidermal growth factor receptor [Source:MGI Symbol;Acc:MGI:95294] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000220377 | ENSMUSG00000020124 | Usp15 | ubiquitin specific peptidase 15 [Source:MGI Symbol;Acc:MGI:101857] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000020349 | ENSMUSG00000020135 | Apc2 | adenomatosis polyposis coli 2 [Source:MGI Symbol;Acc:MGI:1346052] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000105359 | ENSMUSG00000020135 | Apc2 | adenomatosis polyposis coli 2 [Source:MGI Symbol;Acc:MGI:1346052] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000000137 | ENSMUSG00000020152 | Actr2 | ARP2 actin-related protein 2 [Source:MGI Symbol;Acc:MGI:1913963] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000020501 | ENSMUSG00000020265 | Sumo3 | small ubiquitin-like modifier 3 [Source:MGI Symbol;Acc:MGI:1336201] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000099538 | ENSMUSG00000020265 | Sumo3 | small ubiquitin-like modifier 3 [Source:MGI Symbol;Acc:MGI:1336201] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000124024 | ENSMUSG00000020265 | Sumo3 | small ubiquitin-like modifier 3 [Source:MGI Symbol;Acc:MGI:1336201] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000137841 | ENSMUSG00000020265 | Sumo3 | small ubiquitin-like modifier 3 [Source:MGI Symbol;Acc:MGI:1336201] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000102864 | ENSMUSG00000020275 | Rel | reticuloendotheliosis oncogene [Source:MGI Symbol;Acc:MGI:97897] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000109412 | ENSMUSG00000020300 | Cpeb4 | cytoplasmic polyadenylation element binding protein 4 [Source:MGI Symbol;Acc:MGI:1914829] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000155278 | ENSMUSG00000020300 | Cpeb4 | cytoplasmic polyadenylation element binding protein 4 [Source:MGI Symbol;Acc:MGI:1914829] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000020551 | ENSMUSG00000020305 | Asb3 | ankyrin repeat and SOCS box-containing 3 [Source:MGI Symbol;Acc:MGI:1929749] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000137306 | ENSMUSG00000020305 | Asb3 | ankyrin repeat and SOCS box-containing 3 [Source:MGI Symbol;Acc:MGI:1929749] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000074669 | ENSMUSG00000020358 | Hnrnpab | heterogeneous nuclear ribonucleoprotein A/B [Source:MGI Symbol;Acc:MGI:1330294] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000101249 | ENSMUSG00000020358 | Hnrnpab | heterogeneous nuclear ribonucleoprotein A/B [Source:MGI Symbol;Acc:MGI:1330294] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000109103 | ENSMUSG00000020358 | Hnrnpab | heterogeneous nuclear ribonucleoprotein A/B [Source:MGI Symbol;Acc:MGI:1330294] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000145353 | ENSMUSG00000020362 | Cnot6 | CCR4-NOT transcription complex, subunit 6 [Source:MGI Symbol;Acc:MGI:2144529] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000020634 | ENSMUSG00000020366 | Mapk9 | mitogen-activated protein kinase 9 [Source:MGI Symbol;Acc:MGI:1346862] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000102778 | ENSMUSG00000020366 | Mapk9 | mitogen-activated protein kinase 9 [Source:MGI Symbol;Acc:MGI:1346862] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000109179 | ENSMUSG00000020366 | Mapk9 | mitogen-activated protein kinase 9 [Source:MGI Symbol;Acc:MGI:1346862] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000164643 | ENSMUSG00000020366 | Mapk9 | mitogen-activated protein kinase 9 [Source:MGI Symbol;Acc:MGI:1346862] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000178543 | ENSMUSG00000020366 | Mapk9 | mitogen-activated protein kinase 9 [Source:MGI Symbol;Acc:MGI:1346862] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000020755 | ENSMUSG00000020463 | Ppp4r3b | protein phosphatase 4 regulatory subunit 3B [Source:MGI Symbol;Acc:MGI:2144474] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000020794 | ENSMUSG00000020492 | Ska2 | spindle and kinetochore associated complex subunit 2 [Source:MGI Symbol;Acc:MGI:1913390] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000020846 | ENSMUSG00000020538 | Srebf1 | sterol regulatory element binding transcription factor 1 [Source:MGI Symbol;Acc:MGI:107606] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000134660 | ENSMUSG00000020538 | Srebf1 | sterol regulatory element binding transcription factor 1 [Source:MGI Symbol;Acc:MGI:107606] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000107872 | ENSMUSG00000020546 | Stxbp4 | syntaxin binding protein 4 [Source:MGI Symbol;Acc:MGI:1342296] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000107875 | ENSMUSG00000020546 | Stxbp4 | syntaxin binding protein 4 [Source:MGI Symbol;Acc:MGI:1342296] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000020886 | ENSMUSG00000020572 | Nampt | nicotinamide phosphoribosyltransferase [Source:MGI Symbol;Acc:MGI:1929865] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000092915 | ENSMUSG00000020741 | Cluh | clustered mitochondria (cluA/CLU1) homolog [Source:MGI Symbol;Acc:MGI:1921398] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000117818 | ENSMUSG00000020741 | Cluh | clustered mitochondria (cluA/CLU1) homolog [Source:MGI Symbol;Acc:MGI:1921398] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000155998 | ENSMUSG00000020790 | Ankfy1 | ankyrin repeat and FYVE domain containing 1 [Source:MGI Symbol;Acc:MGI:1337008] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000076270 | ENSMUSG00000020817 | Rabep1 | rabaptin, RAB GTPase binding effector protein 1 [Source:MGI Symbol;Acc:MGI:1860236] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000021282 | ENSMUSG00000020899 | Pfas | phosphoribosylformylglycinamidine synthase (FGAR amidotransferase) [Source:MGI Symbol;Acc:MGI:2684864] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000021416 | ENSMUSG00000021028 | Mbip | MAP3K12 binding inhibitory protein 1 [Source:MGI Symbol;Acc:MGI:1918320] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
| GO:0005737 | ENSMUST00000110464 | ENSMUSG00000021109 | Hif1a | hypoxia inducible factor 1, alpha subunit [Source:MGI Symbol;Acc:MGI:106918] | mmu-miR-24-2-5p | cellular_component | cytoplasm | 2.94e-94 |
document location: Final_Report/Target_Enrichment_Analysis/Target_Enrichment/3_GO_miRNA_Gene.xlsx
Barplot of enriched GO terms:
document location: Final_Report/Target_Enrichment_Analysis/GO_Pictures/GO_bar_graph.png
Scatterplot of enriched GO terms:
Number of target genes enriched in GO terms, p value and rich factor are shown in scatterplot. Rich factor=(number of target genes in GO term)/(total number of genes in GO term). The larger rich factor is, the higher enrichment is.
document location: Final_Report/Target_Enrichment_Analysis/Target_Enrichments/GO_enrichment_scatterplot.pdf
KEGG (Kyoto Encyclopedia of Genes and Genomes) (http://www.kegg.jp/) is a collection of databases dealing with genomes, biological pathways, diseases, drugs, and chemical substances. KEGG is utilized for bioinformatics research and education, including data analysis in genomics, metagenomics, metabolomics and other omics studies, modeling and simulation in systems biology, and translational research in drug development.
Significant KEGG pathways were calculated by Hypergeometric equation as shown below. TB gene number=number of total genes; TS gene number=number of target genes in total genes; B gene number=total number of genes in KEGG pathways; S gene number=number of target genes in this KEGG pathway. Those KEGG pathways with p value<0.05 were defined as significant KEGG pathways.
Significant KEGG pathways:
| Pathway Id | Pathway description | S gene number | TS gene number | B gene number | TB gene number | Pvalue of Fisher's Exact Test |
| ko04310 | Wnt signaling pathway | 141 | 6841 | 141 | 7580 | 4.53e-07 |
| ko04360 | Axon guidance | 129 | 6841 | 129 | 7580 | 1.58e-06 |
| ko05200 | Pathways in cancer | 378 | 6841 | 392 | 7580 | 1.74e-06 |
| ko04550 | Signaling pathways regulating pluripotency of stem cells | 139 | 6841 | 140 | 7580 | 8.27e-06 |
| ko04010 | MAPK signaling pathway | 246 | 6841 | 253 | 7580 | 1.16e-05 |
| ko04144 | Endocytosis | 222 | 6841 | 228 | 7580 | 2.15e-05 |
| ko04142 | Lysosome | 122 | 6841 | 123 | 7580 | 4.32e-05 |
| ko04014 | Ras signaling pathway | 221 | 6841 | 228 | 7580 | 7.98e-05 |
| ko04120 | Ubiquitin mediated proteolysis | 135 | 6841 | 137 | 7580 | 8.89e-05 |
| ko04390 | Hippo signaling pathway | 150 | 6841 | 153 | 7580 | 0.00 |
| ko05169 | Epstein-Barr virus infection | 197 | 6841 | 203 | 7580 | 0.00 |
| ko04141 | Protein processing in endoplasmic reticulum | 162 | 6841 | 166 | 7580 | 0.00 |
| ko04152 | AMPK signaling pathway | 125 | 6841 | 127 | 7580 | 0.00 |
| ko05166 | HTLV-I infection | 261 | 6841 | 272 | 7580 | 0.00 |
| ko04071 | Sphingolipid signaling pathway | 120 | 6841 | 122 | 7580 | 0.00 |
| ko04510 | Focal adhesion | 200 | 6841 | 207 | 7580 | 0.00 |
| ko05205 | Proteoglycans in cancer | 198 | 6841 | 205 | 7580 | 0.00 |
| ko04919 | Thyroid hormone signaling pathway | 116 | 6841 | 118 | 7580 | 0.00 |
| ko04068 | FoxO signaling pathway | 132 | 6841 | 135 | 7580 | 0.00 |
| ko04668 | TNF signaling pathway | 106 | 6841 | 108 | 7580 | 0.00 |
| ko00562 | Inositol phosphate metabolism | 63 | 6841 | 63 | 7580 | 0.00 |
| ko04721 | Synaptic vesicle cycle | 62 | 6841 | 62 | 7580 | 0.00 |
| ko04015 | Rap1 signaling pathway | 205 | 6841 | 214 | 7580 | 0.00 |
| ko04024 | cAMP signaling pathway | 190 | 6841 | 198 | 7580 | 0.00 |
| ko04070 | Phosphatidylinositol signaling system | 81 | 6841 | 82 | 7580 | 0.00 |
| ko05231 | Choline metabolism in cancer | 99 | 6841 | 101 | 7580 | 0.00 |
| ko05323 | Rheumatoid arthritis | 80 | 6841 | 81 | 7580 | 0.00 |
| ko04916 | Melanogenesis | 98 | 6841 | 100 | 7580 | 0.00 |
| ko00330 | Arginine and proline metabolism | 58 | 6841 | 58 | 7580 | 0.00 |
| ko04728 | Dopaminergic synapse | 126 | 6841 | 130 | 7580 | 0.00 |
| ko05217 | Basal cell carcinoma | 55 | 6841 | 55 | 7580 | 0.00 |
| ko05145 | Toxoplasmosis | 109 | 6841 | 112 | 7580 | 0.00 |
| ko04114 | Oocyte meiosis | 109 | 6841 | 112 | 7580 | 0.00 |
| ko04910 | Insulin signaling pathway | 136 | 6841 | 141 | 7580 | 0.00 |
| ko04110 | Cell cycle | 120 | 6841 | 124 | 7580 | 0.01 |
| ko04920 | Adipocytokine signaling pathway | 71 | 6841 | 72 | 7580 | 0.01 |
| ko04722 | Neurotrophin signaling pathway | 118 | 6841 | 122 | 7580 | 0.01 |
| ko04660 | T cell receptor signaling pathway | 102 | 6841 | 105 | 7580 | 0.01 |
| ko04330 | Notch signaling pathway | 49 | 6841 | 49 | 7580 | 0.01 |
| ko04340 | Hedgehog signaling pathway | 49 | 6841 | 49 | 7580 | 0.01 |
| ko04012 | ErbB signaling pathway | 85 | 6841 | 87 | 7580 | 0.01 |
| ko04666 | Fc gamma R-mediated phagocytosis | 84 | 6841 | 86 | 7580 | 0.01 |
| ko05031 | Amphetamine addiction | 66 | 6841 | 67 | 7580 | 0.01 |
| ko05222 | Small cell lung cancer | 82 | 6841 | 84 | 7580 | 0.01 |
| ko05212 | Pancreatic cancer | 65 | 6841 | 66 | 7580 | 0.01 |
| ko04611 | Platelet activation | 125 | 6841 | 130 | 7580 | 0.01 |
| ko05214 | Glioma | 64 | 6841 | 65 | 7580 | 0.01 |
| ko04921 | Oxytocin signaling pathway | 151 | 6841 | 158 | 7580 | 0.01 |
| ko04724 | Glutamatergic synapse | 110 | 6841 | 114 | 7580 | 0.01 |
| ko04146 | Peroxisome | 80 | 6841 | 82 | 7580 | 0.01 |
| ko04350 | TGF-beta signaling pathway | 79 | 6841 | 81 | 7580 | 0.01 |
| ko03018 | RNA degradation | 78 | 6841 | 80 | 7580 | 0.01 |
| ko04020 | Calcium signaling pathway | 172 | 6841 | 181 | 7580 | 0.01 |
| ko05100 | Bacterial invasion of epithelial cells | 76 | 6841 | 78 | 7580 | 0.01 |
| ko05132 | Salmonella infection | 76 | 6841 | 78 | 7580 | 0.01 |
| ko00564 | Glycerophospholipid metabolism | 91 | 6841 | 94 | 7580 | 0.01 |
| ko04380 | Osteoclast differentiation | 119 | 6841 | 124 | 7580 | 0.01 |
| ko01230 | Biosynthesis of amino acids | 75 | 6841 | 77 | 7580 | 0.02 |
| ko05033 | Nicotine addiction | 40 | 6841 | 40 | 7580 | 0.02 |
| ko04612 | Antigen processing and presentation | 74 | 6841 | 76 | 7580 | 0.02 |
| ko04810 | Regulation of actin cytoskeleton | 204 | 6841 | 216 | 7580 | 0.02 |
| ko05321 | Inflammatiory bowel disease (IBD) | 57 | 6841 | 58 | 7580 | 0.02 |
| ko04520 | Adherens junction | 72 | 6841 | 74 | 7580 | 0.02 |
| ko05221 | Acute myeloid leukemia | 56 | 6841 | 57 | 7580 | 0.02 |
| ko04621 | NOD-like receptor signaling pathway | 56 | 6841 | 57 | 7580 | 0.02 |
| ko05220 | Chronic myeloid leukemia | 71 | 6841 | 73 | 7580 | 0.02 |
| ko04512 | ECM-receptor interaction | 85 | 6841 | 88 | 7580 | 0.02 |
| ko04662 | B cell receptor signaling pathway | 70 | 6841 | 72 | 7580 | 0.02 |
| ko00240 | Pyrimidine metabolism | 98 | 6841 | 102 | 7580 | 0.02 |
| ko04723 | Retrograde endocannabinoid signaling | 98 | 6841 | 102 | 7580 | 0.02 |
| ko00500 | Starch and sucrose metabolism | 53 | 6841 | 54 | 7580 | 0.03 |
| ko05340 | Primary immunodeficiency | 35 | 6841 | 35 | 7580 | 0.03 |
| ko05144 | Malaria | 52 | 6841 | 53 | 7580 | 0.03 |
| ko05213 | Endometrial cancer | 51 | 6841 | 52 | 7580 | 0.03 |
| ko04915 | Estrogen signaling pathway | 94 | 6841 | 98 | 7580 | 0.03 |
| ko04115 | p53 signaling pathway | 66 | 6841 | 68 | 7580 | 0.03 |
| ko03460 | Fanconi anemia pathway | 50 | 6841 | 51 | 7580 | 0.03 |
| ko00410 | beta-Alanine metabolism | 32 | 6841 | 32 | 7580 | 0.04 |
| ko05211 | Renal cell carcinoma | 64 | 6841 | 66 | 7580 | 0.04 |
| ko00010 | Glycolysis / Gluconeogenesis | 64 | 6841 | 66 | 7580 | 0.04 |
| ko04720 | Long-term potentiation | 64 | 6841 | 66 | 7580 | 0.04 |
| ko01200 | Carbon metabolism | 103 | 6841 | 108 | 7580 | 0.04 |
| ko00510 | N-Glycan biosynthesis | 48 | 6841 | 49 | 7580 | 0.04 |
| ko05030 | Cocaine addiction | 48 | 6841 | 49 | 7580 | 0.04 |
| ko00514 | Other types of O-glycan biosynthesis | 31 | 6841 | 31 | 7580 | 0.04 |
| ko05210 | Colorectal cancer | 62 | 6841 | 64 | 7580 | 0.04 |
| ko04710 | Circadian rhythm | 30 | 6841 | 30 | 7580 | 0.05 |
| ko05032 | Morphine addiction | 88 | 6841 | 92 | 7580 | 0.05 |
| ko04150 | mTOR signaling pathway | 59 | 6841 | 61 | 7580 | 0.05 |
| ko00512 | Mucin type O-glycan biosynthesis | 28 | 6841 | 28 | 7580 | 0.06 |
| ko04912 | GnRH signaling pathway | 85 | 6841 | 89 | 7580 | 0.06 |
| ko05215 | Prostate cancer | 85 | 6841 | 89 | 7580 | 0.06 |
| ko04514 | Cell adhesion molecules (CAMs) | 145 | 6841 | 154 | 7580 | 0.06 |
| ko04370 | VEGF signaling pathway | 58 | 6841 | 60 | 7580 | 0.06 |
| ko04730 | Long-term depression | 58 | 6841 | 60 | 7580 | 0.06 |
| ko04727 | GABAergic synapse | 84 | 6841 | 88 | 7580 | 0.06 |
| ko04971 | Gastric acid secretion | 71 | 6841 | 74 | 7580 | 0.06 |
| ko04917 | Prolactin signaling pathway | 71 | 6841 | 74 | 7580 | 0.06 |
| ko05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 71 | 6841 | 74 | 7580 | 0.06 |
document location: Final_Report/Target_Enrichment_Analysis/Target_Enrichment/4_KEGG_significant.xlsx
Target gene of KEGG enrichment analysis:
| KEGG ID | Transcript ID | Gene ID | Symbol | Gene Annoation | miRNA | KEGG Name | Pvalue of Fisher's Exact Test |
| ko04310 | ENSMUST00000020349 | ENSMUSG00000020135 | Apc2 | adenomatosis polyposis coli 2 [Source:MGI Symbol;Acc:MGI:1346052] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000105359 | ENSMUSG00000020135 | Apc2 | adenomatosis polyposis coli 2 [Source:MGI Symbol;Acc:MGI:1346052] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000020634 | ENSMUSG00000020366 | Mapk9 | mitogen-activated protein kinase 9 [Source:MGI Symbol;Acc:MGI:1346862] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000102778 | ENSMUSG00000020366 | Mapk9 | mitogen-activated protein kinase 9 [Source:MGI Symbol;Acc:MGI:1346862] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000109179 | ENSMUSG00000020366 | Mapk9 | mitogen-activated protein kinase 9 [Source:MGI Symbol;Acc:MGI:1346862] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000164643 | ENSMUSG00000020366 | Mapk9 | mitogen-activated protein kinase 9 [Source:MGI Symbol;Acc:MGI:1346862] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000178543 | ENSMUSG00000020366 | Mapk9 | mitogen-activated protein kinase 9 [Source:MGI Symbol;Acc:MGI:1346862] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000020904 | ENSMUSG00000020580 | Rock2 | Rho-associated coiled-coil containing protein kinase 2 [Source:MGI Symbol;Acc:MGI:107926] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000022504 | ENSMUSG00000021936 | Mapk8 | mitogen-activated protein kinase 8 [Source:MGI Symbol;Acc:MGI:1346861] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000111945 | ENSMUSG00000021936 | Mapk8 | mitogen-activated protein kinase 8 [Source:MGI Symbol;Acc:MGI:1346861] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000025075 | ENSMUSG00000024232 | Bambi | BMP and activin membrane-bound inhibitor [Source:MGI Symbol;Acc:MGI:1915260] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000041163 | ENSMUSG00000036961 | Wnt8b | wingless-type MMTV integration site family, member 8B [Source:MGI Symbol;Acc:MGI:109485] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000086854 | ENSMUSG00000046709 | Mapk10 | mitogen-activated protein kinase 10 [Source:MGI Symbol;Acc:MGI:1346863] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000112846 | ENSMUSG00000046709 | Mapk10 | mitogen-activated protein kinase 10 [Source:MGI Symbol;Acc:MGI:1346863] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000112847 | ENSMUSG00000046709 | Mapk10 | mitogen-activated protein kinase 10 [Source:MGI Symbol;Acc:MGI:1346863] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000112848 | ENSMUSG00000046709 | Mapk10 | mitogen-activated protein kinase 10 [Source:MGI Symbol;Acc:MGI:1346863] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000170792 | ENSMUSG00000046709 | Mapk10 | mitogen-activated protein kinase 10 [Source:MGI Symbol;Acc:MGI:1346863] | mmu-miR-24-2-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000133689 | ENSMUSG00000006932 | Ctnnb1 | catenin (cadherin associated protein), beta 1 [Source:MGI Symbol;Acc:MGI:88276] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000154356 | ENSMUSG00000006932 | Ctnnb1 | catenin (cadherin associated protein), beta 1 [Source:MGI Symbol;Acc:MGI:88276] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000163844 | ENSMUSG00000006932 | Ctnnb1 | catenin (cadherin associated protein), beta 1 [Source:MGI Symbol;Acc:MGI:88276] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000007959 | ENSMUSG00000007815 | Rhoa | ras homolog family member A [Source:MGI Symbol;Acc:MGI:1096342] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000071816 | ENSMUSG00000021820 | Camk2g | calcium/calmodulin-dependent protein kinase II gamma [Source:MGI Symbol;Acc:MGI:88259] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000080440 | ENSMUSG00000021820 | Camk2g | calcium/calmodulin-dependent protein kinase II gamma [Source:MGI Symbol;Acc:MGI:88259] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000100837 | ENSMUSG00000021820 | Camk2g | calcium/calmodulin-dependent protein kinase II gamma [Source:MGI Symbol;Acc:MGI:88259] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000063465 | ENSMUSG00000021994 | Wnt5a | wingless-type MMTV integration site family, member 5A [Source:MGI Symbol;Acc:MGI:98958] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000112272 | ENSMUSG00000021994 | Wnt5a | wingless-type MMTV integration site family, member 5A [Source:MGI Symbol;Acc:MGI:98958] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000030839 | ENSMUSG00000028988 | Ctnnbip1 | catenin beta interacting protein 1 [Source:MGI Symbol;Acc:MGI:1915756] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000109308 | ENSMUSG00000031902 | Nfatc3 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3 [Source:MGI Symbol;Acc:MGI:103296] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000211991 | ENSMUSG00000031902 | Nfatc3 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3 [Source:MGI Symbol;Acc:MGI:103296] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000043214 | ENSMUSG00000033220 | Rac2 | RAS-related C3 botulinum substrate 2 [Source:MGI Symbol;Acc:MGI:97846] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000006716 | ENSMUSG00000033227 | Wnt6 | wingless-type MMTV integration site family, member 6 [Source:MGI Symbol;Acc:MGI:98960] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000054294 | ENSMUSG00000044674 | Fzd1 | frizzled class receptor 1 [Source:MGI Symbol;Acc:MGI:1196625] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000089752 | ENSMUSG00000053754 | Chd8 | chromodomain helicase DNA binding protein 8 [Source:MGI Symbol;Acc:MGI:1915022] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000149975 | ENSMUSG00000053754 | Chd8 | chromodomain helicase DNA binding protein 8 [Source:MGI Symbol;Acc:MGI:1915022] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000200169 | ENSMUSG00000053754 | Chd8 | chromodomain helicase DNA binding protein 8 [Source:MGI Symbol;Acc:MGI:1915022] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000099224 | ENSMUSG00000074698 | Csnk2a1 | casein kinase 2, alpha 1 polypeptide [Source:MGI Symbol;Acc:MGI:88543] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000203081 | ENSMUSG00000078816 | Prkcg | protein kinase C, gamma [Source:MGI Symbol;Acc:MGI:97597] | mmu-miR-8114 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000080537 | ENSMUSG00000001847 | Rac1 | RAS-related C3 botulinum substrate 1 [Source:MGI Symbol;Acc:MGI:97845] | mmu-miR-451a_R+1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000100489 | ENSMUSG00000001847 | Rac1 | RAS-related C3 botulinum substrate 1 [Source:MGI Symbol;Acc:MGI:97845] | mmu-miR-451a_R+1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000022971 | ENSMUSG00000022346 | Myc | myelocytomatosis oncogene [Source:MGI Symbol;Acc:MGI:97250] | mmu-miR-451a_R+1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000159327 | ENSMUSG00000022346 | Myc | myelocytomatosis oncogene [Source:MGI Symbol;Acc:MGI:97250] | mmu-miR-451a_R+1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000160009 | ENSMUSG00000022346 | Myc | myelocytomatosis oncogene [Source:MGI Symbol;Acc:MGI:97250] | mmu-miR-451a_R+1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000161976 | ENSMUSG00000022346 | Myc | myelocytomatosis oncogene [Source:MGI Symbol;Acc:MGI:97250] | mmu-miR-451a_R+1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000167731 | ENSMUSG00000022346 | Myc | myelocytomatosis oncogene [Source:MGI Symbol;Acc:MGI:97250] | mmu-miR-451a_R+1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000023015 | ENSMUSG00000022382 | Wnt7b | wingless-type MMTV integration site family, member 7B [Source:MGI Symbol;Acc:MGI:98962] | mmu-miR-451a_R+1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000109424 | ENSMUSG00000022382 | Wnt7b | wingless-type MMTV integration site family, member 7B [Source:MGI Symbol;Acc:MGI:98962] | mmu-miR-451a_R+1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000167968 | ENSMUSG00000022382 | Wnt7b | wingless-type MMTV integration site family, member 7B [Source:MGI Symbol;Acc:MGI:98962] | mmu-miR-451a_R+1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000080537 | ENSMUSG00000001847 | Rac1 | RAS-related C3 botulinum substrate 1 [Source:MGI Symbol;Acc:MGI:97845] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000010941 | ENSMUSG00000010797 | Wnt2 | wingless-type MMTV integration site family, member 2 [Source:MGI Symbol;Acc:MGI:98954] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000142739 | ENSMUSG00000017376 | Nlk | nemo like kinase [Source:MGI Symbol;Acc:MGI:1201387] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000018630 | ENSMUSG00000018486 | Wnt9b | wingless-type MMTV integration site family, member 9B [Source:MGI Symbol;Acc:MGI:1197020] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000022906 | ENSMUSG00000022297 | Fzd6 | frizzled class receptor 6 [Source:MGI Symbol;Acc:MGI:108474] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000179165 | ENSMUSG00000022297 | Fzd6 | frizzled class receptor 6 [Source:MGI Symbol;Acc:MGI:108474] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000023015 | ENSMUSG00000022382 | Wnt7b | wingless-type MMTV integration site family, member 7B [Source:MGI Symbol;Acc:MGI:98962] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000109424 | ENSMUSG00000022382 | Wnt7b | wingless-type MMTV integration site family, member 7B [Source:MGI Symbol;Acc:MGI:98962] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000167968 | ENSMUSG00000022382 | Wnt7b | wingless-type MMTV integration site family, member 7B [Source:MGI Symbol;Acc:MGI:98962] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000023507 | ENSMUSG00000022812 | Gsk3b | glycogen synthase kinase 3 beta [Source:MGI Symbol;Acc:MGI:1861437] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000114750 | ENSMUSG00000022812 | Gsk3b | glycogen synthase kinase 3 beta [Source:MGI Symbol;Acc:MGI:1861437] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000172271 | ENSMUSG00000023411 | Nfatc4 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 [Source:MGI Symbol;Acc:MGI:1920431] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000025075 | ENSMUSG00000024232 | Bambi | BMP and activin membrane-bound inhibitor [Source:MGI Symbol;Acc:MGI:1915260] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000176867 | ENSMUSG00000024913 | Lrp5 | low density lipoprotein receptor-related protein 5 [Source:MGI Symbol;Acc:MGI:1278315] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000065601 | ENSMUSG00000025217 | Btrc | beta-transducin repeat containing protein [Source:MGI Symbol;Acc:MGI:1338871] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000111936 | ENSMUSG00000025217 | Btrc | beta-transducin repeat containing protein [Source:MGI Symbol;Acc:MGI:1338871] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000037607 | ENSMUSG00000028284 | Map3k7 | mitogen-activated protein kinase kinase kinase 7 [Source:MGI Symbol;Acc:MGI:1346877] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000080933 | ENSMUSG00000028284 | Map3k7 | mitogen-activated protein kinase kinase kinase 7 [Source:MGI Symbol;Acc:MGI:1346877] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000108183 | ENSMUSG00000028284 | Map3k7 | mitogen-activated protein kinase kinase kinase 7 [Source:MGI Symbol;Acc:MGI:1346877] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000108184 | ENSMUSG00000028284 | Map3k7 | mitogen-activated protein kinase kinase kinase 7 [Source:MGI Symbol;Acc:MGI:1346877] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000030839 | ENSMUSG00000028988 | Ctnnbip1 | catenin beta interacting protein 1 [Source:MGI Symbol;Acc:MGI:1915756] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000032180 | ENSMUSG00000030093 | Wnt7a | wingless-type MMTV integration site family, member 7A [Source:MGI Symbol;Acc:MGI:98961] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000034086 | ENSMUSG00000031661 | Nkd1 | naked cuticle 1 homolog (Drosophila) [Source:MGI Symbol;Acc:MGI:2135954] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000034973 | ENSMUSG00000032402 | Smad3 | SMAD family member 3 [Source:MGI Symbol;Acc:MGI:1201674] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000078049 | ENSMUSG00000033016 | Nfatc1 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 [Source:MGI Symbol;Acc:MGI:102469] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000167977 | ENSMUSG00000033016 | Nfatc1 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 [Source:MGI Symbol;Acc:MGI:102469] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000170905 | ENSMUSG00000033016 | Nfatc1 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 [Source:MGI Symbol;Acc:MGI:102469] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000041163 | ENSMUSG00000036961 | Wnt8b | wingless-type MMTV integration site family, member 8B [Source:MGI Symbol;Acc:MGI:109485] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000063982 | ENSMUSG00000045005 | Fzd5 | frizzled class receptor 5 [Source:MGI Symbol;Acc:MGI:108571] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000056919 | ENSMUSG00000046707 | Csnk2a2 | casein kinase 2, alpha prime polypeptide [Source:MGI Symbol;Acc:MGI:88547] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000086854 | ENSMUSG00000046709 | Mapk10 | mitogen-activated protein kinase 10 [Source:MGI Symbol;Acc:MGI:1346863] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000112847 | ENSMUSG00000046709 | Mapk10 | mitogen-activated protein kinase 10 [Source:MGI Symbol;Acc:MGI:1346863] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000112848 | ENSMUSG00000046709 | Mapk10 | mitogen-activated protein kinase 10 [Source:MGI Symbol;Acc:MGI:1346863] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000170792 | ENSMUSG00000046709 | Mapk10 | mitogen-activated protein kinase 10 [Source:MGI Symbol;Acc:MGI:1346863] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000058755 | ENSMUSG00000049791 | Fzd4 | frizzled class receptor 4 [Source:MGI Symbol;Acc:MGI:108520] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000059595 | ENSMUSG00000050965 | Prkca | protein kinase C, alpha [Source:MGI Symbol;Acc:MGI:97595] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000099224 | ENSMUSG00000074698 | Csnk2a1 | casein kinase 2, alpha 1 polypeptide [Source:MGI Symbol;Acc:MGI:88543] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000117102 | ENSMUSG00000081683 | Fzd10 | frizzled class receptor 10 [Source:MGI Symbol;Acc:MGI:2136761] | mmu-miR-199a-5p | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000000127 | ENSMUSG00000000125 | Wnt3 | wingless-type MMTV integration site family, member 3 [Source:MGI Symbol;Acc:MGI:98955] | mmu-miR-1968-5p_R-1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000086844 | ENSMUSG00000000782 | Tcf7 | transcription factor 7, T cell specific [Source:MGI Symbol;Acc:MGI:98507] | mmu-miR-1968-5p_R-1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000109071 | ENSMUSG00000000782 | Tcf7 | transcription factor 7, T cell specific [Source:MGI Symbol;Acc:MGI:98507] | mmu-miR-1968-5p_R-1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000005606 | ENSMUSG00000005469 | Prkaca | protein kinase, cAMP dependent, catalytic, alpha [Source:MGI Symbol;Acc:MGI:97592] | mmu-miR-1968-5p_R-1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000165590 | ENSMUSG00000005871 | Apc | adenomatosis polyposis coli [Source:MGI Symbol;Acc:MGI:88039] | mmu-miR-1968-5p_R-1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000154356 | ENSMUSG00000006932 | Ctnnb1 | catenin (cadherin associated protein), beta 1 [Source:MGI Symbol;Acc:MGI:88276] | mmu-miR-1968-5p_R-1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000163844 | ENSMUSG00000006932 | Ctnnb1 | catenin (cadherin associated protein), beta 1 [Source:MGI Symbol;Acc:MGI:88276] | mmu-miR-1968-5p_R-1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000165240 | ENSMUSG00000015957 | Wnt11 | wingless-type MMTV integration site family, member 11 [Source:MGI Symbol;Acc:MGI:101948] | mmu-miR-1968-5p_R-1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000018966 | ENSMUSG00000018822 | Sfrp5 | secreted frizzled-related sequence protein 5 [Source:MGI Symbol;Acc:MGI:1860298] | mmu-miR-1968-5p_R-1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000022051 | ENSMUSG00000021567 | Nkd2 | naked cuticle 2 homolog (Drosophila) [Source:MGI Symbol;Acc:MGI:1919543] | mmu-miR-1968-5p_R-1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000118096 | ENSMUSG00000021567 | Nkd2 | naked cuticle 2 homolog (Drosophila) [Source:MGI Symbol;Acc:MGI:1919543] | mmu-miR-1968-5p_R-1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000023015 | ENSMUSG00000022382 | Wnt7b | wingless-type MMTV integration site family, member 7B [Source:MGI Symbol;Acc:MGI:98962] | mmu-miR-1968-5p_R-1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000109424 | ENSMUSG00000022382 | Wnt7b | wingless-type MMTV integration site family, member 7B [Source:MGI Symbol;Acc:MGI:98962] | mmu-miR-1968-5p_R-1 | Wnt signaling pathway | 4.53e-07 |
| ko04310 | ENSMUST00000167968 | ENSMUSG00000022382 | Wnt7b | wingless-type MMTV integration site family, member 7B [Source:MGI Symbol;Acc:MGI:98962] | mmu-miR-1968-5p_R-1 | Wnt signaling pathway | 4.53e-07 |
document location: Final_Report/Target_Enrichment_Analysis/Target_Enrichment/4_KEGG_miRNA_Gene.xlsx
Scatterplot of enriched KEGG pathways:
Number of target genes enriched in KEGG pathway, p value and rich factor are shown in scatterplot. Rich factor=(number of target genes in KEGG pathway)/(total number of genes in KEGG pathway). The larger rich factor is, the higher enrichment is.
document location: Final_Report/Target_Enrichment_Analysis/Target_Enrichments/KEGG_enrichment_scatterplot.pdf
KEGG pathway maps:
Graphical map objects
The KEGG pathway map is a moleculalr interaction/reaction network diagram represented in terms of the KEGG Orthology (KO) groups, so that experimental evidence in specific organisms can be generalized to other organisms through genomic information. Each map is manually drawn with in-house software called KegSketch, which generates the KGML+ file. This file is an SVG file containing graphics objects that are associated with KEGG objects (see KEGG object identifiers). Basic graphics objects in the reference KEGG pathway maps are:
boxes - ortholog (KO) groups identified by K numbers and, in metabolic maps, reactions identified by R numbers as well
circles - other molecules, usually chemical compounds identified by C numbers, but including glycans identified by G numbers
lines - reactions identified by R numbers in metabolic maps; ortholog (KO) groups identified by K numbers in global metabolism maps
and in organism specific pathway maps that are computationally generated:
boxes - genes or gene products identified by the combination of the KEGG organism code and gene identifiers
These map objects can be searched in the search box at the top of the KEGG PATHWAY page, in the search box in each pathway map, and by the KEGG Mapper tools.
Convention of map number prefix
Each pathway map is identified by the combination of 2-4 letter code and 5 digit number (see KEGG Identifiers). The prefix has the following meaning:
map - Reference pathway
ko - Reference pathway (KO)
ec - Reference pathway (EC)
rn - Reference pathway (Reaction)
org - Organism-specific pathway map
Only the first reference pathway map is manually drawn; all other maps are computationally generated. For metabolic pathways, each box (or line) in the reference map is linked to the K number (KO identifeir), the EC number, and the R number (reaction identifier). The KO, EC, and reaction maps are linked to only one of them. For all metabolic and non-metabolic maps, K numbers are converted to gene identifiers in each organism to generate organism-specific pathways.
As shown above, "map" pathways are not colored, "ko/ec/rn" pathways are colored blue, and organism-specific pathways are colored green, where coloring indicates that map objects exist and are linked to corresponding entries. For global metabolism maps, "map" pathways are fully colored, so that "ko/ec/rn" pathways and organism-specific pathways are generated by reducing the coloring indicating the absence of corresponding entries.
In this study, all KEGG pathway maps were deposited in Final_Report/Target_Enrichment_Analysis/KEGG_Pictures/.
Cytoscape is an open source software platform for visualizing molecular interaction networks and biological pathways and integrating these networks with annotations, gene expression profiles and other state data. Node files and edge files (Core elements in cytoscape) are deposited in /Final_Report /Target_Enrichment_Analysis /Network_Result /Node_info/ and Final_Report /Target_Enrichment_Analysis /Network_Result /Network. After opening Cytoscape software, you could click File->Import->Network->File to load edge files and File->Import->Style to load node files. For more details, please browse http://manual.cytoscape.org/en/stable/index.html or download manual from Cytoscape3_6_0Manual/pdf.
[1] Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem., 2010, 79: 351-379.
[2] Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu. Rev. Med., 2009, 60: 167-179.
[3] Axtell MJ. Classification and comparison of small RNAs from plants. Annu. Rev. Plant Biol., 2013, 64: 137-159.
[4] Jones-Rhoades MW, Bartel DP, Bartel B. MicroRNAs and their regulatory roles in plants. Annu. Rev. Plant Biol., 2006, 57: 19-53.
[5] Sun W, Julie Li Y-S, Huang H-D et al. microRNA: a master regulator of cellular processes for bioengineering systems. Annu. Rev. Biomed. Eng., 2010, 12: 1-27.
[6] Iwakawa H-o, Tomari Y. The functions of microRNAs: mRNA decay and translational repression. Trends Cell Biol., 2015, 25(11): 651-665.
[7] Agarwal V, Bell GW, Nam J-W et al. Predicting effective microRNA target sites in mammalian mRNAs. elife, 2015, 4: e05005.
[8] Friedman RC, Farh KK-H, Burge CB et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 2009, 19(1): 92-105.
[9] Nam J-W, Rissland OS, Koppstein D et al. Global analyses of the effect of different cellular contexts on microRNA targeting.Mol. Cell., 2014, 53(6): 1031-1043.
[10] Betel D, Koppal A, Agius P et al. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol., 2010, 11(8): R90.
[11] Betel D, Wilson M, Gabow A et al. The microRNA. org resource: targets and expression. Nucleic Acids Res., 2008, 36(suppl 1): D149-D153.
[12] Enright AJ, John B, Gaul U et al. MicroRNA targets in Drosophila. Genome Biol., 2003, 5(1): R1.
[13] Dai X, Zhao PX. psRNATarget: a plant small RNA target analysis server. Nucleic Acids Res., 2011, 39(suppl 2): W155-W159.
[14] Franceschini, A., et al. Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens. PNAS, 2014, 111(12), 4548-4553.
[15] Zhou, L., Canagarajah, B., Zhao, Y., Baibakov, B., Tokuhiro, K., Maric, D., & Dean, J. BTBD18 Regulates a Subset of piRNA-Generating Loci through Transcription Elongation in Mice. Developmental Cell, 2017, 40(5), 453-466.
[16] Han, X., et al. Integration of small RNAs, degradome and transcriptome sequencing in hyperaccumulator Sedum alfredii uncovers a complex regulatory network and provides insights into cadmium phytoremediation. Plant Biotech. J., 2015, 14(6), 1470-1483
2575 West Bellfort Street
Suite 270
Houston, TX
77054 USA
Local (713) 664-7087
Toll Free: 1-888-528-8818
Fax: (713) 664-8181